Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 01, 2024 | Jun. 30, 2023 | |
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Registrant Name | FISCALNOTE HOLDINGS, INC. | ||
Entity Central Index Key | 0001823466 | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Accelerated Filer | ||
Entity Shell Company | false | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Entity File Number | 001-396972 | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 88-3772307 | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Address, Address Line One | 1201 Pennsylvania Avenue NW, 6th Floor | ||
Entity Address, City or Town | Washington, D.C. | ||
Entity Address, State or Province | WA | ||
Entity Address, Postal Zip Code | 20004 | ||
City Area Code | 202 | ||
Local Phone Number | 793-5300 | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Public Float | $ 290,009,098 | ||
Auditor Firm ID | 49 | ||
Auditor Name | RSM US LLP | ||
Auditor Location | McLean, Virginia | ||
Documents Incorporated by Reference | DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive proxy statement relating to its 2024 Annual Meeting of Stockholders (the “Proxy Statement”) to be filed with the Securities and Exchange Commission pursuant to Regulation 14A, not later than 120 days after the close of the registrant’s fiscal year, are incorporated by reference in Part III of this Annual Report on Form 10-K. Except with respect to information specifically incorporated by reference in this Annual Report on Form 10-K, the Proxy Statement is not deemed to be filed as part of this Annual Report on Form 10-K. | ||
Common Class A | |||
Entity Common Stock, Shares Outstanding | 122,718,798 | ||
Title of 12(b) Security | Class A common stock, par value $0.0001 per share | ||
Trading Symbol | NOTE | ||
Security Exchange Name | NYSE | ||
Common Class B | |||
Entity Common Stock, Shares Outstanding | 8,290,921 | ||
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share | |||
Title of 12(b) Security | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per warrant | ||
Trading Symbol | NOTE.WS | ||
Security Exchange Name | NYSE |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 16,451 | $ 60,388 |
Restricted cash | 849 | 835 |
Short-term investments | 7,134 | |
Accounts receivable, net | 16,931 | 14,909 |
Costs capitalized to obtain revenue contracts, net | 3,326 | 2,794 |
Prepaid expenses | 2,593 | 4,315 |
Other current assets | 2,521 | 2,764 |
Total current assets | 49,805 | 86,005 |
Property and equipment, net | 6,141 | 7,325 |
Capitalized software costs, net | 13,372 | 13,946 |
Noncurrent costs capitalized to obtain revenue contracts, net | 4,257 | 3,976 |
Operating lease assets | 17,782 | 21,005 |
Goodwill | 187,703 | 194,362 |
Customer relationships, net | 53,917 | 56,348 |
Database, net | 18,838 | 21,020 |
Other intangible assets, net | 18,113 | 28,728 |
Other non-current assets | 633 | 442 |
Total assets | 370,561 | 433,157 |
Current liabilities: | ||
Current maturities of long-term debt | 105 | 68 |
Accounts payable and accrued expenses | 12,909 | 13,739 |
Deferred revenue, current portion | 43,530 | 35,569 |
Customer deposits | 3,032 | 3,252 |
Contingent liabilities from acquisitions, current portion | 130 | 696 |
Operating lease liabilities, current portion | 3,066 | 6,709 |
Other current liabilities | 2,878 | 2,079 |
Total current liabilities | 65,650 | 62,112 |
Long-term debt, net of current maturities | 222,310 | 161,980 |
Deferred tax liabilities | 2,178 | 714 |
Deferred revenue, net of current portion | 875 | 918 |
Contingent liabilities from acquisitions, net of current portion | 883 | |
Operating lease liabilities, net of current portion | 26,162 | 29,110 |
Public and private warrant liabilities | 4,761 | 18,892 |
Other non-current liabilities | 5,166 | 13,858 |
Total liabilities | 327,102 | 288,467 |
Commitment and contingencies (Note 18) | ||
Stockholders' equity: | ||
Additional paid-in capital | 860,485 | 846,205 |
Accumulated other comprehensive loss | (622) | (785) |
Accumulated deficit | (816,416) | (700,743) |
Total stockholders' equity | 43,459 | 144,690 |
Total liabilities and stockholders' equity | 370,561 | 433,157 |
Common Class A | ||
Stockholders' equity: | ||
Common stock value | 11 | 12 |
Common Class B | ||
Stockholders' equity: | ||
Common stock value | $ 1 | $ 1 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Common Class A | ||
Common stock par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 1,700,000,000 | 1,700,000,000 |
Common stock, shares, issued | 121,679,829 | 123,125,595 |
Common stock, shares, outstanding | 121,679,829 | 123,125,595 |
Common Class B | ||
Common stock par value | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 9,000,000 | 9,000,000 |
Common stock, shares, issued | 8,290,921 | 8,290,921 |
Common stock, shares, outstanding | 8,290,921 | 8,290,921 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | ||
Revenues: | |||
Total revenues | $ 132,645 | $ 113,765 | |
Operating expenses: | |||
Cost of revenues | [1] | 40,251 | 31,937 |
Research and development | [1] | 18,186 | 20,736 |
Sales and marketing | [1] | 45,722 | 42,678 |
Editorial | [1] | 17,869 | 15,956 |
General and administrative | [1] | 65,550 | 77,801 |
Amortization of intangible assets | [1] | 11,509 | 10,451 |
Impairment of goodwill and other long-lived assets | [1] | 32,064 | |
Transaction (gains) costs, net | [1] | (767) | 2,395 |
Total operating expenses | [1] | 230,384 | 201,954 |
Operating loss | (97,739) | (88,189) | |
Interest expense, net | 29,940 | 95,741 | |
Change in fair value of financial instruments | (15,983) | (12,747) | |
Gain on PPP loan upon extinguishment | (7,667) | ||
Loss on debt extinguishment, net | 45,250 | ||
Loss on settlement | 3,474 | 11,700 | |
Other expense, net | 68 | 1,045 | |
Net loss before income taxes | (115,238) | (221,511) | |
Provision (benefit) from income taxes | 223 | (3,254) | |
Net loss | (115,461) | (218,257) | |
Other comprehensive income (loss) | 163 | (154) | |
Total comprehensive loss | (115,298) | (218,411) | |
Net loss | (115,461) | (218,257) | |
Deemed dividend | (26,570) | ||
Net loss used to compute basic loss per share | (115,461) | (244,827) | |
Net loss used to compute diluted loss per share | $ (115,461) | $ (244,827) | |
Earnings (loss) per share attributable to common shareholders: | |||
Basic | $ (0.88) | $ (3.68) | |
Diluted | $ (0.88) | $ (3.68) | |
Weighted average shares used in computing earnings (loss) per share attributable to common shareholders: | |||
Basic | 131,400,109 | 66,513,704 | |
Diluted | 131,400,109 | 66,513,704 | |
Subscription | |||
Revenues: | |||
Total revenues | $ 119,082 | $ 100,522 | |
Advisory, advertising, and other | |||
Revenues: | |||
Total revenues | $ 13,563 | $ 13,243 | |
[1] (1) Amounts include stock-based compensation expenses, as follows: Years Ended December 31, 2023 2022 Cost of revenues $ 283 $ 81 Research and development 1,384 1,007 Sales and marketing 2,057 762 Editorial 400 603 General and administrative 22,933 35,594 |
Consolidated Statements of Op_2
Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) (Unaudited) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Stock-based compensation expenses | $ 1,803 | |
Cost of Revenues | ||
Stock-based compensation expenses | 283 | $ 81 |
Research and Development | ||
Stock-based compensation expenses | 1,384 | 1,007 |
Sales and Marketing Expense | ||
Stock-based compensation expenses | 2,057 | 762 |
Editorial | ||
Stock-based compensation expenses | 400 | 603 |
General and Administrative | ||
Stock-based compensation expenses | $ 22,933 | $ 35,594 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands | Total | Cumulative-Effect Adjustment | Common Class A | Class A Common Stock and Class B Common Stock | Preferred Stock | Preferred Stock Common Class A | Common Stock | Common Stock Common Class A | Common Stock Class A Common Stock and Class B Common Stock | Additional Paid-in Capital | Additional Paid-in Capital Common Class A | Additional Paid-in Capital Class A Common Stock and Class B Common Stock | Accumulated Other Comprehensive Loss | Accumulated Deficit | Accumulated Deficit Cumulative-Effect Adjustment | Accumulated Deficit Common Class A |
Beginning Balance at Dec. 31, 2021 | $ (482,045) | $ (631) | $ (481,414) | |||||||||||||
Balance, shares at Dec. 31, 2021 | 49,552,808 | |||||||||||||||
Balance at Dec. 31, 2021 | $ 449,211 | |||||||||||||||
Balance, shares at Dec. 31, 2021 | 18,346,466 | |||||||||||||||
Change in par value | $ 2 | $ (2) | ||||||||||||||
Accretion of preferred stock to redemption value | $ 26,570 | |||||||||||||||
Accretion of preferred stock to redemption value | (26,570) | (24,351) | (2,219) | |||||||||||||
Issuance of Class A Common Stock upon redemption of preferred stock | $ 475,781 | $ (475,781) | $ 5 | $ 475,776 | ||||||||||||
Issuance of Class A Common Stock upon redemption of preferred stock, shares | (49,552,808) | 47,595,134 | ||||||||||||||
Issuance of Class A Common Stock upon exercise of public warrants | 4,763 | 4,763 | ||||||||||||||
Issuance of common stock upon exercise of public warrants, shares | 614,478 | |||||||||||||||
Issuance of Class A common stock upon vesting of restricted share units, shares | 305,671 | |||||||||||||||
Exercise of stock options | 453 | 86 | $ 367 | |||||||||||||
Exercise of stock options, shares | 821,117 | |||||||||||||||
Shares issued in business acquisitions | 8,590 | $ 346,797 | $ 6 | 8,590 | $ 346,791 | |||||||||||
Shares issued in business acquisitions, shares | 859,016 | 62,664,098 | ||||||||||||||
Repurchase of common stock (Note 18) | (88) | (88) | ||||||||||||||
Repurchase of common stock, shares (Note 18) | (9,785) | |||||||||||||||
Stock-based compensation expense | 38,090 | 37,222 | 868 | |||||||||||||
Stock-based compensation expense, shares | 220,321 | |||||||||||||||
Withholding taxes on net share settlement of stock-based compensation and option exercises | (2,670) | (2,670) | ||||||||||||||
Net loss | (218,257) | (218,257) | ||||||||||||||
Foreign currency translation gain (loss) | (154) | (154) | ||||||||||||||
Ending Balance at Dec. 31, 2022 | 144,690 | $ (212) | $ 13 | 846,205 | (785) | (700,743) | $ (212) | |||||||||
Balance, share at Dec. 31, 2022 | 131,416,516 | |||||||||||||||
Issuance of Class A common stock upon vesting of restricted share units, shares | 1,987,641 | |||||||||||||||
Issuance of Class A common stock upon settlement of contingent consideration | 281 | 281 | ||||||||||||||
Issuance of Class A common stock upon settlement of contingent consideration, shares | 209,261 | |||||||||||||||
Exercise of stock options | 366 | 366 | ||||||||||||||
Exercise of stock options, shares | 251,099 | |||||||||||||||
Return of common stock, value | (21,410) | $ (1) | (21,409) | |||||||||||||
Return of common stock, shares | (5,881,723) | |||||||||||||||
Shares issued in business acquisitions | 9,539 | 9,539 | ||||||||||||||
Shares issued in business acquisitions, shares | 1,885,149 | |||||||||||||||
Issuance of Class A common stock under employee stock purchase plan | $ 318 | $ 318 | ||||||||||||||
Issuance of Class A common stock under employee stock purchase plan, shares | 102,807 | |||||||||||||||
Stock-based compensation expense | 27,057 | 27,057 | ||||||||||||||
Withholding taxes on net share settlement of stock-based compensation and option exercises | (1,872) | (1,872) | ||||||||||||||
Net loss | (115,461) | (115,461) | ||||||||||||||
Foreign currency translation gain (loss) | 163 | 163 | ||||||||||||||
Ending Balance at Dec. 31, 2023 | $ 43,459 | $ 12 | $ 860,485 | $ (622) | $ (816,416) | |||||||||||
Balance, share at Dec. 31, 2023 | 129,970,750 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating Activities: | ||
Net loss | $ (115,461) | $ (218,257) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation | 1,348 | 1,238 |
Amortization of intangible assets and capitalized software development costs | 27,369 | 19,545 |
Amortization of deferred costs to obtain revenue contracts | 3,617 | 2,786 |
Impairment of goodwill and other long-lived assets | 32,064 | |
Non-cash operating lease expense | 3,264 | 6,614 |
Stock-based compensation | 27,057 | 38,047 |
Non-cash earnout benefit | (530) | (238) |
Loss on settlement | 3,474 | 11,700 |
Bad debt expense | 423 | 142 |
Change in fair value of acquisition contingent consideration | (2,043) | (2,121) |
Change in fair value of financial instruments | 15,983 | 12,747 |
Deferred income tax provision (benefit) | 72 | (3,076) |
Paid-in-kind interest, net | 6,060 | 10,958 |
Other non-cash items | 32 | 260 |
Non-cash interest expense | 3,919 | 52,044 |
Loss on debt extinguishment, net | 45,250 | |
Gain on PPP loan forgiveness | (7,667) | |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | (287) | (3,941) |
Prepaid expenses and other current assets | 3,421 | 422 |
Costs capitalized to obtain revenue contracts, net | (4,443) | (4,129) |
Other non-current assets | (180) | (395) |
Accounts payable and accrued expenses | (6,426) | (2,113) |
Deferred revenue | 4,123 | 4,780 |
Customer deposits | (198) | 93 |
Other current liabilities | 269 | (1,938) |
Contingent liabilities from acquisitions, net of current portion | (39) | (1,567) |
Lease liabilities | (6,626) | (8,589) |
Other non-current liabilities | 210 | 274 |
Net cash used in operating activities | (35,494) | (72,625) |
Investing Activities: | ||
Capital expenditures | (7,938) | (11,367) |
Cash paid for business acquisitions, net of cash acquired | (5,010) | 1,125 |
Purchase of investments | (7,369) | |
Net cash used in investing activities | (20,317) | (10,242) |
Financing Activities: | ||
Proceeds from Business Combination | 175,000 | |
Issuance costs of common stock | (45,242) | |
Proceeds from long-term debt, net of issuance costs | 11,500 | 166,014 |
Principal payments of long-term debt | (107) | (189,105) |
Proceeds from exercise of public warrants | 4,498 | |
Proceeds from exercise of stock options and ESPP purchases | 684 | 453 |
Repurchase of common stock | (88) | |
Net cash provided by financing activities | 12,077 | 111,530 |
Effects of exchange rates on cash | (189) | (449) |
Net change in cash, cash equivalents, and restricted cash | (43,923) | 28,214 |
Cash, cash equivalents, and restricted cash, beginning of period | 61,223 | 33,009 |
Cash, cash equivalents, and restricted cash, end of period | 17,300 | 61,223 |
Supplemental Noncash Investing and Financing Activities: | ||
Acquisition of warrant liabilities | 34,947 | |
Accretion of preferred stock to redemption value | 26,570 | |
Issuance of common stock in connection with business acquisitions | 9,539 | 8,590 |
Warrants issued in conjunction with long-term debt issuance | 178 | 436 |
Issuance of common stock upon exercise of public warrants | 265 | |
Fees payable to debt holders settled through increase of debt principal | 100 | |
Property and equipment purchases in accounts payable | 161 | |
Supplemental Cash Flow Activities: | ||
Cash paid for interest | 20,679 | 35,157 |
Cash paid for taxes | $ 55 | 55 |
Class A Common Stock | ||
Supplemental Noncash Investing and Financing Activities: | ||
Issuance of common stock upon redemption of preferred stock | 475,781 | |
Class A Common Stock and Class B Common Stock | ||
Supplemental Noncash Investing and Financing Activities: | ||
Issuance of common stock in connection with Business Combination | $ 346,797 |
Summary of Business and Signifi
Summary of Business and Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Business and Significant Accounting Policies | 1. Summary of Business and Significant Accounting Policies Description of Business FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political and regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C. On July 29, 2022 (the “Closing Date”), the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions (the “Closing”), DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in these notes to the financial statements to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the Closing. Basis of Presentation and Interim Financial Information We accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. This determination was primarily based on: • Old FiscalNote stockholders having the largest voting interest in New FiscalNote; • the board of directors of New FiscalNote having ten members, and Old FiscalNote’s former stockholders having the ability to nominate the majority of the members of the board of directors; • Old FiscalNote management continuing to hold executive management roles for the post-combination company and being responsible for the day-to-day operations; • the post-combination company assuming the Old FiscalNote name; • New FiscalNote maintaining the pre-existing Old FiscalNote headquarters; and • the intended strategy of New FiscalNote being a continuation of Old FiscalNote’s strategy. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded. While DSAC was the legal acquirer in the Business Combination, because Old FiscalNote was determined as the accounting acquirer, the historical financial statements of Old FiscalNote became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in the consolidated financial statements reflect (i) the historical operating results of Old FiscalNote prior to the Business Combination; (ii) the combined results of the Company and Old FiscalNote following the closing of the Business Combination; (iii) the assets and liabilities of Old FiscalNote at their historical cost; and (iv) the Company’s equity structure for all periods presented. In connection with the Business Combination, the Company has converted the equity structure for the periods prior to the Business Combination to reflect the number of shares of New FiscalNote’s common stock issued to Old FiscalNote’s stockholders in connection with the recapitalization transaction based on an exchange ratio of 1.187 (the "Exchange Ratio"), determined pursuant to the terms of the Business Combination . As such, the shares, corresponding capital amounts and earnings per share, as applicable, related to Old FiscalNote’s, convertible preferred stock, and common stock prior to the Business Combination have been retroactively converted as shares by applying the Exchange Ratio. Liquidity Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. The Company's ability to maintain its minimum cash requirement, fund its future cash interest requirements under its senior term loan and fund its operations depend in part on general economic, financial, competitive, legislative, regulatory and other conditions that may be beyond the Company's control. Accordingly, the Company continues to closely monitor expenses to assess whether any immediate, or long-term changes, are necessary to maintain compliance with its financial covenants. The Company’s cash, cash equivalents, restricted cash, and short-term investments were $ 24,434 as of December 31, 2023, compared with $ 61,223 as of December 31, 2022 . Further, the Company had negative working capital (excluding cash, restricted cash, and short-term investments) of $ 40,279 and $ 37,330 at December 31, 2023 and December 31, 2022, respectively, and had an accumulated deficit of $ 816,416 and $ 700,743 as of December 31, 2023 and December 31, 2022, respectively, and has incurred net losses of $ 115,461 and $ 218,257 for the years ended December 31, 2023 and 2022, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development. In addition, as disclosed in Note 9, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants are based on the Company’s current expectations regarding continued growth in revenues, collections, cost structure, current cash burn rate and other operating assumptions. The Company believes our cash on hand at December 31, 2023, net proceeds from the sale of Board.org (see Note 19, Subsequent Events ), proceeds from our expected product sales, and available borrowings under our Senior Term Loan for certain acquisition activity, will be sufficient to meet our obligations and our required covenants for at least the next twelve months from the date of this filing. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management include the determination of: • revenue recognition; • the average period of benefit associated with costs capitalized to obtain revenue contracts; • the fair value of assets acquired and liabilities assumed for business combinations; • the useful lives of intangible assets; • capitalization of software development costs; • valuation of financial instruments; • impairment of goodwill and long-lived assets; • the fair value of certain stock awards issued; • the fair value of certain consideration issued as part of business combinations; • the recognition, measurement, and valuation of current and deferred income taxes and uncertain tax positions; and • the incremental borrowing rate used to calculate lease balances. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, which forms the basis for making judgments about the carrying values of assets and liabilities. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances have been eliminated in consolidation. Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. Over the past several years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence, and reach in various market segments. While the Company has offerings in multiple market segments and operates in multiple countries, the Company’s business operates in one operating segment because the Company’s CODM evaluates the Company’s financial information and resources, and assesses the performance of these resources, on a consolidated basis. Concentrations of Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation. The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success. No single customer accounted for more than 10 % of the Company's accounts receivable balance as of December 31, 2023 and December 31, 2022 . Revenue derived from the U.S. Federal Government was 16 % and 18 % of revenue for the years ended December 31, 2023 and December 31, 2022. As of December 31, 2023 and December 31, 2022 , assets located in the United States were approximately 85 % and 92 % percent of total assets. No vendors and two vendors individually accounted for more than 10 % of the Company’s accounts payable as of December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022 , no vendor and one vendor represented more than 10 % of the total purchases made. Revenue Recognition The Company recognizes revenues upon the satisfaction of its performance obligation(s) (upon transfer of control of promised goods or services to its customers) in an amount that reflects the consideration to which it expects to be entitled to in exchange for those goods or services. The Company has elected to exclude sales and similar taxes from the transaction price. The Company determines the amount of revenue to be recognized through the application of the following steps: (i) identification of contracts with customers, (ii) identification of distinct performance obligations in the contract, (iii) determination of contract transaction price, (iv) allocation of contract transaction price to the performance obligations, and (v) determination of revenue recognition based on timing of satisfaction of the performance obligation(s). The Company derives its revenues from subscription revenue arrangements and advisory, advertising, and other revenues. Subscription Revenue Subscription revenue consists of revenue earned from subscription-based arrangements that provide customers the right to use the Company’s software and products in a cloud-based infrastructure. Subscription revenue is driven primarily by the number of active licenses, the types of products and the price of the subscriptions. The Company also earns subscription-based revenue by licensing to customers its digital content, including transcripts, news and analysis, images, video, and podcast data. Subscription revenue is generally non-refundable regardless of the actual use and is recognized ratably over the non-cancellable contract term beginning on the commencement date of each contract, which is the date the Company’s service is first made available to customers. The Company's contracts with customers may include promises to transfer multiple services. For these contracts, the Company accounts for individual promises separately if they are distinct performance obligations. Determining whether services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the standalone selling price (“SSP”) for each distinct performance obligation. In instances where SSP is not directly observable, such as when the Company does not sell the services separately, the Company determines the SSP using available information, including market conditions and other observable inputs. The Company typically invoices its customers annually. Typical payment terms provide that customers pay within 30 days of invoice. Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue, depending on whether transfer of control to customers has occurred. Deferred revenue results from amounts billed to or cash received from customers in advance of the revenue being recognized. Contract assets represent a conditional right to consideration for satisfied performance obligations that become a receivable when the conditions are satisfied. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collection and are included in other current assets in the accompanying consolidated balance sheets. Advisory, Advertising, and Other Revenues Advisory revenue is typically earned under contracts for specific deliverables and is non-recurring in nature, although the Company may sell different advisory services to repeat customers. One-time advisory revenue is invoiced according to the terms of the contract, usually delivered to the customer over a short period of time, during which revenue is recognized. Advertising revenue is primarily generated by delivering advertising in its publications (Roll Call and CQ) in both print and digital formats. Revenue for print advertising is recognized upon publication of the advertisement. Revenue for digital advertising is recognized over the period of the advertisement or, if the contract contains impression guarantees, based on delivered impressions. Book revenue is recognized when the product is shipped to the customer, which is when control of the product is transferred to the customer. Shipping and handling costs are treated as a fulfillment activity and are expensed as incurred. Events revenue is deferred and only recognized when the event has taken place and is included in other revenues . Costs Capitalized to Obtain Revenue Contracts The Company capitalizes incremental costs of obtaining a contract. Certain sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions incurred for obtaining new contracts are deferred and then amortized as selling and marketing expenses on a straight-line basis over a period of benefit that the Company has determined to be approximately four years . The four-year amortization period was determined based on several factors, including the nature of the technology and proprietary data underlying the services being purchased, customer contract renewal rates and industry competition. The Company updates its estimate of the period of benefit periodically and whenever events or circumstances indicate that the period of benefit could change significantly. Such changes, if any, are accounted for prospectively as a change in estimate. The Company has elected to use a practical expedient to expense commissions for renewal contracts when the renewal period is 12 months or less . The Company does not have material costs to fulfill contracts with customers. Cost of Revenues Cost of revenues primarily consists of expenses related to hosting the Company’s service, the costs of data center capacity, amortization of developed technology and capitalized software development costs, certain fees paid to various third parties for the use of their technology, services, or data, costs of compensation, including bonuses, stock compensation, benefits and other expenses for employees associated with providing professional services and other direct costs of production. Also included in cost of revenues are costs related to develop, publish, print, and deliver publications. Cash, Cash Equivalents, and Restricted Cash The Company considers cash on deposit and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At December 31, 2023 , over 57 % of the Company’s cash and cash equivalents were held at JPMorgan Chase Bank, N.A. In 2017, as an incentive for entering into a lease and building out the Company’s head office in Washington, D.C., the District granted to the Company $ 750 to finance the security deposit of the new office. The Company is required to meet certain covenants, such as maintaining its headquarters in Washington, D.C., and may have to reimburse the District if the covenants are not met. The amount of the grant is reflected as restricted cash, including any interest earned, in the accompanying consolidated balance sheets. Investments The Company has invested in highly liquid investments that have investment-grade ratings. These investments are accounted for at fair value through the consolidated statement of operations. The Company is able to easily liquidate these into cash; accordingly, the Company has presented these investments as available for current operations and are presented as short-term investments within current assets in the condensed consolidated balance sheets. Purchases and sales of short-term investments are classified in the investing section of our consolidated statement of cash flows. Property and Equipment Property and equipment are stated at cost and depreciated on a straight-line basis over the assets’ estimated useful lives, which generally are five years for furniture and fixtures, three years for equipment, and the shorter of the useful life or the lease term for leasehold improvements. Software license fees for externally purchased software are capitalized and amortized over the life of the license. Property and equipment are evaluated for impairment in accordance with management’s policy for finite-lived intangible assets and other long-lived assets (see Note 7, Intangible Assets). Capitalized Software Development Costs The Company capitalizes costs to develop software for internal use, including website development costs, when it is determined the development efforts will result in new or additional functionality or new products. Costs incurred prior to meeting these criteria and costs associated with implementation activities and ongoing maintenance are expensed as incurred and included in operating expenses in the accompanying consolidated statements of operations and comprehensive loss. Costs capitalized as internal use software are amortized on a straight-line basis over an estimated useful life that the Company has determined to be three years . Amortization of capitalized software development costs is included in the costs of revenues in the accompanyi ng consolidated statements of operations and comprehensive loss. Software development costs are evaluated for impairment in accordance with management’s policy for finite-lived intangible assets and other long-lived assets (see Note 7, Intangible Assets). Business Combinations The Company must estimate the fair value of assets acquired and liabilities assumed in a business combination at the acquisition date. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair values of the tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statement of operations and comprehensive loss. Acquisition-Related Intangibles and Other Long-Lived Assets The Company recognizes acquisition-related intangible assets, such as customer relationships and developed technology, in connection with business combinations. The Company amortizes the cost of acquisition-related intangible assets that have finite useful lives generally on a straight-line basis. The Company evaluates acquisition-related intangibles and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of asset groups are measured by a comparison of the carrying amount of an asset group to future undiscounted net cash flows expected to be generated by the asset group. This includes assumptions about future prospects for the business that the asset group relates to and typically involves computations of the estimated future cash flows to be generated by these businesses. Based on these judgments and assumptions, the Company determines whether the Company needs to take an impairment charge to reduce the value of the asset group stated on the Company’s consolidated balance sheets to reflect its estimated fair value. When the Company considers such assets to be impaired, the amount of impairment the Company recognizes is measured by the amount by which the carrying amount of the asset group exceeds its fair value. During the fourth quarter of 2023, the Company recorded non-cash impairment charges totaling $ 6,223 (see Note 7, Intangible Assets). There were no impairments of long-lived assets during the year ended December 31, 2022. Goodwill Impairment Goodwill is not amortized, but is evaluated for impairment annually, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. For purposes of assessing potential impairment, the Company estimates the fair value of its reporting units based on the price a market participant would be willing to pay in a potential sale of the reporting unit, and compares this amount to the carrying value of the reporting unit. If the Company determines that the carrying value of the reporting unit exceeds its fair value, an impairment charge would be required. The annual goodwill impairment test is performed on October 1st. During the year ended December 31, 2023, the Company recorded non-cash goodwill impairment charges totaling $ 25,841 (see Note 8, Goodwill). There were no impairments of goodwill during the year ended December 31, 2022 . Leases The Company determines if an arrangement is a lease or contains a lease at the inception of the contract. The Company’s leases include certain variable lease payments associated with non-lease components, such as common area maintenance costs and real estate taxes, which are generally charged based on actual amounts incurred by the lessor. The non-lease components are combined with the lease component to account for both as a single lease component. Lease liabilities, which represent the Company's obligation to make lease payments arising from the lease, and corresponding right-of-use assets, which represent the Company's right to use an underlying asset for the lease term, are recognized at the commencement date of the lease based on the present value of fixed future payments over the lease term. The Company calculates the present value of future payments using a discount rate equal to the Company’s incremental borrowing rate. For operating leases, lease expense relating to fixed payments is recognized on a straight-line basis over the lease term and lease expense relating to variable payments is expensed as incurred. The Company did no t have any finance leases at January 1, 2022 (date of adoption), December 31, 2022 and at December 31, 2023. The Company records costs associated with leases within general and administrative expenses on the consolidated statements of operations and comprehensive loss. The Company subleases certain leased office spaces to third parties and recognizes sublease income on a straight-line basis over the sublease term as an offset to lease expense as part of the general and administrative expense in the consolidated statements of operations and comprehensive loss. Warrant Liabilities The Company evaluates its financial instruments, including its outstanding warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company has outstanding public and private warrants, both of which do not meet the criteria for equity classification and are accounted for as liabilities. Accordingly, the Company recognizes the warrants as liabilities at fair value and adjusts the warrants to fair value at each reporting period. The warrant liabilities are subject to re-measurement at each balance sheets date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations and comprehensive loss. Stock-Based Compensation Stock-based compensation awards consist of stock options and restricted stock units (collectively “stock-based awards”). The Company has historically issued stock options with exercise prices equal to the fair value of the underlying stock price. Prior to the completion of the Business Combination and listing of the Company’s Class A common stock on the public stock exchange, the fair value of Old FiscalNote common stock underlying the stock options was determined based on then-current valuation estimates at the time of grant. Because such grants occurred prior to the public trading of the Company’s Class A common stock, the fair value of Old FiscalNote common stock was typically determined with assistance of periodic valuation analyses from an independent third-party valuation firm. The Company calculates the fair value of stock options using the Black-Scholes option-pricing model. For share-based awards with performance conditions, the Company periodically assesses whether the performance conditions have been met or are probable of being met in order to determine the timing and amount of compensation expense to be recognized for each reporting period. Compensation expense for all option awards is recorded on a straight-line basis over the requisite service period of the awards, which is generally the option’s vesting period. These amounts are reduced by the forfeitures as the forfeitures occur. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax laws is recognized in the consolidated statements of operations and comprehensive loss in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are expected to be realized based on the weighting of positive and negative evidence. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the applicable tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that the position is sustainable upon examination by the taxing authority, solely based on its technical merits. The tax benefit recognized is measured as the largest amount of benefit which is greater than 50 percent likely to be realized upon settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in the income tax provision. Foreign Currency Translation The functional currency of the Company’s major foreign subsidiaries is generally the local currency. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using historical exchange rates. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as a separate component on the consolidated statements of operations and comprehensive loss. Foreign currency transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive loss for the period and historically have not been material. Currency gains and losses on the translation of intercompany loans made to foreign subsidiaries that are of a long-term investment nature are included in accumulated other comprehensive loss. Related Party Transactions From time to time the Company has entered into related party transactions with certain of the Company's directors and officers. These transactions have historically included term loans, convertible debt, and convertible preferred stock. Fair Value Measurements The Company accounts for assets and liabilities in accordance with accounting standards that define fair value and establish a consistent framework for measuring fair value on either a recurring or a nonrecurring basis. Fair value is an exit price representing the amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Accounting standards include disclosure requirements relating to the fair values used for certain financial instruments and establish a fair value hierarchy. The hierarchy prioritizes valuation inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Assets or liabil |
Business Combination
Business Combination | 12 Months Ended |
Dec. 31, 2023 | |
Business Combination | 4. Business Combinations 2023 Acquisitions Dragonfly Acquisition On January 27, 2023, the Company entered into a Sale and Purchase Agreement for all of the issued and outstanding share capital of Dragonfly Eye Limited ("Dragonfly"), a UK-based SaaS-based geopolitical and security intelligence provider of actionable data and analysis delivered through Dragonfly's SaaS-based, proprietary Security Intelligence and Analysis Service subscription platform and API. The aggregate purchase price consisted of (i) $ 5.6 million in cash (£ 4.5 million pounds sterling), (ii) 1,885,149 shares of the Company’s Class A Common Stock, and (iii) $ 11.1 million (£ 8.9 million pounds sterling) in aggregate principal amount of subordinated convertible promissory notes (“Seller Convertible Notes”). The purchase price was subject to customary adjustments based on working capital and the amount of Dragonfly’s transaction expenses and net indebtedness that remain unpaid as of the closing date, and indemnification obligations for certain claims made following the Closing Date. The Company incurred expenses of $ 1,272 in connection with the transaction during the year ended December 31, 2023 (inclusive of $ 446 of amounts paid on January 27, 2023 that were recognized as expense during the three months ended March 31, 2023). The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236 The Class A common stock issued as consideration as part of the acquisition of Dragonfly represents non-cash activity on the consolidated statement of stockholders equity and consolidated statement of cash flows. Additionally, the sellers were eligible to receive an additional payment from the Company of up to approximately $ 4.3 million, (£ 3.5 ) million pounds sterling, (the “Earnout”) based on the achievement of certain U.S. GAAP revenue targets for 2023 by Dragonfly. In the event any part of the Earnout becomes payable, the Company may satisfy its payment obligations to the sellers with cash or common stock, pursuant to the Sale and Purchase Agreement. The 2023 revenue targets for the earnout were not met. Certain employees of Dragonfly are eligible for employee earnout bonus awards ("Employee Earnout Awards") based on 2024 revenue targets. The Employee Earnout Awards are subject to forfeiture in the event that Dragonfly does not achieve its revenue target or these employees terminate their employment. Any Employee Earnout Awards that are forfeited are reallocated to the other eligible employees. No expense was recognized for such awards for the year ended December 31, 2023. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236 The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 The estimated fair values of the customer relationships, developed technology and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. The purchase price allocation includes UK deferred assets and liabilities for acquired book and tax basis differences. Goodwill recorded for this acquisition is no t tax deductible. 2022 Acquisitions Aicel Acquisition On July 29, 2022, the Company acquired all of the outstanding stock of Seoul, South Korea-based Aicel Technologies (“Aicel”), an AI-driven enterprise SaaS company that delivers market intelligence and data insights. The acquisition consideration of $ 8,678 consisted of 723,684 common shares of Old FiscalNote that were then exchanged into 859,016 Class A common shares of New FiscalNote pursuant to the Exchange Ratio and contingent consideration. Pursuant to the terms of the acquisition agreement, certain of the sellers of Aicel are eligible for additional contingent consideration of 12,491 shares of the Company’s Class A common stock. The Company incurred expenses of approximately $ 300 in connection with the transaction, of which approximately $ 96 was recognized during the year ended December 31, 2021. The acquisition date fair value of the consideration transferred for Aicel consisted of the following: Fair value of Class A common stock $ 8,590 Fair value of contingent consideration 88 Total $ 8,678 The fair value of the Class A common stock issued was estimated based on the fair value of the Company’s common stock on the date of the acquisition. The fair value of the contingent consideration is estimated based on the expected future cash flows and revenues along with the fair value of the Company’s Class A common stock on the date of acquisition. The contingent consideration consists of shares of the Company’s Class A common stock and is scheduled to be delivered within eighteen months upon achievement of certain revenue targets pursuant to the terms of the prevailing purchase agreement. The contingent consideration is payable to certain selling shareholders and contains no future service conditions. The fair value of the contingent consideration was recorded as equity as the number of shares that ultimately may be issued upon achievement of the revenue targets is fixed. Classification as equity requires fair value measurement initially and there are no subsequent re-measurements. Settlement of equity-classified contingent consideration is accounted for within equity. The acquisition also includes contingent payments in the form of up to $ 300 in cash, 28,522 shares of the Company’s Class A common stock on a post-exchange basis and 24,833 of restricted stock upon achievement of certain revenue targets. The common stock, restricted stock and cash portions of the contingent payments will be paid within eighteen months upon achievement of certain revenue targets . The contingent payments are payable to certain employees, contingent on them remaining employed through the contingency payout date. The estimated fair value of the contingent payments on the date of acquisition is considered post-combination compensation expense and recognized based on management’s determination of the likelihood of the revenue targets being met. In the event that compensation expense is recognized and the revenue targets are not met, the previously recognized compensation expense is reversed. Post-combination compensation expense of $ 637 was recognized during the year ended December 31, 2022, $ 300 of which was accrued as a contingent liability and the remainder recorded as equity-based compensation. In December 2022, the $ 300 contingent liability was paid. The Company recorded equity-based compensation related to the restricted stock contingent payments of $ 124 and $ 52 for the year ended December 31, 2023 and December 31, 2022, respectively. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 1,525 Current assets, net 447 Property and equipment, net 53 Equity method investment 45 Intangible assets 3,000 Deferred revenues ( 602 ) Other current liabilities ( 453 ) Debt ( 1,131 ) Total net assets acquired 2,884 Goodwill 5,794 Total purchase price $ 8,678 The excess of the purchase price over the net tangible and intangible assets was recorded as goodwill, which is primarily attributed to the future economic benefits arising from other assets acquired and could not be individually identified and separately recognized including expected synergies and assembled workforce. The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Developed technology $ 1,200 8 Database 750 8 Customer relationships 650 11 Tradename 400 7 Total intangible assets acquired $ 3,000 The estimated fair values of the developed technology, database, customer relationships, and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. DT-Global Asset Acquisition On September 30, 2022, the Company acquired certain assets of DT-Global Business Consulting, a Vienna, Austria subscription-based market intelligence company which provides in-depth expertise and analysis for Central & Eastern Europe, Commonwealth of Independent States, and Middle East-Africa areas. The aggregate purchase price was $ 600 , which included an upfront cash payment of $ 400 and purchase price holdbacks of $ 100 , along with $ 100 of contingent consideration related to operational milestones. The Company accounted for this acquisition as an asset purchase. In connection with the acquisition, the Company incurred direct transaction costs of approximately $ 43 which have been classified as costs of acquisition. The costs of acquisition are allocated to the acquired assets and assumed liabilities based on their fair values at the date of acquisition, and any excess is allocated to intangible assets. The costs of acquisition exceeded the fair value of net assets acquired by approximately $ 1,012 . The Company allocated the $ 1,012 excess to the customer relationship intangible asset. The intangible asset will be amortized over 15 years . As of December 31, 2022, the contingent consideration was determined to be probable and reasonably estimable, the consideration of $ 52 was attributed to the customer relationship intangible asset with a corresponding liability of $ 52 recorded as part of Contingent Liabilities from Acquisitions on the consolidated balance sheets and a payment of the liability of $ 39 was made in January 2023, resulting in a remaining liability of $ 13 as of December 31, 2023 . |
DSAC | |
Business Combination | Note 2. Business Combination with DSAC On July 29, 2022, Old FiscalNote and DSAC consummated the transactions contemplated by the Business Combination Agreement. In connection with the Closing, each share of preferred stock of Old FiscalNote was converted into common stock and, immediately thereafter, each share of common stock of Old FiscalNote that was issued and outstanding immediately prior to the effective time of the Business Combination (other than excluded shares as contemplated by the Business Combination Agreement) was canceled and converted into the right to receive approximately 1.187 shares (the “Exchange Ratio”) of New FiscalNote common stock. The shares of New FiscalNote common stock received as consideration by Tim Hwang, Co-Founder and Chief Executive Officer, and Gerald Yao, Co-Founder, Chief Strategy Officer, and Global Head of ESG (together with Mr. Hwang, the “Co-Founders”), are Class B shares, and entitle the Co-Founders or their permitted transferees to 25 votes per share until the earlier of (a) transfer by the holder(s) of New FiscalNote Class B common stock to any other person, except for specified trusts, retirement accounts, corporations or similar entities formed for financial or estate planning purposes and beneficially owned by the holders of New FiscalNote Class B common stock, (b) the death or incapacity of such holder(s) of New FiscalNote Class B common stock, (c) the date specified by an affirmative vote of a majority of the outstanding New FiscalNote Class B common stock, voting as a single class, (d) the date on which the outstanding shares of New FiscalNote Class B common stock represent less than 50% of the shares of New FiscalNote Class B common stock that were outstanding as of the Closing Date, or (e) the seven-year anniversary of the Closing Date. At the Closing, each option to purchase Old FiscalNote’s common stock, whether vested or unvested, was assumed and converted into an option to purchase a number of shares of New FiscalNote Class A common stock in the manner set forth in the Business Combination Agreement. Each restricted stock unit of Old FiscalNote was assumed and converted into restricted stock units of New FiscalNote settling in a number of New FiscalNote Class A common stock in the manner set forth in the Business Combination Agreement. Pursuant to the terms of the Business Combination Agreement, the holders of Old FiscalNote equity instruments outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of additional shares subject to achievement of certain conditions (see Note 11, Earnout Shares and RSUs). In connection with the Closing, FiscalNote also entered into the $ 150.0 million new senior term loan facility (the “Senior Term Loan”) with Runway Growth Finance Corp., ORIX Growth Capital, LLC, Clover Orochi LLC, and ACM ASOF VIII SaaS FinCo LLC (together the “Senior Lenders”). The Senior Term Loan was consummated simultaneously with the Closing. The Company accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. Refer to Note 1, Summary of Business and Significant Accounting Policies, for further details. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded. Upon the closing of the Transactions and the Senior Term Loan, the Company received total gross proceeds of $ 325.0 million, which consisted of $ 61.0 million from DSAC’s trust, $ 114.0 million from the backstop agreement with the sponsor of DSAC, and $ 150.0 million from the Senior Term Loan. Such gross proceeds were offset by $ 45.2 million transaction costs, which principally consisted of advisory, legal and other professional fees, and were recorded in Additional Paid-in Capital, net of proceeds from the DSAC trust and $ 3.5 million of debt issuance costs paid out of the proceeds of the Senior Term Loan on the Closing Date, of which $ 2.8 million was capitalized and $ 0.7 million included in the loss on debt extinguishment. Cumulative debt repayments, inclusive of accrued but unpaid interest, of $ 210.7 million were paid in conjunction with the close, which consisted of a $ 75.3 million repayment of the First Out Term Loan, $ 61.7 million repayment of the Last Out Term Loan, a $ 50.0 million payment used to retire the non-converting portion of the Senior Secured Subordinated Promissory Note, a $ 16.3 million repayment of the 8090 FV Subordinated Promissory Note, and $ 7.4 million repayment of the 2021 Seller Notes. |
Revenues
Revenues | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Revenues | Note 3. Revenues Disaggregation of Revenue The following table depicts the Company's disaggregated revenue for the periods presented: Years Ended December 31, 2023 2022 Subscription $ 119,082 $ 100,522 Advisory 5,455 4,914 Advertising 1,632 2,703 Books 1,166 736 Other revenue 5,310 4,890 Total $ 132,645 $ 113,765 Revenue by Geographic Locations The following table depicts the Company’s revenue by geographic operations for the periods presented: Years Ended December 31, 2023 2022 North America $ 107,108 $ 98,951 Europe 19,749 10,072 Australia 1,193 1,122 Asia 4,595 3,620 Total $ 132,645 $ 113,765 Revenues by geography are determined based on the region of the Company's contracting entity, which may be different than the region of the customer. North America revenue consists solely of revenue attributed to the United States. For the years ended December 31, 2023 and 2022 , revenue attributed to the United Kingdom represented approximately twelve percent and six percent of total revenues, respectively. No other foreign country represented more than five percent of total revenue during the years ended December 31, 2023 and 2022, respectively. Contract Assets The Company had contract assets of $ 1,183 and $ 1,464 , as of December 31, 2023 and December 31, 2022, respectively. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collections. They represent a conditional right to consideration for satisfied performance obligations that becomes a receivable when the conditions are satisfied. They are recorded as part of other current assets on the consolidated balance sheets. Deferred Revenue Details of the Company’s deferred revenue for the periods presented are as follows: Balance at December 31, 2021 $ 30,097 Acquired deferred revenue 1,055 Revenue recognized in the current period from amounts in the prior balance ( 29,351 ) New deferrals, net of amounts recognized in the current period 35,139 Effects of foreign currency ( 453 ) Balance at December 31, 2022 36,487 Acquired deferred revenue 3,933 Revenue recognized in the current period from amounts in the prior balance ( 35,598 ) New deferrals, net of amounts recognized in the current period 39,220 Effects of foreign currency 363 Balance at December 31, 2023 $ 44,405 Costs to Obtain During the years ended December 31, 2023 and 2022, the Company capitalized $ 4,421 and $ 4,081 of costs to obtain revenue contracts and amortized $ 3,617 and $ 2,786 to sales and marketing expense during the years ended December 31, 2023 and 2022 , respectively. There were no impairments of costs to obtain revenue contracts for the years ended December 31, 2023 and 2022. Unsatisfied Performance Obligations At December 31, 2023, the Company had $ 109,151 of remaining contract consideration for which revenue has not been recognized due to unsatisfied performance obligations. The Company expects to recognize this revenue over the next five years. |
Business Combinations
Business Combinations | 12 Months Ended |
Dec. 31, 2023 | |
Business Combinations [Abstract] | |
Business Combination | 4. Business Combinations 2023 Acquisitions Dragonfly Acquisition On January 27, 2023, the Company entered into a Sale and Purchase Agreement for all of the issued and outstanding share capital of Dragonfly Eye Limited ("Dragonfly"), a UK-based SaaS-based geopolitical and security intelligence provider of actionable data and analysis delivered through Dragonfly's SaaS-based, proprietary Security Intelligence and Analysis Service subscription platform and API. The aggregate purchase price consisted of (i) $ 5.6 million in cash (£ 4.5 million pounds sterling), (ii) 1,885,149 shares of the Company’s Class A Common Stock, and (iii) $ 11.1 million (£ 8.9 million pounds sterling) in aggregate principal amount of subordinated convertible promissory notes (“Seller Convertible Notes”). The purchase price was subject to customary adjustments based on working capital and the amount of Dragonfly’s transaction expenses and net indebtedness that remain unpaid as of the closing date, and indemnification obligations for certain claims made following the Closing Date. The Company incurred expenses of $ 1,272 in connection with the transaction during the year ended December 31, 2023 (inclusive of $ 446 of amounts paid on January 27, 2023 that were recognized as expense during the three months ended March 31, 2023). The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236 The Class A common stock issued as consideration as part of the acquisition of Dragonfly represents non-cash activity on the consolidated statement of stockholders equity and consolidated statement of cash flows. Additionally, the sellers were eligible to receive an additional payment from the Company of up to approximately $ 4.3 million, (£ 3.5 ) million pounds sterling, (the “Earnout”) based on the achievement of certain U.S. GAAP revenue targets for 2023 by Dragonfly. In the event any part of the Earnout becomes payable, the Company may satisfy its payment obligations to the sellers with cash or common stock, pursuant to the Sale and Purchase Agreement. The 2023 revenue targets for the earnout were not met. Certain employees of Dragonfly are eligible for employee earnout bonus awards ("Employee Earnout Awards") based on 2024 revenue targets. The Employee Earnout Awards are subject to forfeiture in the event that Dragonfly does not achieve its revenue target or these employees terminate their employment. Any Employee Earnout Awards that are forfeited are reallocated to the other eligible employees. No expense was recognized for such awards for the year ended December 31, 2023. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236 The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 The estimated fair values of the customer relationships, developed technology and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. The purchase price allocation includes UK deferred assets and liabilities for acquired book and tax basis differences. Goodwill recorded for this acquisition is no t tax deductible. 2022 Acquisitions Aicel Acquisition On July 29, 2022, the Company acquired all of the outstanding stock of Seoul, South Korea-based Aicel Technologies (“Aicel”), an AI-driven enterprise SaaS company that delivers market intelligence and data insights. The acquisition consideration of $ 8,678 consisted of 723,684 common shares of Old FiscalNote that were then exchanged into 859,016 Class A common shares of New FiscalNote pursuant to the Exchange Ratio and contingent consideration. Pursuant to the terms of the acquisition agreement, certain of the sellers of Aicel are eligible for additional contingent consideration of 12,491 shares of the Company’s Class A common stock. The Company incurred expenses of approximately $ 300 in connection with the transaction, of which approximately $ 96 was recognized during the year ended December 31, 2021. The acquisition date fair value of the consideration transferred for Aicel consisted of the following: Fair value of Class A common stock $ 8,590 Fair value of contingent consideration 88 Total $ 8,678 The fair value of the Class A common stock issued was estimated based on the fair value of the Company’s common stock on the date of the acquisition. The fair value of the contingent consideration is estimated based on the expected future cash flows and revenues along with the fair value of the Company’s Class A common stock on the date of acquisition. The contingent consideration consists of shares of the Company’s Class A common stock and is scheduled to be delivered within eighteen months upon achievement of certain revenue targets pursuant to the terms of the prevailing purchase agreement. The contingent consideration is payable to certain selling shareholders and contains no future service conditions. The fair value of the contingent consideration was recorded as equity as the number of shares that ultimately may be issued upon achievement of the revenue targets is fixed. Classification as equity requires fair value measurement initially and there are no subsequent re-measurements. Settlement of equity-classified contingent consideration is accounted for within equity. The acquisition also includes contingent payments in the form of up to $ 300 in cash, 28,522 shares of the Company’s Class A common stock on a post-exchange basis and 24,833 of restricted stock upon achievement of certain revenue targets. The common stock, restricted stock and cash portions of the contingent payments will be paid within eighteen months upon achievement of certain revenue targets . The contingent payments are payable to certain employees, contingent on them remaining employed through the contingency payout date. The estimated fair value of the contingent payments on the date of acquisition is considered post-combination compensation expense and recognized based on management’s determination of the likelihood of the revenue targets being met. In the event that compensation expense is recognized and the revenue targets are not met, the previously recognized compensation expense is reversed. Post-combination compensation expense of $ 637 was recognized during the year ended December 31, 2022, $ 300 of which was accrued as a contingent liability and the remainder recorded as equity-based compensation. In December 2022, the $ 300 contingent liability was paid. The Company recorded equity-based compensation related to the restricted stock contingent payments of $ 124 and $ 52 for the year ended December 31, 2023 and December 31, 2022, respectively. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 1,525 Current assets, net 447 Property and equipment, net 53 Equity method investment 45 Intangible assets 3,000 Deferred revenues ( 602 ) Other current liabilities ( 453 ) Debt ( 1,131 ) Total net assets acquired 2,884 Goodwill 5,794 Total purchase price $ 8,678 The excess of the purchase price over the net tangible and intangible assets was recorded as goodwill, which is primarily attributed to the future economic benefits arising from other assets acquired and could not be individually identified and separately recognized including expected synergies and assembled workforce. The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Developed technology $ 1,200 8 Database 750 8 Customer relationships 650 11 Tradename 400 7 Total intangible assets acquired $ 3,000 The estimated fair values of the developed technology, database, customer relationships, and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. DT-Global Asset Acquisition On September 30, 2022, the Company acquired certain assets of DT-Global Business Consulting, a Vienna, Austria subscription-based market intelligence company which provides in-depth expertise and analysis for Central & Eastern Europe, Commonwealth of Independent States, and Middle East-Africa areas. The aggregate purchase price was $ 600 , which included an upfront cash payment of $ 400 and purchase price holdbacks of $ 100 , along with $ 100 of contingent consideration related to operational milestones. The Company accounted for this acquisition as an asset purchase. In connection with the acquisition, the Company incurred direct transaction costs of approximately $ 43 which have been classified as costs of acquisition. The costs of acquisition are allocated to the acquired assets and assumed liabilities based on their fair values at the date of acquisition, and any excess is allocated to intangible assets. The costs of acquisition exceeded the fair value of net assets acquired by approximately $ 1,012 . The Company allocated the $ 1,012 excess to the customer relationship intangible asset. The intangible asset will be amortized over 15 years . As of December 31, 2022, the contingent consideration was determined to be probable and reasonably estimable, the consideration of $ 52 was attributed to the customer relationship intangible asset with a corresponding liability of $ 52 recorded as part of Contingent Liabilities from Acquisitions on the consolidated balance sheets and a payment of the liability of $ 39 was made in January 2023, resulting in a remaining liability of $ 13 as of December 31, 2023 . |
Leases
Leases | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Leases | Note 5. Leases The Company has operating leases, principally for corporate offices under non-cancelable operating leases. The non-cancellable base terms of these leases typically range from one to nine years . The Company’s lease terms may include options to extend or terminate the lease. The period which is subject to an option to extend or terminate the lease is included in the lease term if it is reasonably certain that the option will be exercised. The following table details the composition of lease expense for the year presented: Year Ended Years Ended December 31, 2023 December 31, 2022 Operating lease cost (a) $ 6,138 $ 9,769 Variable lease cost 841 518 Short-term lease cost 550 1,236 Total lease costs $ 7,529 $ 11,523 Sublease income $ ( 1,442 ) $ ( 5,350 ) (a) Excludes operating lease assets impairment charge of $ 378 related to an unoccupied existing office space lease recorded in the first quarter of 2022. The following tables present the future minimum lease payments and additional information about the Company's lease obligations as of December 31, 2023: 2024 $ 5,402 2025 5,183 2026 5,298 2027 5,288 2028 5,163 Thereafter 13,004 Total minimum lease payments 39,338 Less: Amounts representing interest 10,110 Net minimum lease payments $ 29,228 December 31, 2023 December 31, 2022 Weighted average remaining lease term (in years) 7.2 7.5 Weighted average discount rate 8.5 % 8.5 % The following table presents supplemental cash flow information for the period presented: Year Ended Year Ended December 31, 2023 December 31, 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows for operating leases $ 9,481 $ 11,805 Supplemental noncash information on lease liabilities arising from obtaining operating lease assets: Operating lease assets obtained in exchange for lease obligations $ 272 $ 2,074 In March 2022, the Company ceased use of excess office space under one of its existing leases, with the intent to sublease this space. In accordance with ASC 360, the Company evaluated the asset group for impairment, which included the associated operating lease asset for the office space, as the change in circumstances indicated the carrying amount of the asset group may not be recoverable. The Company compared the expected future undiscounted cash flows for the office space to the carrying amount and determined that it was impaired. The Company recognized the excess of the carrying value over the fair value of the asset group, which totaled $ 378 , as an impairment expense as part of general and administrative expenses on the consolidated statements of operations and comprehensive loss. The impairment charge resulted in a reduction of $ 378 to the operating lease asset. In April 2021, the Company entered into a modification of one of its existing subleases. The Company exercised its termination notification right on this lease which resulted in a termination fee payment of $ 1,682 made on December 31, 2021 (lease termination notice date) and a second termination fee payment of $ 1,682 due on March 31, 2023 (the lease termination effective date). In 2017, as an incentive for entering into a lease and building out the Company’s head office in the District of Columbia, the District authorized a grant to the Company in the amount of $ 750 , which has been disclosed as restricted cash, to finance the security deposit of the new office. The Company is required to meet certain covenants, such as maintaining its headquarters in Washington, D.C. and may have to reimburse the District if the covenants are not met. The Company recorded the grant as a grant liability and will relieve the liability if and when all requirements are met. |
Property, Plant and Equipment
Property, Plant and Equipment | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Note 6. Property, Plant and Equipment The following table details property and equipment as of the dates presented: As of December 31, 2023 2022 Leasehold improvements $ 9,526 $ 9,525 Furniture and fixtures 102 98 Equipment 498 495 Computer equipment 2,332 2,177 Total property and equipment $ 12,458 $ 12,295 Less: accumulated depreciation ( 6,317 ) ( 4,970 ) Total property and equipment, net $ 6,141 $ 7,325 Long-term assets outside of the United States were less than $ 1,000 at both December 31, 2023 and 2022. Depreciation expense was $ 1,348 and $ 1,238 for the years ended December 31, 2023 and 2022 , respectively, and is recorded as part of the general and administrative expenses on the consolidated statements of operations and comprehensive loss. |
Intangible Assets
Intangible Assets | 12 Months Ended |
Dec. 31, 2023 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Intangible Assets | Note 7. Intangible Assets The following table summarizes the gross carrying amounts and accumulated amortization of the Company’s intangible assets by major class: December 31, 2023 December 31, 2022 Weighted Average Gross Carrying Amount Accumulated Amortization Impairment Net Gross Carrying Amount Accumulated Amortization Net Remaining Useful Life (Years) December 31, 2023 Customer relationships $ 88,544 $ ( 32,392 ) $ ( 2,235 ) $ 53,917 $ 81,002 $ ( 24,654 ) $ 56,348 8.3 Developed technology 37,205 ( 26,743 ) ( 1,909 ) 8,553 35,350 ( 17,673 ) 17,677 6.6 Databases 29,895 ( 11,057 ) - 18,838 29,912 ( 8,892 ) 21,020 8.8 Tradenames 12,077 ( 4,367 ) ( 579 ) 7,131 11,480 ( 3,216 ) 8,264 8.3 Expert network 2,692 ( 1,291 ) - 1,401 2,559 ( 800 ) 1,759 3.1 Patents 784 ( 217 ) ( 8 ) 559 700 ( 200 ) 500 17.6 Content library 592 ( 123 ) - 469 592 ( 64 ) 528 7.9 To tal $ 171,789 $ ( 76,190 ) $ ( 4,731 ) $ 90,868 $ 161,595 $ ( 55,499 ) $ 106,096 Finite-lived intangible assets are stated at cost, net of amortization, generally using the straight-line method over the expected useful lives of the intangible assets. Amortization of intangible assets, excluding developed technology, was $ 11,509 and $ 10,451 for the years ended December 31, 2023 and 2022, respectively. Amortization of developed technology was recorded as part of cost of revenues in the amount of $ 8,942 and $ 5,030 for the years ended December 31, 2023 and 2022, respectively. The expected future amortization expense for intangible assets as of December 31, 2023 is as follows: 2024 $ 13,364 2025 11,771 2026 11,481 2027 11,069 2028 9,992 Thereafter 33,191 Total $ 90,868 The Company regularly reviews the remaining useful lives of its intangible assets. In the second quarter of 2023 the Company revised the remaining useful life of certain developed technologies. Accordingly, the Company recognized $ 3,890 of amortization expense during the year ended December 31, 2023. This is represented in the weighted average remaining useful life for developed technology assets and future amortization expense presented above. Capitalized software development costs Capitalized software development costs are as follows: December 31, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Impairment Net Gross Carrying Amount Accumulated Amortization Net Capitalized software development costs $ 27,659 $ ( 12,795 ) $ ( 1,492 ) $ 13,372 $ 19,815 $ ( 5,869 ) $ 13,946 During the years ended December 31, 2023 and 2022, the Company capitalized interest on capitalized software development costs in the amount of $ 424 and $ 740 , respectively. Amortization of capitalized software development costs was recorded as part of cost of revenues for the years ended December 31, 2023 and 2022 in the amount of $ 6,918 and $ 4,064 , respectively. The estimated useful life is determined at the time each project is placed in service. Impairment of long-lived assets During each fiscal year, we periodically assessed whether any indicators of impairment existed related to our intangible assets. As of each interim period end during each fiscal year, we concluded that a triggering event had not occurred that would more likely than not reduce the fair value of intangible assets below their carrying value. We identified a triggering event during the fourth quarter of 2023, primarily related to the prolonged decline in the Company’s stock price and market capitalization. This triggering event indicated we should test the related long-lived assets for impairment in certain of our asset groups. We tested each applicable asset group by first performing a recoverability test, comparing projected undiscounted cash flows from the use and eventual disposition of each asset group to its carrying value. This test indicated that the undiscounted cash flows were not sufficient to recover the carrying value of certain asset groups. We then compared the carrying value of the individual long-lived assets within those asset groups against their fair value in order to determine if impairment existed. As a result, we recorded a total non-cash impairment charge for intangible assets of $ 6,223 during the fourth quarter of 2023. This impairment charge relates to capitalized software development costs, developed technology, customer relationships, tradenames and patents within the FactSquared and Predata asset groups. |
Goodwill
Goodwill | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill [Roll Forward] | |
Goodwill | Note 8. Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of net assets acquired. Goodwill amounts are not amortized, but are rather tested for impairment at least annually as of October 1 of each year. The changes in the carrying amounts of goodwill, which are generally not deductible for tax purposes, are as follows: Balance at December 31, 2021 $ 188,768 Acquisitions 5,794 Impact of foreign currency fluctuations ( 200 ) Balance at December 31, 2022 194,362 Acquisition 18,535 Impairment ( 25,841 ) Impact of foreign currency fluctuations 647 Balance at December 31, 2023 $ 187,703 The Company has the following goodwill reporting units: Public Policy & Issues Management ("PPIM"); Geopolitical & Market Intelligence ("GMI"); Advocacy; Community; AI-Driven Intelligence ("FNAI"); and Environmental, Sustainability, and Governance ("ESG"). The Company performed the required annual impairment test as of October 1, 2022 at the reporting unit level, which resulted in no impairment of goodwill. During the first quarter of 2023, we continued to monitor our reporting units for triggering events that might indicate an impairment. Due to the decline in the Company’s stock price and market capitalization in the first quarter of 2023, and the underperformance of the Company’s ESG reporting unit compared to internal projections, the Company performed a quantitative goodwill impairment assessment as of March 31, 2023. This quantitative assessment resulted in all the goodwill in our ESG reporting unit being impaired; accordingly, an impairment charge of $ 5,837 was recognized during the three months ended March 31, 2023. Prior to the quantitative goodwill impairment test performed at March 31, 2023 the Company tested the recoverability of its long-lived assets, and concluded that such assets were not impaired. The Company performed the required annual impairment test as of October 1, 2023 at the reporting unit level, which resulted in no impairment of goodwill. Toward the end of the fourth quarter of 2023, we continued to monitor our reporting units for triggering events that might indicate an impairment. Due to the decline in the Company’s stock price and market capitalization toward the end of the fourth quarter of 2023, and certain decisions made by management as of December 31, 2023, the Company performed a quantitative goodwill impairment assessment as of December 31, 2023. This quantitative assessment resulted in a goodwill impairment charge of $ 20,004 inside our FNAI reporting unit recognized in the fourth quarter of 2023. Prior to the quantitative goodwill impairment test performed at December 31, 2023, the Company tested the recoverability of its long-lived assets, and concluded that certain of its intangibles were impaired. See Note 7, Intangible Assets. The fair value estimate of the Company's reporting units was derived based on an income approach. Under the income approach, the Company estimated the fair value of reporting units based on the present value of estimated future cash flows, which the Company considers to be a Level 3 unobservable input in the fair value hierarchy. The Company prepared cash flow projections based on management's estimates of revenue growth rates and operating margins, taking into consideration the historical performance and the current macroeconomic, industry, and market conditions. The Company based the discount rate on the weighted-average cost of capital considering Company-specific characteristics and the uncertainty related to our reporting unit's ability to execute on the projected cash flows. At December 31, 2023 the Company's PPIM reporting unit had a negative carrying value and $ 83,524 of goodwill. Potential indicators of impairment include significant changes in performance relative to expected operating results, significant negative industry or economic trends, or a significant decline in the Company's stock price and/or market capitalization for a sustained period of time. It is reasonably possible that one or more of these impairment indicators could occur or intensify in the near term, which may result in an impairment of long-lived assets or further impairment of goodwill. |
Debt
Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Note 9. Debt The following presents the carrying value of the Company’s debt as of the respective period ends: December 31, 2023 December 31, 2022 Senior Term Loan $ 158,228 $ 150,647 New GPO Note 36,954 - Convertible notes 14,052 12,219 Dragonfly Convertible Note 9,002 - Era Convertible Note 5,977 - Aicel Convertible Note 1,156 1,174 PPP loan 144 251 Total gross debt 225,513 164,291 Debt issuance costs ( 3,098 ) ( 2,243 ) Total 222,415 162,048 Less: Current maturities ( 105 ) ( 68 ) Total long-term debt $ 222,310 $ 161,980 a) Senior Term Loan Concurrently with the Closing, FiscalNote, Inc., a wholly owned indirect subsidiary of FiscalNote Holdings, Inc., entered into a Senior Term Loan consisting of a fully funded principal amount of $ 150.0 million and an uncommitted incremental loan facility totaling $ 100.0 million available upon notice if the Company meets certain financial growth criteria and other customary requirements (the “New Incremental Term Facility”) (collectively the “Senior Credit Facility”). The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0 % per annum or (ii) 9.0 % payable monthly in cash, and (b) interest payable in kind component of 1.00 % per annum, payable in kind monthly. Beginning on August 15, 2025, 50 % of the outstanding principal amount of the Senior Term Loan must be repaid in even amounts on a monthly basis over the remaining 24 months , with the final balance due on July 15, 2027 . The Senior Credit Facility will mature on July 29, 2027 , the five-year anniversary of the Closing Date. On March 17, 2023, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Senior Term Loan dated July 29, 2022. Among other things, Amendment No. 1 provided for the extension of an incremental term loan by one of the lenders under the facility in the principal amount of $ 6,000 which was received by the Company on March 31, 2023, on the same terms as the existing term loans (the “Incremental Facility”). In connection with the funding of the Incremental Facility, the Company issued the lender warrants expiring July 15, 2027 , to purchase up to 80,000 Class A Common Stock at an exercise price of $ 0.01 per share, in a transaction exempt from registration under the Securities Act of 1933, as amended, in reliance on Regulation D promulgated thereunder. The lender warrants represent a non-cash financing activity. On May 16, 2023, the Company, entered into Amendment No. 2 ("Amendment No. 2") to the Senior Term Loan dated July 29, 2022. Among other things, Amendment No. 2 joined Dragonfly Eye Limited and Oxford Analytica Limited (“Oxford Analytica”), each a wholly owned subsidiary of the Company, as Guarantors under the Senior Term Loan. On August 3, 2023, the Company entered into Amendment No. 3 ("Amendment No. 3") to the Senior Term Loan dated July 29, 2022. Among other things, Amendment No. 3 provides for: (a) the extension of the July 2023 Deferred Fee from July 29, 2023 to July 29, 2024, (b) the increase of the July 2023 Deferred Fee from $ 1,734 to $ 2,034 , (c) increase of the Restatement Date Final Agreement from $ 7,410 to $ 8,970 and (d) the revision to the minimum annual recurring revenue and adjusted EBITDA covenants (as both are defined in the Senior Term Loan). On March 11, 2024, the Company entered into Amendment No. 4 ("Amendment No. 4") to the Senior Term Loan date July 29, 2022, as part of the sale of Board.org. See Note 19, Subsequent Events, for additional details. The Prime Rate wa s 8.5 % a t December 31, 2023. For the year ended December 31, 2023, the Company incurred $ 20,791 and $ 1,581 of cash interest and paid-in-kind interest, respectively, on the Senior Term Loan. Paid-in-kind interest is reflected as a component of the carrying value of the Senior Term Loan as the payment of such interest will occur upon the settlement of the Senior Term Loan. The Company may prepay the Senior Term Loan in whole, subject to a 2.0 % prepayment fee if prepaid prior to July 30, 2024, 1.0 % prepayment fee if prepaid after July 30, 2024 but prior to July 30, 2025, and no prepayment fee if prepaid on or after July 30, 2025. Prior to Amendment No. 3 (entered into on August 3, 2023) the Company was obligated to pay certain of the new lenders deferred debt issuance costs of $ 1,734 at the earlier of prepayment or July 29, 2023 (the "July 2023 Deferred Fee"). Pursuant to Amendment No. 3, the July 2023 Deferred Fee was deferred through the earlier of prepayment or July 29, 2024 and was increased to $ 2,034 . Accordingly, the Company is recognizing the accretion of the July 2023 Deferred Fee as interest expense, which at December 31, 2023 is $ 1,859 and is recognized in accounts payable and accrued expenses in the consolidated balance sheets. The Company must also pay to the lenders a final payment of $ 8,970 (of which $ 1,035 was incurred pursuant to Amendment No. 1 and $ 1,560 was incurred pursuant to Amendment No. 3) at the earlier of prepayment or maturity of the Senior Term Loan. The Company is recognizing the accretion of the final payment as interest expense, which at December 31, 2023 is $ 2,347 and is recognized in other non-current liabilities in the consolidated balance sheets. The Company incurred $ 2,435 of lender fees that were paid out of the net proceeds of the Senior Term Loan on the Closing Date. The Company also incurred $ 732 of fees paid to third parties. Capitalized debt issuance costs on the Closing Date totaled $ 3,167 . The Company amortizes debt discounts over the term of the Senior Term Loans using the effective interest method. The amortization recorded for year ended December 31, 2023 is $ 682 , an d is included within interest expense in the consolidated statements of operations and comprehensive loss. The remaining unamortized debt discount at December 31, 2023 is $ 2,412 , excluding any deferred fees, and is reflected net against debt on the consolidated balance sheets. The Senior Term Loan is senior to all other debt and has a first priority lien on substantially all of the Company’s assets. The Senior Term Loan contains customary negative covenants related to borrowing, events of default and covenants, including certain non-financial covenants and covenants limiting the Company’s ability to dispose of assets, undergo a change in control, merge with or acquire stock, and make investments, in each case subject to certain exceptions. In addition to the negative covenants, there were four financial covenants in place at December 31, 2023: a minimum cash balance requirement, minimum annual recurring revenue requirement, an adjusted EBITDA requirement (as defined in the Senior Term Loan, as amended) and a capital expenditure limitation. At December 31, 2023 the Company was in compliance with all required financial covenants. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Senior Term Loan due and payable the lenders can elect to increase the interest rate by 5.0 % per annum. b) New GPO Note On June 30, 2023 (the “Subscription Date”), the Company entered into an Exchange and Settlement Agreement (the “Exchange and Settlement Agreement”) with GPO FN Noteholder LLC (the “Investor”) pursuant to which (i) the Investor returned 5,881,723 shares of Class A Common Stock held by the Investor to the Company for cancellation, (ii) the Company issued to the Investor a subordinated convertible promissory note in an initial principal amount of $ 46,794 (the “New GPO Note”), and (iii) the parties agreed to a mutual settlement and release of all claims (including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement, relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor. The exchange and settlement are non-cash exchanges in the consolidated statement of cash flows. The before mentioned transactions closed on July 3, 2023. The New GPO Note will mature on July 3, 2028 , unless earlier redeemed or repurchased by the Company or converted in accordance with the terms thereof. The New GPO Note bears interest at a rate of 7.50 % per annum payable quarterly in arrears, as follows: (i) for the first year following the date of issuance, interest will be payable in kind by adding interest to the principal amount of the New GPO Note; and (ii) for any period thereafter, interest will be payable in cash or freely tradeable shares of Class A Common Stock, at the Company’s option, with the value per share determined with reference to the trailing 30-day volume weighted average trading price prior to the interest payment date, subject to certain exceptions under which the Company will be permitted to pay PIK Interest. The New GPO Note is subordinate to the Company’s obligations under its Senior Term Loan which limits certain actions that the Company and the Investor may take under the New GPO Note. At any time prior to the July 3, 2028, the Investor is entitled to convert all or any portion of the principal amount of the New GPO Note and accrued interest thereon into shares of Class A Common Stock at $ 8.28 per share. The New GPO Note is subject to customary anti-dilution adjustments for stock splits and similar transactions and, subject to standard exceptions, weighted average anti-dilution protection. The principal amount, together with accrued interest thereon, of the New GPO Note is redeemable by the Company in whole or in part based on certain conditions as defined in the New GPO Note. The Company elected to account for the New GPO Note using the fair value option. The New GPO Note was recorded at its June 30, 2023 acquisition date fair value of $ 36,583 . The Company initially recorded a loss contingency of $ 11,700 in its fiscal year 2022 financial statements representing the difference between the fair value of the shares returned by the Investor and the fair value of the New GPO Note on the date of exchange. With the execution of the Exchange and Settlement Agreement and New GPO Note, the Company recorded an additional non-cash loss on settlement with GPO of $ 3,474 in the consolidated statement of operations for the year ended December 31, 2023. The fair market value at December 31, 2023 was $ 36,954 . The non-cash gain was recorded in the change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss in the amount of $ 1,411 for the year ended December 31, 2023. The Company incurred total interest expense related to the new GPO note of $ 1,781 fo r the year ended December 31, 2023. c) Convertible Notes At December 31, 2023 , the holders of four convertible notes that were previously issued by Old FiscalNote (the “Convertible Notes”) with a principal and accrued PIK balance of $ 14,052 , remained outstanding through their maturity in 2027. The Company incurred total interest expense related to the Convertible Notes, including the amortization of the various discounts, of $ 2,170 and $ 39,219 for the years ended December 31, 2023 and 2022, respectively. Concurrently with the Closing, the Company repaid or converted to shares of Class A Common Stock of New FiscalNote all other previously outstanding debt instruments. The Company recorded $ 11,541 o f interest expense during the year ended December 31, 2022, related to debt that was extinguished during 2022. d) Dragonfly Seller Convertible Notes In connection with the Company's acquisition of Dragonfly, the Company financed part of the purchase with the issuance of convertible notes. The Dragonfly Convertible Notes were issued in a principal amount of £ 8.9 million pounds sterling (approximately $ 11,050 on the closing date of the acquisition), with interest at an annual rate of 8 %, which can be paid in cash or paid-in-kind. The paid-in-kind interest will be annually credited to the principal amount. All principal and accrued interest are due upon maturity on January 27, 2028 . At any time after August 2, 2023, the Company can convert any portion of the principal and accrued interest at the volume weighted-average price for the five consecutive trading day period ending on the last trading day of the calendar month preceding the date the Company provides notice of conversion to the Sellers. At any time after the 18 month anniversary of the Dragonfly acquisition closing date, the lender has the right to convert the outstanding principal and accrued interest for FiscalNote common stock at $ 10.00 per share, subject to adjustment in the event of any stock dividend, stock split, reverse stock split, combination or other similar recapitalization with respect to common stock. The Company elected to account for the Dragonfly Seller Convertible Notes using the fair value option. The Dragonfly Seller Convertible Notes were recorded at their acquisition date fair value of $ 8,635 . The fair market value at December 31, 2023 was $ 9,002 . The non-cash gain was recorded in the change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss in the amount of $ 673 for the year ended December 31, 2023. The Company incurred total interest expense related to the Dragonfly Seller Convertible Notes of $ 838 during the year ended December 31, 2023. e) Era Convertible Note In connection with the Company’s strategic commercial partnership, the Company issued a convertible note (“Era Convertible Note”) to a third-party lender dated December 8, 2023. The Era Convertible Note was issued in a principal amount of $ 5,500 , with cash interest at rate equal to the applicable federal rate published by the Internal Revenue Service beginning on the six-month anniversary of the Issuance Date. The Company has agreed to issue up to $ 2,000 of additional notes to Era at Era's Election prior to February 6, 2024. All principal and unpaid interest are due on maturity at December 8, 2027 . The Notes are contractually subordinated to the Company’s obligations under its senior secured indebtedness, and accordingly the Company’s right to make certain cash payments in connection therewith is limited by the terms of such subordination agreement (the “Subordination Agreement”). Era may convert the Notes into shares of Common Stock (the “Underlying Shares”), beginning on the six-month anniversary of the Issuance Date based on the volume weighted average price of the trailing 30 trading day period prior to the conversion. In addition, the Company may elect to convert the Note into the Underlying Shares if the Underlying Shares are registered for resale under the Securities Act of 1933, as amended (the “Securities Act”). The Co-Pilot Agreement requires the Company to issue additional shares of Common Stock (“Additional Shares”) to Era if Era’s sales of the Additional Shares and the Underlying Shares during the Redemption Period do not generate aggregate cash proceeds to Era that equal or exceed the sum of (1) the aggregate principal amount of Notes purchased by Era, plus (2) up to $ 3.75 million. Any such Additional Shares would be valued based on the volume weighted average price of the trailing 30 trading day period, calculated prior to the date of any such issuance. The Company elected to account for the Era Convertible Note using the fair value option. The Era Convertible Note was recorded at its December 8, 2023 acquisition date fair value of $ 5,500 . The fair market value at December 31, 2023 was $ 5,977 . The non-cash loss was recorded in the change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss in the amount of a loss of $ 477 for the year ended December 31, 2023. f) Aicel Convertible Note In connection with the Company’s acquisition of Aicel, the Company assumed a convertible note (“Aicel Convertible Note”) issued by Aicel in a private placement to a third-party lender dated July 27, 2022. The Aicel Convertible Note was issued in a principal amount of $ 1,131 , with paid-in-kind interest at an annual rate of 1 %. All principal and accrued and unpaid interest are due on maturity at July 27, 2027 . The Aicel Convertible Note provides for no prepayments until maturity without written consent of the lender. The Aicel Convertible Note can be converted upon the occurrence of certain events, including (i) Aicel initial public offering (“IPO”), (ii) change in control of Aicel (the acquisition of Aicel by FiscalNote did not constitute a change in control as defined in the purchase agreement), or (iii) sale of substantially all of Aicel’s assets (collectively, a “Conversion Event”). The Company has the right to convert the Aicel Convertible Note into shares of common stock issued in an IPO, if (a) the Conversion Event is an IPO and (b) the price per share paid in an IPO is greater than the stipulated initial conversion price. The lender has the right to elect to convert the Aicel Convertible Note into shares of common stock upon the occurrence of a Conversion Event. At any time after the second anniversary of the Aicel acquisition closing date until the earlier of (a) the Aicel Convertible Note maturity date, or (b) the occurrence of any liquidity event, the lender has the right to require FiscalNote to repurchase the outstanding principal in exchange for FiscalNote common stock. The lender will receive a number of shares of FiscalNote equal to the outstanding principal plus accrued interest divided by the FiscalNote common stock price and rounded to the nearest whole share. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Aicel Convertible Note due and payable the lenders can elect to increase the paid-in-kind interest rate to 12.0 % per annum. The Company concluded that the contingent default interest provision was required to be bifurcated and treated as an embedded derivative liability. The associated value was immaterial and required no initial amount to be recorded. The Company determined that the remaining embedded features were clearly and closely related to the debt host and did not require bifurcation from the debt host. The Aicel Convertible Note was recorded at its acquisition fair value of $ 1,131 . The Company incurred total interest expense related to the Aicel Convertible Note o f $ 11 and $ 5 for the years ended December 31, 2023 and 2022. The Aicel Convertible Note had a carrying balance o f $ 1,156 as of December 31, 2023 . g) PPP loan On April 13, 2020, the Company received funding in the principal amount of $ 8,000 under the CARES Act. Interest accrues at 1 %. On February 14, 2022, the SBA forgave $ 7,667 of the PPP Loan with the remaining balance of $ 333 to be repaid over five years . The Company recognized the forgiveness of the PPP Loan as a gain on debt extinguishment on the consolidated statements of operations and comprehensive loss. As of December 31, 2023, the Company recorded $ 105 of the remaining PPP Loan as short-term debt and $ 39 as long-term debt on the consolidated balance sheets. Total Debt The following table summarizes the total estimated fair value of the Company's debt as of December 31, 2023 and December 31, 2022, respectively. December 31, 2023 December 31, 2022 Senior Term Loan $ 168,702 $ 165,540 New GPO Note 36,954 - Convertible notes 13,992 16,942 Dragonfly Seller Convertible Notes 10,407 - Era Convertible Notes 5,977 - Total $ 236,032 $ 182,482 These fair values are deemed Level 3 liabilities within the fair value measurement framework. Maturities of debt during the years subsequent to December 31, 2023 are as follows: 2024 $ 105 2025 30,340 2026 39,000 2027 110,111 2028 45,957 Total $ 225,513 Warrants Old FiscalNote Warrants At December 31, 2023 , 118,700 warrants (previously issued by Old FiscalNote to lenders prior to the Senior Term Loan) with an exercise price of $ 8.56 , remain outstanding. These warrants are accounted for as a liability with a fair value o f $ 23 at December 31, 2023, and are included as part of the other non-current liabilities within the consolidated balance sheets. Warrants associated with Amendment No. 1 On March 17, 2023, in connection with Amendment No. 1 discussed above, the Company issued 80,000 warrants with an exercise price of $ 0.01 . These warrants are accounted for as a liability with a fair value of $ 90 at December 31, 2023 , and are included as part of the other non-current liabilities within the consolidated balance sheets. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders’ Equity | Note 10. Stockholders’ Equity Authorized Capital Stock The Company’s charter authorizes the issuance of 1,809,000,000 shares, which includes Class A common stock, Class B common stock, and preferred stock. Class A Common Stock Subsequent to the Closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE WS,” respectively. Pursuant to the Company’s charter, the Company is authorized to issue 1,700,000,000 shares of Class A common stock, par value $ 0.0001 per share. As of December 31, 2023, the Company had 121,679,829 sh ares of Class A common stock issued and outstanding. Prior to the Business Combination, Old FiscalNote had outstanding shares of Series A, Series B, Series C, Series C-1, Series D, Series D-1, Series E, Series F, and Series G convertible preferred stock (collectively, “Old FiscalNote Preferred Stock”). The Preferred Stock was recognized as temporary equity and recorded at its redemption value. Accordingly, for periods prior to the closing of the Transactions, Old FiscalNote recognized changes in its redemption value of its Preferred Stock of $ 26,570 for both the period from January 1, 2022 to July 29, 2022 and for the year ended December 31, 2022, respectively. Upon the Closing of the Business Combination, each share of Old FiscalNote’s Preferred Stock was converted into common stock and, immediately thereafter, each share of common stock that was issued and outstanding immediately prior to the effective time of the Business Combination was cancelled and converted into New FiscalNote Class A common stock with the application of the Exchange Ratio as discussed in Note 2, Business Combination with DSAC. Additionally, the Company has outstanding warrants to purchase shares of New FiscalNote Class A common stock that became exercisable upon the Closing of the Business Combination. Refer to Note 12, Warrant Liabilities. Class B Common Stock Pursuant to the Company’s charter, the Company is authorized to issue 9,000,000 shares of Class B common stock, par value $ 0.0001 per share. In connection with the Closing of the Business Combination, the Co-Founders, or entities controlled by the Co-Founders, received Class B shares of New FiscalNote common stock as consideration (see further details in Note 2, Business Combination with DSAC). As of December 31, 2023, 8,290,921 shares of Class B common stock were issued and outstanding. Preferred Stock Pursuant to the Company’s charter, the Company is authorized to issue 100,000,000 shares of preferred stock, par value $ 0.0001 per share. Our board of directors has the authority without action by the stockholders, to designate and issue shares of preferred stock in one or more classes or series, and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights of each class or series of preferred stock, including, without limitation, dividend rights, conversion rights, redemption privileges and liquidation preferences, which rights may be greater than the rights of the holders of the common stock. As of December 31, 2023 , there were no shares of preferred stock issued and outstanding. Dividends The Company's Class A and Class B common stock are entitled to dividends if and when any dividend is declared by the Company's board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of the Company's business and have no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company's board of directors and will depend on, among other things, the Company's financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company's board of directors may deem relevant. |
Earnout Shares and RSUs
Earnout Shares and RSUs | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Earnout Shares and RSUs | Note 11. Earnout Shares and RSUs The shareholders and other equity holders of Old FiscalNote as described below are entitled to receive up to 19,195,100 additional shares of Class A common stock of New FiscalNote (the “Earnout Awards”) in the form of Earnout Shares or as shares reserved for issuances upon settlement of Earnout RSUs, as described below. The Earnout Awards are split into five tranches each consisting of 3,839,020 shares of Class A common stock in New FiscalNote. Certain Old FiscalNote equity holders will receive Earnout Restricted Stock Units (the “Earnout RSUs”), which are settled in Class A common stock. The right to receive Earnout Awards will expire five years after the Closing Date (the “Earnout Period”). Each tranche of the Earnout Awards will be issued only when the dollar volume-weighted average price of one share of New FiscalNote Class A common stock is greater than or equal to $ 10.50 , $ 12.50 , $ 15.00 , $ 20.00 , or $ 25.00 , respectively, for any 10 trading days within any period of 20 consecutive trading days during the Earnout Period (collectively, the “Triggering Events”). Pursuant to the terms of the Business Combination Agreement, the holders of Old FiscalNote common stock, Old FiscalNote warrants, vested Old FiscalNote options and vested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares subject to achievement of the Triggering Event. Holders of unvested Old FiscalNote options and unvested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares in the form of Earnout RSUs subject to achievement of the Triggering Event. To the extent the equity award issued upon New FiscalNote's assumption of such any Old FiscalNote Option or Old FiscalNote RSU (each a “Converted Award”) is outstanding and has vested as of the occurrence of a Triggering Event, the holder thereof will receive a proportionate allocation of Earnout Shares in lieu of Earnout RSUs. If a Converted Award is forfeited after the Closing Date but prior to the Triggering Event, no Earnout RSUs will be issued for such Converted Award. The right to receive Earnout RSUs that have been forfeited shall be reallocated pro-rata to the remaining holders of vested Converted Awards in the form of Earnout Shares and unvested Converted Awards in the form of Earnout RSUs in the manner described above. Reallocated Earnout RSUs are subject to the remaining vesting schedule and conditions of the Converted Award held by such equity holder. The forfeiture and subsequent reallocation of the Earnout RSUs are accounted for as the forfeiture of the original award and the grant of a new award. A portion of the Earnout Shares that may be issued to Old FiscalNote common stockholders, Old FiscalNote vested option holders and Old FiscalNote warrant holders and all of the Earnout RSUs were determined to represent additional compensation for accounting purposes pursuant to ASC 718, “Compensation-Stock Compensation”. The Company recognizes stock-compensation expense based on the fair value of the Earnout Awards over the requisite service period for each tranche. Upon Closing, the Company recognized $ 17,712 of share-based compensation expense for vested Earnout Awards. The Company recognized $ 1,803 and $ 686 of share-based compensation expense during the years ended December 31, 2023 and 2022, respectively. The remaining Earnout Shares were determined to represent an equity transaction in conjunction with the reverse recapitalization and were evaluated pursuant to ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. These remaining Earnout Shares will be accounted for as a liability as the arrangement is indexed to something other than the Company’s stock. The liability is revalued at each reporting period with changes being recorded as a non-operating gain or loss in the consolidated statements of operations and comprehensive loss. The other non-current liability wa s $ 68 as of December 31, 2023 and 2022, respectively. As of December 31, 2023, there was $ 730 of unrecognized compensation expense related to the Earnout Awards to be recognized over a weighted-average period of approximately three years . As of December 31, 2023 , no Earnout Shares and no Earnout RSUs have been issued as no Triggering Events have occurred. |
Warrant Liabilities
Warrant Liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
Warrant Liabilities | Note 12. Warrant Liabilities Upon the Closing of the Business Combination, the Company assumed 8,750,000 public warrants and 7,000,000 private placement warrants that were previously issued by Old DSAC. Each public warrant and private placement warrant is exercisable for 1.571428 shares of New FiscalNote Class A common stock (or an aggregate of up to 24,750,000 shares of New FiscalNote Class A common stock). During the year ended December 31, 2023 , there were no public warrants exercised into shares of Class A common stock. No private placement warrants have been exercised to date. Accordingly, as of December 31, 2023, the Company had 8,358,964 public warrants and 7,000,000 private placement warrants outstanding with a per share fair value of $ 0.31 . These warrants are accounted for as a liability and have an aggregate fair value of $ 4,761 at December 31, 2023. During the year ended December 31, 2022, 391,036 public warrants were exercised into 614,478 shares of Class A common stock. No private placement warrants have been exercised to date. Accordingly, as of December 31, 2022, the Company had 8,358,964 public warrants and 7,000,000 private placement warrants outstanding with a per share fair value of $ 1.23 . These warrants are accounted for as a liability and have an aggregate fair value of $ 18,892 at December 31, 2022. Public Warrants Each public warrant entitles the registered holder to acquire 1.571428 shares of the Company’s Class A common stock at a price of $ 7.32 per share, subject to adjustment as discussed below. The warrants became exercisable on August 29, 2022. A holder may exercise his or her warrants only for a whole number of shares of Class A common stock. The public warrants will expire July 29, 2027 , or earlier upon redemption or liquidation. Redemption of warrants for cash The Company may call the public warrants for redemption for cash: • in whole and not in part; • at a price of $ 0.01 per warrant; • upon a minimum of 30 days ’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $ 11.45 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company for cash, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants for shares of Class A common stock The Company may redeem the outstanding warrants for shares of Class A common stock: • in whole and not in part; • at $ 0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined by reference to an agreed table, based on the redemption date and the “fair market value” of Class A common stock (as defined below) except as otherwise described below; • if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $ 6.36 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and • if and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of our Class A common stock) as the outstanding public warrants, as described above. • The “fair market value” of the Class A common stock shall mean the average of the last reported sales price for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.567 shares of Class A common stock per warrant (subject to adjustment). Private Placement Warrants The private placement warrants are not redeemable by the Company so long as they are held by the sponsor of DSAC or its permitted transferees, except in certain limited circumstances. The DSAC Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis and the DSAC Sponsor and its permitted transferees has certain registration rights related to the private placement warrants (including the shares of Class A common stock issuable upon exercise of the private placement warrants). Except as described in this section, the private placement warrants have terms and provisions that are identical to those of the public warrants. If the private placement warrants are held by holders other than the DSAC Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the public warrants. Old FiscalNote Warrants In connection with the Closing, certain holders of Old FiscalNote warrant holders exercised their warrants and received 365,002 shares of Old FiscalNote which were then converted into 433,259 shares of Class A common stock of New FiscalNote based on the Exchange Ratio. At December 31, 2023, 118,700 warrants with an exercise price of $ 8.56 , remain outstanding. These warrants are accounted for as a liability with a fair value o f $ 22 at December 31, 2023 , and are included as part of the other non-current liabilities within the consolidated balance sheets. |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Stock-Based Compensation | 13. Stock-Based Compensation 2022 Long-Term Incentive Plan In connection with the Business Combination, the Company's board of directors adopted, and its stockholders approved, the 2022 Long-Term Incentive Plan (the “2022 Plan”) under which 20,285,600 shares of Class A common stock were initially reserved for issuance. The 2022 Plan allows for the issuance of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, other stock-based awards and cash-based awards. The number of shares of the Company’s Class A common stock available for issuance under the 2022 Plan automatically increases on the first day of each calendar year, beginning on and including January 1, 2023 and ending on and including January 1, 2027 equal to the lesser of (i) 3 % of the total number of shares (e.g., each and every class of the Company's common stock) outstanding on the immediately preceding December 31 or (ii) 13,523,734 shares; provided, however, that the Company's Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares (the “Share Reserve”). The shares may be authorized, but unissued, or reacquired shares of the Company's shares or from the Company's treasury shares. Furthermore, subject to adjustments as set forth in the 2022 Plan, in no event will the maximum aggregate number of shares that may be available for delivery under the 2022 Plan pursuant to incentive stock options exceed the Share Reserve. The shares underlying any awards under the 2022 Plan that are forfeited, canceled, settled in cash, or otherwise terminated (other than by exercise) shall be added back to the Share Reserve available for issuance under the 2022 Plan and, to the extent permissible, the shares that may be issued as incentive stock options. During the year ended December 31, 2023, the Company issued 451,902 stock options, 25,000 performance based stock options, 6,531,510 restricted stock units , and 75,000 p erformance based restricted stock units. At December 31, 2023, 9,241,285 stock options, 28,313 performance stock options, 6,369,107 re stricted stock units, and 75,000 p erformance based restricted stock units remain outstanding. As of December 31, 2023, the Company had 7,916,823 shares of Class A common stock available for issuance under the 2022 Plan. The Company recognized $ 24,165 and $ 36,449 of stock-based compensation expense for all long term incentive plans in effect during the years ended December 31, 2023 and 2022, respectively. The Company recognized $ 675 a nd $ 603 of stock-based compensation expense related to acquisition earnouts during the years ended December 31, 2023 and 2022, respectively. 2022 Employee Stock Purchase Plan In connection with the Business Combination, the Company’s board of directors adopted, and its stockholders approved, the 2022 Employee Stock Purchase Plan (the “ESPP”) whereby eligible employees may authorize payroll deductions of up to 15 % of their regular base salary to purchase shares at the lower of 85 % of the fair market value of the common stock on the date of commencement of the offering period or on the last day of the six-month offering period beginning in 2023. The plan is defined as compensatory, and accordingly, a stock-based compensation charge of $ 414 was recorded as the difference between the fair market value and the discounted purchase price of the Company's common stock for the year ended December 31, 2023. As of December 31, 2023, 102,807 sh ares have been issued under the ESPP and the Company had 4,396,208 s hares of Class A common stock available for issuance under the ESPP. 2013 Equity Incentive Plan Prior to the Closing of the Business Combination, the Company maintained the 2013 Equity Incentive Plan (the “2013 Plan”) that allowed for granting of incentive and non-qualified stock options to employees, directors, and consultants of 12,294,973 shares of common stock. In connection with the Business Combination, each option granted under the 2013 Plan that was outstanding immediately prior to the Business Combination, whether vested or unvested, was assumed and converted into an option to purchase a number of shares of Class A common stock (rounded down to the nearest whole share) equal to the product of (i) the number of shares of Old FiscalNote common stock subject to such Old FiscalNote option immediately prior to the Business Combination and (ii) the Exchange Ratio, at an exercise price per share (rounded up to the nearest whole cent) equal to the quotient obtained by dividing (A) the exercise price per share of such Old FiscalNote option immediately prior to the consummation of the Business Combination by (B) the Exchange Ratio. Stock option activity prior to the Business Combination was retroactively adjusted to reflect this conversion. Awards outstanding under the 2013 Plan were assumed by New FiscalNote upon the Closing and continue to be governed by the terms and conditions of the 2013 Plan and applicable award agreement. Shares of the Company's common stock subject to awards granted under the 2013 Plan that expire unexercised or are cancelled, terminated, or forfeited in any manner without issuance of shares thereunder following the effective date of the 2022 Plan (as defined below), will not become available for issuance under the 2022 Plan. In connection with the completion of the Business Combination and the adoption of the 2022 Plan, no additional awards will be granted under the 2013 Plan. In determining related stock-based compensation expense for any award under the 2013 Equity Plan, the Company made an accounting policy election to account for forfeitures of awards as they occur and therefore stock-based compensation expense presented below has not been adjusted for any estimated forfeitures. The Company has historically issued stock options with exercise prices equal to the fair value of the underlying stock price. Prior to the completion of the Business Combination and listing of the Company’s common stock on the public stock exchange, the fair value of Old FiscalNote common stock that underlies the stock options was determined based on then-current valuation estimates at the time of grant. Because such grants occurred prior to the public trading of the Company’s common stock, the fair value of Old FiscalNote common stock was determined with assistance of periodic valuation analyses from an independent third-party valuation firm. The following table summarizes activities related to stock options and performance stock units during the period presented: Stock Options awards Number of Weighted-average Weighted-average Aggregate Outstanding at December 31, 2021 8,695,002 $ 3.28 7.3 $ 52,941 Granted 2,121,495 6.27 Exercised ( 223,323 ) 1.07 Cancelled and forfeited ( 850,643 ) 3.34 Outstanding at December 31, 2022 9,742,531 $ 3.82 7.5 $ 24,659 Vested and exercisable as of December 31, 2022 4,729,547 $ 2.51 6.5 $ 18,197 Vested and expected to vest as of December 31, 2022 9,742,531 Outstanding at December 31, 2022 9,742,531 $ 3.82 7.5 $ 24,659 Granted 476,902 3.98 Exercised ( 327,447 ) 1.81 Cancelled and forfeited ( 432,441 ) 6.55 Expired ( 189,947 ) 3.71 Outstanding at December 31, 2023 9,269,598 $ 3.74 6.1 $ - Vested and exercisable as of December 31, 2023 5,425,239 $ 3.11 5.1 Vested and expected to vest as of December 31, 2023 3,844,359 The following table summarizes the weighted-average assumptions used to estimate the fair value of stock options granted during the periods presented: Years Ended Years Ended December 31, 2023 December 31, 2022 Expected volatility 45.00 % 30.09 % Expected life (years) 6.00 5.95 Expected dividend yield 0.00 % 0.00 % Risk-free interest rate 4.18 % 2.84 % Fair value of options $ 1.58 $ 4.39 At December 31, 2023, there was $ 3,803 of total unrecognized compensation cost related to outstanding unvested stock option awards including performance stock units that is expected to be recognized over a weighted-average period of approximately two years . The following table summarizes the Company’s restricted stock unit activity for the periods presented: Restricted Stock Units Number of Weighted-average Weighted-average Aggregate Outstanding at December 31, 2021 773,063 $ 6.26 7.5 $ 6,943 Granted 3,767,746 9.11 Vested ( 1,380,892 ) 8.27 Cancelled and forfeited ( 210,186 ) 8.38 Outstanding at December 31, 2022 2,949,731 $ 8.81 2.7 $ 18,672 Expected to vest as of December 31, 2022 2,949,731 Outstanding at December 31, 2022 2,949,731 $ 8.81 2.7 $ 18,672 Granted 6,606,510 4.42 Vested ( 2,532,946 ) 7.08 Cancelled and forfeited ( 579,188 ) 3.46 Outstanding at December 31, 2023 6,444,107 $ 5.38 1.0 $ 7,346 Expected to vest as of December 31, 2023 6,444,107 At December 31, 2023, there was $ 23,087 of total unrecognized compensation cost related to outstanding unvested restricted stock units that are expected to be recogn ized over a weighted-average period of approximately two years . Prior to 2022, the Company granted various executives 2,673,751 performance stock options that vest upon the occurrence of a successful public company listing and the Company’s stock price achieving certain price targets and 756,812 performance stock units that vest upon the occurrence of a successful public company listing and time served. The aggregate grant-date fair value of these executive performance stock options and stock units was estimated to be $ 7,295 . As of December 31, 2023, there were 2,526,649 performance stock options outstanding. The Company recognized $ 965 and $ 4,994 of share-based compensation expense for performance stock options and stock units for the years ended December 31, 2023 and 2022 , respectively, for which the related performance condition was met upon consummation of the Business Combination on July 29, 2022. |
Transaction Costs, net
Transaction Costs, net | 12 Months Ended |
Dec. 31, 2023 | |
Transaction Costs Gains [Abstract] | |
Transaction Costs, net | Note 14. Transaction Costs, net The Company incurred the following transaction costs related to businesses acquired and the consummation of the Business Combination during the periods presented: Years Ended December 31, 2023 2022 Transaction costs related to acquired businesses $ 1,391 $ 1,181 Non-capitalizable Business Combination costs 415 2,993 Change in contingent consideration liabilities ( 2,043 ) ( 2,121 ) Contingent compensation (benefit) expense ( 530 ) 342 Total transaction costs $ ( 767 ) $ 2,395 |
Earnings (Loss) Per Share
Earnings (Loss) Per Share | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Earnings (Loss) Per Share | 15. Earnings (Loss) Per Share The Company has two classes of common stock authorized: Class A common stock and Class B common stock. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to twenty-five votes per share. The Company allocates undistributed earnings attributable to common stock between the common stock classes on a one‑to‑one basis when computing net loss per share. As a result, basic and diluted net income (loss) per share of Class A common stock and Class B common stock are equivalent. Earnings (loss) per share is computed by dividing net loss attributable to common shareholders by the weighted average number of common shares outstanding during the period on a basic and diluted basis. The Company’s net loss used in computing basic and diluted earnings per share is adjusted for the deemed dividends resulting from the accretion of Old FiscalNote's preferred shares to redemption value and beneficial conversion features, as applicable. The Old FiscalNote preferred shares were outstanding during the year ended December 31, 2021 and from January 1, 2022 to July 29, 2022, respectively. At the closing of the Business Combination, all of Old FiscalNote’s preferred shares were exchanged for Class A common stock of New FiscalNote. Diluted earnings (loss) per share considers the impact of potentially dilutive securities. The components of basic and diluted earnings (loss) per shares are as follows: (in thousands, except per share data) Years Ended December 31, Numerator: 2023 2022 Net loss $ ( 115,461 ) $ ( 218,257 ) Deemed dividend - change in redemption value of preferred stock of Old FiscalNote - ( 26,570 ) Net loss used to compute basic and diluted loss per share $ ( 115,461 ) $ ( 244,827 ) Denominator: Weighted average common stock outstanding, basic and diluted 131,400,109 66,513,704 Net loss per shares, basic $ ( 0.88 ) $ ( 3.68 ) Net loss per shares, diluted $ ( 0.88 ) $ ( 3.68 ) Anti-dilutive securities excluded from diluted loss per share: Anti-dilutive Earnout Awards 19,195,100 19,195,100 Anti-dilutive stock options 979,901 4,844,643 Anti-dilutive Convertible Notes 2,305,666 2,004,928 Anti-dilutive contingently issuable shares 174,468 1,423,339 Anti-dilutive restricted stock units 6,393,154 2,949,731 Anti-dilutive New GPO Note 5,867,750 - Anti-dilutive Aicel Convertible Notes 113,896 116,886 Total anti-dilutive securities excluded from diluted loss per share: 35,029,935 30,534,627 The weighted-average common shares and thus the net loss per share calculations and potentially dilutive security amounts for all periods prior to the Business Combination have been retrospectively adjusted to the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse recapitalization. Historically reported weighted average shares outstanding have been multiplied by the Exchange Ratio (see Note 2, Business Combination with DSAC). |
Provision (Benefit) from Income
Provision (Benefit) from Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Provision (Benefit) from Income Taxes | Note 16. Provision (Benefit) from Income Taxes The (benefit) provision for income taxes consisted of the following as of the dates presented: As of December 31, 2023 2022 Current taxes Federal provision $ 80 $ 7 State provision (benefit) 55 ( 75 ) Foreign provision (benefit) 16 ( 110 ) Total current provision (benefit) 151 ( 178 ) Deferred taxes Federal benefit ( 9,882 ) ( 32,725 ) State benefit ( 2,690 ) ( 12,632 ) Foreign benefit ( 3,415 ) ( 2,949 ) Valuation allowance 16,059 45,230 Total deferred provision (benefit) 72 ( 3,076 ) Total provision (benefit) from income taxes $ 223 $ ( 3,254 ) The reconciliation between the U.S. federal statutory income tax rate to the Company’s estimated annual effective tax for the periods presented is as follows: Years Ended December 31, 2023 2022 U.S. Federal provision at statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit ( 0.1 )% 0.5 % Effects of rate other than statutory ( 0.5 )% ( 0.2 )% AHYDO interest disallowance ( 0.2 )% ( 0.5 )% Warrant revaluation 2.6 % 1.5 % Stock compensation ( 2.4 )% 0.0 % Impairment from goodwill and other long-lived assets ( 4.7 )% 0.0 % Nondeductible expenses from recapitalization ( 2.9 )% ( 4.4 )% Change in valuation allowance ( 12.2 )% ( 16.5 )% Others ( 0.8 )% 0.1 % Effective tax rate ( 0.2 )% 1.5 % The Company’s effective tax rate differs from the U.S. statutory rate of 21 percent primarily due to state taxes, stock compensation, goodwill impairment, and the impact of a valuation allowance on the Company’s deferred tax assets, disallowed interest expense, and non-includible income relating to a fair value adjustment on contingent consideration. Deferred Income Taxes Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities were as follows as of the dates presented: As of December 31, 2023 2022 Deferred tax assets Stock compensation $ 7,341 $ 6,389 Section 163(j) interest limitation 33,161 27,686 Disallowed original issue discount interest 1,527 1,092 Deferred rent - 104 Deferred revenue 7,143 6,378 Reserves and accruals 878 3,855 Capitalized research and development 8,541 5,197 Lease liability 7,375 9,110 Federal net operating loss carryforward 31,682 30,966 State net operating loss carryforward 8,559 8,202 Foreign net operating loss carryforward 7,876 4,563 Other deferred tax assets 898 782 Total deferred tax assets 114,981 104,324 Deferred tax liabilities Basis difference in fixed assets ( 1,505 ) ( 1,772 ) Basis difference in intangibles assets and goodwill ( 20,931 ) ( 23,584 ) Right of use asset ( 4,362 ) ( 5,158 ) Other deferred tax liabilities ( 2,819 ) ( 3,010 ) Total deferred tax liabilities ( 29,617 ) ( 33,524 ) Valuation allowance ( 87,542 ) ( 71,514 ) Net deferred tax liabilities $ ( 2,178 ) $ ( 714 ) At December 31, 2023, the Company had U.S. federal net operating loss (“NOL”) carryforwards of approximately $ 150,662 , o f which $ 43,109 is subject to expiration beginning in 2033 to 2037 , and state net operating loss carryforwards of $ 142,064 , which begin to expire in 2029 . The utilization of the Company’s net operating loss carryforwards may be subject to substan tial annual limitation due to the ownership change limitations provided by section 382 of the Internal Revenue Code and similar state provisions. Such an annual limitation could result in the expiration of the net operating loss and tax credit carryforwards before utilization. Future changes in stock ownership may result in an ownership change. The Company determined that it underwent an ownership change during 2014 and 2015 as defined by section 382. As a result of the 2014 ownership change, the Company determined that $ 1,271 of net operating loss carryforward would not be available in future periods. The Company is still in process of analyzing its NOL limitations with respect to 2023. The Company is not aware of any tax law provisions aside from section 382 of the Internal Revenue Code that might limit the availability or utilization of loss or credit amounts. Changes in tax law may also impact our ability to use our net operating loss and tax credit carryforwards. The Company regularly assesses the realizability of its deferred tax assets and establishes a valuation allowance if it is more likely than not that some or all of its deferred tax assets will not be realized. The Company evaluates and weighs all available positive and negative evidence such as historic results, future reversals of existing deferred tax liabilities, projected future taxable income, as well as prudent and feasible tax-planning strategies. Generally, more weight is given to objectively verifiable evidence, such as the cumulative loss in recent years. The Company increased the valuation allowance established on its deferred tax assets by $ 16,028 and $ 40,605 for the tax years ended December 31, 2023 and 2022 , respectively. In 2022, the Company also wrote-off certain deferred tax assets and a related valuation allowance of $ 4,823 to equity in connection with the conversion of convertible notes in exchange for shares upon closing of the Business Combination. The Company continues to maintain a valuation allowance on its Federal deferred tax assets related to NOL carryforwards and interest expense limitations under 163(j) and on State deferred tax assets associated with states where FiscalNote files separately and CQ Roll Call’s deferred tax liabilities are not able to be utilized. The Company will continue to assess the realizability of the deferred tax assets in each of the applicable jurisdictions going forward. On December 22, 2017, the Tax Cuts and Jobs Act (“TCJA”) was signed into law. Under the TCJA provisions, effective with tax years beginning on or after January 1, 2022, taxpayers can no longer immediately expense qualified research and development (R&D) expenditures and are required to capitalize and amortize the costs under section 174. Accordingly, the Company capitalized $23 ,180 and $30 ,719 of R&D expenses as of the years ended December 31, 2023 and 2022 , respectively. These costs will be amortized for tax purposes over 5 years for R&D performed in the U.S. and over 15 years for R&D performed outside the U.S. Unrecognized Tax Benefits and Other Considerations The Company records liabilities related to its uncertain tax positions. Tax positions for the Company and its subsidiaries are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company believes that it has provided adequate reserves for its income tax uncertainties in all open tax years. As the outcome of the tax audits cannot be predicted with certainty, if any issues arising in the Company's tax audits progress in a manner inconsistent with management's expectations, the Company could adjust its provision for income taxes in the future. For the year ended December 31, 2023, the Company reported an uncertain tax position totaling $ 639 rela ting to a state tax filing position. In addition, the Company derecognized $ 89 deferred tax liabilities relating to historically reported R&D credits as the statute of limitations had expired during the year ended December 31, 2022. T he Company has the following activities relating to unrecognized tax benefits for the periods presented: Years Ended December 31, 2023 2022 Beginning balances at December 31, 2022 and 2021 $ 639 $ 728 Lapses in statutes of limitations - ( 89 ) Ending balances at December 31, 2023 and 2022 $ 639 $ 639 The Company’s policy is to include interest and penalties related to unrecognized tax benefits, if any, with the provision for income taxes in the consolidated statements of operations. Included in the balance of unrecognized tax benefits as of December 31, 2023 and December 31, 2022 are $ 639 , respectively, of tax benefits that, if recognized, would affect the effective tax rate. During the years ended December 31, 2023 and 2022, $ 80 and $ 72 of interest and $ 0 and $ 96 of penalties were recognized, respectively, relating to uncertain tax benefits. As part of the 2018 CQRC Acq uisition, the Company recognized an uncertain tax position relating to its research and development (“R&D”) credit carry forwards of $ 0 during the years ended December 31, 2023 and 2022, respectively. The Company recognized an uncertain tax position related to a DC state combined filing that did not reach a more likely than not conclusion. The Company files income tax returns in the U.S. federal jurisdiction, various state jurisdictions, and various foreign jurisdictions. As of December 31, 2023, the Company is not under examination by income tax authorities in federal, state, or other jurisdictions. All tax returns will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any net operating loss or credits. We believe that an adequate provision has been made for any adjustments that may result from tax examinations. Although the timing of the resolution, settlement, and closure of audits is not certain, we do not believe it is reasonably possible that our unrecognized tax benefits will materially change in the next 12 months. Future sales of foreign subsidiaries are not exempt from capital gains tax in the U.S. The Company considers itself permanently reinvested in its foreign subsidiaries, and accordingly, no deferred income tax liability has been recorded for any potential taxable gain that may be realized on a future disposition or liquidation of any of its foreign subsidiaries. It is not practicable for the Company to quantify any deferred income tax liability that would be attributable to those events. Net Operating Losses At December 31, 2023, the Company had gross U.S. net operating loss carryforwards available to reduce future taxable income in the amount of $ 150,662 o f which a portion is subject to annual limitation. Based on estimates as of December 31, 2023, the Company expects that approximately $ 48,602 of the gross U.S. net operating loss carryforwards would be available to offset taxable income in 2024. |
Fair Value Measurements and Dis
Fair Value Measurements and Disclosures | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements and Disclosures | Note 17. Fair Value Measurements and Disclosures Fair value is defined as the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels, which are described below: Level 2 – Observable inputs other than quoted prices that are either directly or indirectly observable for the asset or liability Level 3 – Unobservable inputs that are supported by little or no market activity The carrying value of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2023 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,044 $ - $ - $ 3,044 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,591 $ - $ - $ 2,591 Private placement warrants - 2,170 - 2,170 Contingent liabilities from acquisitions - - 130 130 Liability classified warrants (a) - - 23 23 New GPO Note - - 36,954 36,954 Dragonfly Seller Convertible Note - - 9,002 9,002 Era Convertible Note - - 5,977 5,977 (a) Included in other current liabilities on the balance sheet The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2022 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Liabilities: Public warrants $ 10,282 $ - $ - $ 10,282 Private placement warrants - 8,610 - 8,610 Contingent liabilities from acquisitions - - 1,579 1,579 Liability classified warrants (a) - - 182 182 (a) Included in other current liabilities on the balance sheet The following table summarizes changes in fair value of the Company’s level 3 liabilities during the periods presented : Contingent Liability Classified Warrants Embedded Redemption Embedded Redemption Embedded Redemption Balance at December 31, 2021 $ 5,104 $ 1,021 $ 4,228 $ 28,058 $ 2,400 Liability classified warrants at issuance date - 436 - - - Contingent consideration at acquisition date 400 - - - - Contingent compensation recognized 1,273 - - - - Change in fair value included in the determination of net loss(a) ( 2,121 ) ( 115 ) ( 2,097 ) 3,923 1,264 Earned contingent consideration settled ( 531 ) - - - - Cash contingent compensation earned and subsequently settled ( 1,567 ) - - - - Unearned contingent compensation reversal ( 979 ) - - - - Extinguishment and/or settlement upon conversion - ( 1,160 ) ( 2,131 ) ( 31,981 ) ( 3,664 ) Balance at December 31, 2022 1,579 182 - - - Liability classified warrants at issuance date - - - - - Contingent consideration at acquisition date 1,445 - - - - Contingent compensation recognized 337 - - - - Change in fair value included in the determination of net loss (a) ( 357 ) ( 159 ) - - - Earned contingent consideration settled ( 281 ) - - - - Cash contingent compensation earned and subsequently settled ( 39 ) - - - - Unearned contingent compensation reversal ( 1,687 ) - - - - Unearned contingent consideration reversal ( 867 ) Balance at December 31, 2023 $ 130 $ 23 $ - $ - $ - (a) The change in contingent liabilities from acquisitions is recorded as transaction costs on the consolidated statements of operations and comprehensive loss. Short-Term Investments The fair value of the short-term investments is based on the quoted market price of the securities on the valuation date. As of December 31, 2023, the estimated fair value of the short-term investments was $ 7,134 . The Company recognized a non-cash loss of $ 98 f or the year ended December 31, 2023 resulting from the change in fair value of the short-term investments. The change in fair value is recorded in the consolidated statements of operations and comprehensive loss. Public Warrants The fair value of the public warrants is estimated based on the quoted market price of such warrants on the valuation date. The public warrants were initially recognized as a liability in connection with the Business Combination on July 29, 2022 at a fair value of $ 5,688 . As of December 31, 2023 and December 31, 2022 , the estimated fair value of the public warrants was $ 2,591 and $ 10,282 , respectively. The Company recognized a non-cash gain of $ 7,691 during the year ended December 31, 2023 , and a non-cash loss of $ 4,594 during the year ended December 31, 2022 resulting from the change in fair value of the public warrants. The change in fair value is recorded in change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss. Private Placement Warrants The private placement warrants were initially recognized as a liability in connection with the Business Combination on July 29, 2022 at a fair value of $ 29,259 . As of December 31, 2023 and December 31, 2022, the estimated fair value of the private warrants was $ 2,170 and $ 8,610 , respectively. The Company recognized a non-cash gain of $ 6,440 during the year ended December 31, 2023 , and a non-cash gain of $ 20,649 during the year ended December 31, 2022 resulting from the change in fair value of the private warrants. The change in fair value is recorded in change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss . The following table presents the assumptions used to determine the fair value of the private placement warrants at July 29, 2022: July 29, 2022 Valuation date share price $ 8.43 Risk-free interest rate 2.7 % Expected volatility 40.0 % Expected dividends 0.0 % Expected term (years) 5.00 Fair value (in dollars) $ 2.66 New GPO Note The New GPO Note was recognized as a liability in connection with the settlement of litigation on the Subscription Date at its estimated fair value of $ 36,583 . As of December 31, 2023, the estimated fair value of the New GPO Note was $ 36,954 . The non-cash gain of $ 1,411 is recorded in the change of fair value of financial instruments in the consolidated statements of operations and comprehensive loss during the year ended December 31, 2023. The estimated fair value of the New GPO Note was determined based on a trinomial lattice model. The following table presents the assumptions used to determine the fair value of the New GPO Note at December 31, 2023 and on the Subscription Date of June 30, 2023: December 31, 2023 June 30, 2023 Common stock share price $ 1.14 $ 3.64 Risk free rate 3.88 % 4.10 % Yield 14.50 % 15.50 % Expected volatility 50.00 % 39.00 % Expected term (years) 4.5 5.0 Dragonfly Seller Convertible Notes The Dragonfly Seller Convertible Notes were recognized as a liability in connection with the acquisition on January 27, 2023 at a fair value of $ 8,635 . As of December 31, 2023, the estimated fair value of the Dragonfly Seller Convertible Notes were $ 9,002 . The non-cash gain of $ 673 is recorded in the change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss during the year ended December 31, 2023 . The following table presents the assumptions used to determine the fair value of the Dragonfly Seller Convertible Notes at December 31, 2023 and January 27, 2023: December 31, 2023 January 27, 2023 Common stock share price $ 1.14 $ 5.06 Risk free rate 3.92 % 3.60 % Yield 15.50 % 17.50 % Expected volatility 50.00 % 40.00 % Expected term (years) 4.1 5.0 As of December 31, 2023, the difference between the aggregate fair value and the unpaid principal balance of the Dragonfly Seller Convertible No tes is $ 367 . Era Convertible Note The Era Convertible Note was recognized as a liability associated with the Company’s strategic commercial partnership on December 8, 2023 at a fair value of $ 5,500 . At December 31, 2023 the fair value of the Era Convertible Note was $ 5,977 . The non-cash loss of $ 477 is recorded in the change in fair value of financial instruments in the consolidated statements of operations and comprehensive loss during the year ended December 31, 2023 . The following table presents the as sumptions used to determine the fair value of the Era Convertible Note at December 31, 2023 and December 8, 2023: December 31, 2023 December 8, 2023 Common stock share price $ 1.14 $ 1.33 Risk free rate 4.17 % 4.63 % Yield 153.24 % 163.43 % Expected volatility 63.00 % 61.00 % Expected term (years) 3.9 4.0 Contingent Liabilities from acquisitions The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At December 31, 2023 and December 31, 2022, the contingent consideration and compensation relates to the following acquisitions: December 31, 2023 December 31, 2022 Curate $ 4 $ 883 FrontierView - 600 Equilibrium 112 43 DT Global 14 53 Total contingent liabilities from acquisitions $ 130 $ 1,579 The Company settled part of the Curate contingent consideration and compensation through an issuance of 83,393 additional shares in a non-cash transaction during the first quarter of 2023 and 83,393 additional shares during the fourth quarter of 2023. The Company estimated the fair value of the Curate contingent consideration and compensation using a Monte Carlo simulation. These fair value measurements are based on significant inputs not observable in the market and thus represents Level 3 measurements as defined in ASC 820. Significant changes in the key assumptions and inputs could result in a significant change in the fair value measurement of the contingent consideration. The following inputs and assumptions were used to value contingent liabilities from acquisitions as of December 31, 2023: Curate Risk premium 11.00 % Risk free rate 5.40 % Revenue volatility 20.00 % Expected life (years) 0.3 Liability classified warrants The Last Out Lender Warrants are classified as Level 3 in the fair value hierarchy. The fair value of the Last Out Lender Warrants (see Note 9, Debt) is calculated using the Black-Scholes calculation with the following inputs: December 31, 2023 Common stock fair value $ 1.14 Time to maturity (years) 1.6 Risk-free interest rate 4.45 % Volatility 122.0 % Exercise price $ 8.56 Non-Financial Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis The Company’s long-lived assets, including property and equipment, intangible assets and goodwill are measured at fair value on a non-recurring basis when an impairment has occurred. Excluding the impairment of an operating lease asset related to certain unoccupied office space and the impairment of goodwill and other long-lived assets as disclosed in Note 5, Leases, Note 7, Intangible Assets, and Note 8, Goodwill, no other impairment events were identified during the years ended December 31, 2023 and 2022. Excluding a total of $ 1,267 ear ned cash contingent compensation related to FrontierView and Forge being transferred from Level 3 to Level 1 during the December 31, 2022, there were no other transfers of assets or liabilities between levels during the years ended December 31, 2023 and 2022. Changes to fair value are recognized as income or expense in the consolidated statements of operations and comprehensive loss. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 18. Commitments and Contingencies Legal Proceedings From time to time the Company is a party to various disputes, claims, lawsuits and other regulatory and legal matters, including both asserted and unasserted legal claims, in the ordinary course of business. The status of each such matter, referred to herein as a loss contingency, is reviewed and assessed in accordance with applicable accounting rules regarding the nature of the matter, the likelihood that a loss will be incurred, and the amounts involved. As discussed in Note 9, "Debt", on June 30, 2023, the Company entered into the Exchange and Settlement Agreement and New GPO Note. Pursuant thereto, on July 3, 2023, (i) the Disputing Lender returned 5,881,723 shares of Class A Common Stock, which the Company subsequently cancelled, (ii) the Company issued the New GPO Note, and (iii) the parties agreed to a mutual settlement and release of all claims (including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement), relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor. Legal fees are recognized as incurred when the legal services are provided, and therefore are not recognized as part of the loss contingency. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 19. Subsequent Events The Company has evaluated subsequent events through March14, 2024, the date that these financial statements were available to be issued. Sale of Board.org On March 11, 2024, FiscalNote, Inc. (the “Seller”), an indirect wholly-owned subsidiary of the Company, entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Exec Connect Intermediate LLC (the “Buyer”) and FiscalNote Boards LLC, a wholly-owned subsidiary of the Seller formerly known as Board.org, LLC (“Board.org”), pursuant to which the Seller sold 100 % of the equity of Board.org to the Buyer (the “Equity Sale”). As consideration for the Equity Sale, at the closing of the Equity Sale (the “Closing”) the Buyer paid the Seller a base purchase price of $ 95 million in cash, subject to adjustments based on Closing working capital, indebtedness and transaction expenses, as well as retention payments payable to certain employees of the Company following the Closing (the “Base Purchase Price”). In addition, the Buyer agreed to make a potential cash earn-out payment to the Seller in the amount of $ 5 million or $ 8 million, less the amount of certain potential retention payments to certain employees of the Company, subject to the Company’s achievement of certain revenue targets for 2024. $ 0.8 million of the Base Purchase Price was deposited into escrow to satisfy certain potential post-Closing purchase price adjustments and indemnification claims. The Purchase Agreement contains representations, warranties and indemnification obligations of the parties customary for transactions similar to those contemplated by the Purchase Agreement. The Buyer has obtained a representation and warranty insurance policy that will provide coverage for certain losses incurred as a result of breaches of certain specified representations and warranties of the Seller contained in the Purchase Agreement, provided that the recovery under such policy is subject to certain exclusions, policy limits and certain other terms and conditions, all as more fully described in the Purchase Agreement. The Seller will not be responsible for any breaches of the representations or warranties other than for breaches of Fundamental Representations or Fraud (as such terms are defined in the Purchase Agreement) beyond the amount held in escrow. Pursuant to a Transition Services Agreement and Employee Lease Agreement entered into in connection with the Closing, the Seller will provide certain transitional support services and employees to Board.org for a period of time following the Closing and Board.org will reimburse the Seller for its direct costs of those services and employees. Amendment No. 4 to Senior Term Loan In connection with the completion of the sale of Board.org on March 11, 2024, the Company also entered into Amendment No. 4 to the Senior Term Loan (“Amendment No. 4”), pursuant to which, among other things, the lenders consented to release the liens on Board.org’s assets and permitted the consummation of the sale in exchange for the permanent retirement of $ 65.7 million (the “Pay-Down Amount”) of term loans under the Senior Term Loan and payment of approximately $ 7.1 million of related prepayment and exit fees. Amendment No. 4 also requires that upon receipt of any earn-out payment under the Purchase Agreement, the Company will prepay outstanding obligations under the Senior Term Loan in an amount equal to 70 % of the net proceeds received from such earn-out payment, together with a prepayment fee and an exit fee, equal to 5.75 % of the amount of such prepayment. In addition, Amendment No. 4 extended the commencement of amortization payments under the Senior Term Loan from August 15, 2025 to August 15, 2026, with such payments to fully amortize the term loans by the maturity date of July 15, 2027 . Amendment No. 4 also increased the Company’s minimum liquidity covenant and modified the Company’s minimum ARR and EBITDA covenants, as defined in the Senior Term Loan, in order to appropriately reflect the sale of Board.org and the absence of its future contributions to the Company’s overall financial performance and position. |
Summary of Business and Signi_2
Summary of Business and Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Description of Business | Description of Business FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political and regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C. On July 29, 2022 (the “Closing Date”), the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions (the “Closing”), DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in these notes to the financial statements to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the Closing. |
Basis of Presentation and Interim Financial Information | Basis of Presentation and Interim Financial Information We accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. This determination was primarily based on: • Old FiscalNote stockholders having the largest voting interest in New FiscalNote; • the board of directors of New FiscalNote having ten members, and Old FiscalNote’s former stockholders having the ability to nominate the majority of the members of the board of directors; • Old FiscalNote management continuing to hold executive management roles for the post-combination company and being responsible for the day-to-day operations; • the post-combination company assuming the Old FiscalNote name; • New FiscalNote maintaining the pre-existing Old FiscalNote headquarters; and • the intended strategy of New FiscalNote being a continuation of Old FiscalNote’s strategy. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded. While DSAC was the legal acquirer in the Business Combination, because Old FiscalNote was determined as the accounting acquirer, the historical financial statements of Old FiscalNote became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the financial statements included in the consolidated financial statements reflect (i) the historical operating results of Old FiscalNote prior to the Business Combination; (ii) the combined results of the Company and Old FiscalNote following the closing of the Business Combination; (iii) the assets and liabilities of Old FiscalNote at their historical cost; and (iv) the Company’s equity structure for all periods presented. In connection with the Business Combination, the Company has converted the equity structure for the periods prior to the Business Combination to reflect the number of shares of New FiscalNote’s common stock issued to Old FiscalNote’s stockholders in connection with the recapitalization transaction based on an exchange ratio of 1.187 (the "Exchange Ratio"), determined pursuant to the terms of the Business Combination . As such, the shares, corresponding capital amounts and earnings per share, as applicable, related to Old FiscalNote’s, convertible preferred stock, and common stock prior to the Business Combination have been retroactively converted as shares by applying the Exchange Ratio. |
Liquidity | Liquidity Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. The Company's ability to maintain its minimum cash requirement, fund its future cash interest requirements under its senior term loan and fund its operations depend in part on general economic, financial, competitive, legislative, regulatory and other conditions that may be beyond the Company's control. Accordingly, the Company continues to closely monitor expenses to assess whether any immediate, or long-term changes, are necessary to maintain compliance with its financial covenants. The Company’s cash, cash equivalents, restricted cash, and short-term investments were $ 24,434 as of December 31, 2023, compared with $ 61,223 as of December 31, 2022 . Further, the Company had negative working capital (excluding cash, restricted cash, and short-term investments) of $ 40,279 and $ 37,330 at December 31, 2023 and December 31, 2022, respectively, and had an accumulated deficit of $ 816,416 and $ 700,743 as of December 31, 2023 and December 31, 2022, respectively, and has incurred net losses of $ 115,461 and $ 218,257 for the years ended December 31, 2023 and 2022, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development. In addition, as disclosed in Note 9, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants are based on the Company’s current expectations regarding continued growth in revenues, collections, cost structure, current cash burn rate and other operating assumptions. The Company believes our cash on hand at December 31, 2023, net proceeds from the sale of Board.org (see Note 19, Subsequent Events ), proceeds from our expected product sales, and available borrowings under our Senior Term Loan for certain acquisition activity, will be sufficient to meet our obligations and our required covenants for at least the next twelve months from the date of this filing. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions in the Company’s consolidated financial statements and notes thereto. Significant estimates and assumptions made by management include the determination of: • revenue recognition; • the average period of benefit associated with costs capitalized to obtain revenue contracts; • the fair value of assets acquired and liabilities assumed for business combinations; • the useful lives of intangible assets; • capitalization of software development costs; • valuation of financial instruments; • impairment of goodwill and long-lived assets; • the fair value of certain stock awards issued; • the fair value of certain consideration issued as part of business combinations; • the recognition, measurement, and valuation of current and deferred income taxes and uncertain tax positions; and • the incremental borrowing rate used to calculate lease balances. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, which forms the basis for making judgments about the carrying values of assets and liabilities. |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances have been eliminated in consolidation. |
Segments | Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. Over the past several years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence, and reach in various market segments. While the Company has offerings in multiple market segments and operates in multiple countries, the Company’s business operates in one operating segment because the Company’s CODM evaluates the Company’s financial information and resources, and assesses the performance of these resources, on a consolidated basis. |
Concentration Risks | Concentrations of Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation. The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success. No single customer accounted for more than 10 % of the Company's accounts receivable balance as of December 31, 2023 and December 31, 2022 . Revenue derived from the U.S. Federal Government was 16 % and 18 % of revenue for the years ended December 31, 2023 and December 31, 2022. As of December 31, 2023 and December 31, 2022 , assets located in the United States were approximately 85 % and 92 % percent of total assets. No vendors and two vendors individually accounted for more than 10 % of the Company’s accounts payable as of December 31, 2023 and December 31, 2022, respectively. During the years ended December 31, 2023 and 2022 , no vendor and one vendor represented more than 10 % of the total purchases made. |
Revenue Recognition | Revenue Recognition The Company recognizes revenues upon the satisfaction of its performance obligation(s) (upon transfer of control of promised goods or services to its customers) in an amount that reflects the consideration to which it expects to be entitled to in exchange for those goods or services. The Company has elected to exclude sales and similar taxes from the transaction price. The Company determines the amount of revenue to be recognized through the application of the following steps: (i) identification of contracts with customers, (ii) identification of distinct performance obligations in the contract, (iii) determination of contract transaction price, (iv) allocation of contract transaction price to the performance obligations, and (v) determination of revenue recognition based on timing of satisfaction of the performance obligation(s). The Company derives its revenues from subscription revenue arrangements and advisory, advertising, and other revenues. Subscription Revenue Subscription revenue consists of revenue earned from subscription-based arrangements that provide customers the right to use the Company’s software and products in a cloud-based infrastructure. Subscription revenue is driven primarily by the number of active licenses, the types of products and the price of the subscriptions. The Company also earns subscription-based revenue by licensing to customers its digital content, including transcripts, news and analysis, images, video, and podcast data. Subscription revenue is generally non-refundable regardless of the actual use and is recognized ratably over the non-cancellable contract term beginning on the commencement date of each contract, which is the date the Company’s service is first made available to customers. The Company's contracts with customers may include promises to transfer multiple services. For these contracts, the Company accounts for individual promises separately if they are distinct performance obligations. Determining whether services are considered distinct performance obligations may require significant judgment. Judgment is also required to determine the standalone selling price (“SSP”) for each distinct performance obligation. In instances where SSP is not directly observable, such as when the Company does not sell the services separately, the Company determines the SSP using available information, including market conditions and other observable inputs. The Company typically invoices its customers annually. Typical payment terms provide that customers pay within 30 days of invoice. Amounts that have been invoiced are recorded in accounts receivable and in deferred revenue, depending on whether transfer of control to customers has occurred. Deferred revenue results from amounts billed to or cash received from customers in advance of the revenue being recognized. Contract assets represent a conditional right to consideration for satisfied performance obligations that become a receivable when the conditions are satisfied. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collection and are included in other current assets in the accompanying consolidated balance sheets. Advisory, Advertising, and Other Revenues Advisory revenue is typically earned under contracts for specific deliverables and is non-recurring in nature, although the Company may sell different advisory services to repeat customers. One-time advisory revenue is invoiced according to the terms of the contract, usually delivered to the customer over a short period of time, during which revenue is recognized. Advertising revenue is primarily generated by delivering advertising in its publications (Roll Call and CQ) in both print and digital formats. Revenue for print advertising is recognized upon publication of the advertisement. Revenue for digital advertising is recognized over the period of the advertisement or, if the contract contains impression guarantees, based on delivered impressions. Book revenue is recognized when the product is shipped to the customer, which is when control of the product is transferred to the customer. Shipping and handling costs are treated as a fulfillment activity and are expensed as incurred. Events revenue is deferred and only recognized when the event has taken place and is included in other revenues |
Costs Capitalized to Obtain Revenue Contracts | Costs Capitalized to Obtain Revenue Contracts The Company capitalizes incremental costs of obtaining a contract. Certain sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Sales commissions incurred for obtaining new contracts are deferred and then amortized as selling and marketing expenses on a straight-line basis over a period of benefit that the Company has determined to be approximately four years . The four-year amortization period was determined based on several factors, including the nature of the technology and proprietary data underlying the services being purchased, customer contract renewal rates and industry competition. The Company updates its estimate of the period of benefit periodically and whenever events or circumstances indicate that the period of benefit could change significantly. Such changes, if any, are accounted for prospectively as a change in estimate. The Company has elected to use a practical expedient to expense commissions for renewal contracts when the renewal period is 12 months or less . The Company does not have material costs to fulfill contracts with customers. |
Cost of Revenues | Cost of Revenues Cost of revenues primarily consists of expenses related to hosting the Company’s service, the costs of data center capacity, amortization of developed technology and capitalized software development costs, certain fees paid to various third parties for the use of their technology, services, or data, costs of compensation, including bonuses, stock compensation, benefits and other expenses for employees associated with providing professional services and other direct costs of production. Also included in cost of revenues are costs related to develop, publish, print, and deliver publications. |
Cash, Cash Equivalents, and Restricted Cash | Cash, Cash Equivalents, and Restricted Cash The Company considers cash on deposit and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At December 31, 2023 , over 57 % of the Company’s cash and cash equivalents were held at JPMorgan Chase Bank, N.A. In 2017, as an incentive for entering into a lease and building out the Company’s head office in Washington, D.C., the District granted to the Company $ 750 to finance the security deposit of the new office. The Company is required to meet certain covenants, such as maintaining its headquarters in Washington, D.C., and may have to reimburse the District if the covenants are not met. The amount of the grant is reflected as restricted cash, including any interest earned, in the accompanying consolidated balance sheets. |
Investments | Investments The Company has invested in highly liquid investments that have investment-grade ratings. These investments are accounted for at fair value through the consolidated statement of operations. The Company is able to easily liquidate these into cash; accordingly, the Company has presented these investments as available for current operations and are presented as short-term investments within current assets in the condensed consolidated balance sheets. Purchases and sales of short-term investments are classified in the investing section of our consolidated statement of cash flows. |
Property and Equipment | Property and Equipment Property and equipment are stated at cost and depreciated on a straight-line basis over the assets’ estimated useful lives, which generally are five years for furniture and fixtures, three years for equipment, and the shorter of the useful life or the lease term for leasehold improvements. Software license fees for externally purchased software are capitalized and amortized over the life of the license. Property and equipment are evaluated for impairment in accordance with management’s policy for finite-lived intangible assets and other long-lived assets (see Note 7, Intangible Assets). |
Capitalized Software Development Costs | Capitalized Software Development Costs The Company capitalizes costs to develop software for internal use, including website development costs, when it is determined the development efforts will result in new or additional functionality or new products. Costs incurred prior to meeting these criteria and costs associated with implementation activities and ongoing maintenance are expensed as incurred and included in operating expenses in the accompanying consolidated statements of operations and comprehensive loss. Costs capitalized as internal use software are amortized on a straight-line basis over an estimated useful life that the Company has determined to be three years . Amortization of capitalized software development costs is included in the costs of revenues in the accompanyi ng consolidated statements of operations and comprehensive loss. Software development costs are evaluated for impairment in accordance with management’s policy for finite-lived intangible assets and other long-lived assets (see Note 7, Intangible Assets). |
Business Combinations | Business Combinations The Company must estimate the fair value of assets acquired and liabilities assumed in a business combination at the acquisition date. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the fair values of the tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the consolidated statement of operations and comprehensive loss. |
Acquisition-Related Intangibles and Other Long-Lived Assets | Acquisition-Related Intangibles and Other Long-Lived Assets The Company recognizes acquisition-related intangible assets, such as customer relationships and developed technology, in connection with business combinations. The Company amortizes the cost of acquisition-related intangible assets that have finite useful lives generally on a straight-line basis. The Company evaluates acquisition-related intangibles and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of asset groups are measured by a comparison of the carrying amount of an asset group to future undiscounted net cash flows expected to be generated by the asset group. This includes assumptions about future prospects for the business that the asset group relates to and typically involves computations of the estimated future cash flows to be generated by these businesses. Based on these judgments and assumptions, the Company determines whether the Company needs to take an impairment charge to reduce the value of the asset group stated on the Company’s consolidated balance sheets to reflect its estimated fair value. When the Company considers such assets to be impaired, the amount of impairment the Company recognizes is measured by the amount by which the carrying amount of the asset group exceeds its fair value. During the fourth quarter of 2023, the Company recorded non-cash impairment charges totaling $ 6,223 (see Note 7, Intangible Assets). There were no impairments of long-lived assets during the year ended December 31, 2022. |
Goodwill Impairment | Goodwill Impairment Goodwill is not amortized, but is evaluated for impairment annually, or whenever events or changes in circumstances indicate that the carrying value may not be recoverable. For purposes of assessing potential impairment, the Company estimates the fair value of its reporting units based on the price a market participant would be willing to pay in a potential sale of the reporting unit, and compares this amount to the carrying value of the reporting unit. If the Company determines that the carrying value of the reporting unit exceeds its fair value, an impairment charge would be required. The annual goodwill impairment test is performed on October 1st. During the year ended December 31, 2023, the Company recorded non-cash goodwill impairment charges totaling $ 25,841 (see Note 8, Goodwill). There were no impairments of goodwill during the year ended December 31, 2022 . |
Leases | Leases The Company determines if an arrangement is a lease or contains a lease at the inception of the contract. The Company’s leases include certain variable lease payments associated with non-lease components, such as common area maintenance costs and real estate taxes, which are generally charged based on actual amounts incurred by the lessor. The non-lease components are combined with the lease component to account for both as a single lease component. Lease liabilities, which represent the Company's obligation to make lease payments arising from the lease, and corresponding right-of-use assets, which represent the Company's right to use an underlying asset for the lease term, are recognized at the commencement date of the lease based on the present value of fixed future payments over the lease term. The Company calculates the present value of future payments using a discount rate equal to the Company’s incremental borrowing rate. For operating leases, lease expense relating to fixed payments is recognized on a straight-line basis over the lease term and lease expense relating to variable payments is expensed as incurred. The Company did no t have any finance leases at January 1, 2022 (date of adoption), December 31, 2022 and at December 31, 2023. The Company records costs associated with leases within general and administrative expenses on the consolidated statements of operations and comprehensive loss. The Company subleases certain leased office spaces to third parties and recognizes sublease income on a straight-line basis over the sublease term as an offset to lease expense as part of the general and administrative expense in the consolidated statements of operations and comprehensive loss. |
Warrant Liabilities | Warrant Liabilities The Company evaluates its financial instruments, including its outstanding warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company has outstanding public and private warrants, both of which do not meet the criteria for equity classification and are accounted for as liabilities. Accordingly, the Company recognizes the warrants as liabilities at fair value and adjusts the warrants to fair value at each reporting period. The warrant liabilities are subject to re-measurement at each balance sheets date until exercised, and any change in fair value is recognized in the Company’s consolidated statement of operations and comprehensive loss. |
Stock-Based Compensation | Stock-Based Compensation Stock-based compensation awards consist of stock options and restricted stock units (collectively “stock-based awards”). The Company has historically issued stock options with exercise prices equal to the fair value of the underlying stock price. Prior to the completion of the Business Combination and listing of the Company’s Class A common stock on the public stock exchange, the fair value of Old FiscalNote common stock underlying the stock options was determined based on then-current valuation estimates at the time of grant. Because such grants occurred prior to the public trading of the Company’s Class A common stock, the fair value of Old FiscalNote common stock was typically determined with assistance of periodic valuation analyses from an independent third-party valuation firm. The Company calculates the fair value of stock options using the Black-Scholes option-pricing model. For share-based awards with performance conditions, the Company periodically assesses whether the performance conditions have been met or are probable of being met in order to determine the timing and amount of compensation expense to be recognized for each reporting period. Compensation expense for all option awards is recorded on a straight-line basis over the requisite service period of the awards, which is generally the option’s vesting period. These amounts are reduced by the forfeitures as the forfeitures occur. |
Income Taxes | Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect on deferred tax assets and liabilities of a change in tax laws is recognized in the consolidated statements of operations and comprehensive loss in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are expected to be realized based on the weighting of positive and negative evidence. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the applicable tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed. The Company’s tax positions are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that the position is sustainable upon examination by the taxing authority, solely based on its technical merits. The tax benefit recognized is measured as the largest amount of benefit which is greater than 50 percent likely to be realized upon settlement with the taxing authority. The Company recognizes interest accrued and penalties related to unrecognized tax benefits in the income tax provision. |
Foreign Currency Transaction | Foreign Currency Translation The functional currency of the Company’s major foreign subsidiaries is generally the local currency. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using historical exchange rates. Adjustments resulting from translating foreign functional currency financial statements into U.S. dollars are recorded as a separate component on the consolidated statements of operations and comprehensive loss. Foreign currency transaction gains and losses are included in other expense, net in the consolidated statements of operations and comprehensive loss for the period and historically have not been material. Currency gains and losses on the translation of intercompany loans made to foreign subsidiaries that are of a long-term investment nature are included in accumulated other comprehensive loss. |
Related Party Transactions | Related Party Transactions From time to time the Company has entered into related party transactions with certain of the Company's directors and officers. These transactions have historically included term loans, convertible debt, and convertible preferred stock. |
Fair Value Measurement | Fair Value Measurements The Company accounts for assets and liabilities in accordance with accounting standards that define fair value and establish a consistent framework for measuring fair value on either a recurring or a nonrecurring basis. Fair value is an exit price representing the amount that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. Accounting standards include disclosure requirements relating to the fair values used for certain financial instruments and establish a fair value hierarchy. The hierarchy prioritizes valuation inputs into three levels based on the extent to which inputs used in measuring fair value are observable in the market. Each fair value measurement is reported in one of three levels: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Assets or liabilities valued based on observable market data for similar instruments, such as quoted prices for similar assets or liabilities. Level 3: Unobservable inputs that are supported by little or no market activity; instruments valued based on the best available data, some of which is internally developed, and considers risk premiums that a market participant would require. |
Recent Accounting Pronouncements Not Yet Effective | Recent Accounting Pronouncements Not Yet Effective In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280) guidance for segment reporting. The new guidance amends segment reporting to include significant segment expenses. The guidance will be effective for the Company's year beginning January 1, 2024. The Company does not expect that this guidance will have a significant impact on our disclosures. The Company has evaluated all issued Accounting Standards Updates and believes the adoption of these standards will not have a material impact on its consolidated statements of operations and comprehensive loss, balance sheets, or cash flows. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments in the ASU enhance income tax disclosures, primarily through standardization, disaggregation of rate reconciliation categories, and income taxes paid by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption allowed. We are currently evaluating the impact of adoption on our financial disclosures. |
Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02 Leases (ASC 842) guidance for the accounting for leases. Under the new guidance, lessees are required to recognize lease assets and lease liabilities on the balance sheets for all leases with terms longer than 12 months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company adopted ASU 2016-02 on January 1, 2022 using the effective date method. By applying ASU 2016-02 at the adoption date, as opposed to at the beginning of the earliest period presented, the Company's reporting for periods prior to January 1, 2022 continues to be in accordance with Leases (ASC 840) . The Company elected the package of practical expedients which permits carrying forward historical accounting positions around lease identification, lease classification and initial direct costs for all leases commencing prior to January 1, 2022. The Company also made a policy election to not separate lease and non-lease components for all of its leases and to exclude leases with a term of 12 months or less at the commencement date from the lease asset and lease liability recognition and measurement requirements under ASC 842. Adoption of the standard on January 1, 2022 resulted in the recording of $ 25,912 of operating lease assets and $ 42,324 of operating lease liabilities. The difference between the operating lease assets and operating lease liabilities at transition represented previously recognized deferred rent, lease incentives, and sublease loss liabilities. The Company did not adjust the prior period balance sheets. Adoption of the standard did not impact our consolidated statements of operations and comprehensive loss and consolidated statements of cash flows. See Note 5, Leases for required disclosures related to leases. In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") guidance with respect to measuring credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate now reflects an entity's current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company adopted ASC 2016-13 on January 1, 2023 using the modified retrospective transition method. Upon adoption, the Company recorded a $ 212 cumulative-effect adjustment to accumulated deficit on the consolidated balance sheets, our allowance for doubtful accounts receivable changed from $ 468 at December 31, 2022 to $ 680 at January 1, 2023 . In December 2019, the FASB issued ASU 2019-12 Simplifying the Accounting for Income Taxes guidance modifying the requirements for the accounting for income taxes. The simplifications include changes in the accounting for (i) intra-period tax allocations, (ii) outside basis differences in business combinations, (iii) interim provisions, (iv) step-up in tax basis goodwill and (v) franchise and other taxes partially based on income, among other changes. The Company adopted ASC 2019-12 on January 1, 2022. The adoption of this new guidance did not have a material impact on the Company's consolidated financial statements. In August 2020, the FASB issued ASU 2020-06 Debt – Debt with Conversion and Other Options (ASC 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASC 815-40) ("ASU 2020-06") guidance modifying the requirements for the accounting for convertible instruments and contracts in an entity’s own equity. The modifications eliminate certain accounting models for convertible debt instruments, eliminate certain requirements for equity classification of embedded derivatives and align earnings per share calculations for convertible instruments. The Company adopted ASC 2020-06 on January 1, 2023 using the modified retrospective approach. The adoption of ASC 2020-06 did not have a material impact on the Company's consolidated financial statements. In October 2021, the FASB issued ASU 2021-08 Business Combinations (ASC 805) Accounting for Contract Assets and Contract Liabilities from Contracts with Customers guidance requiring entities to apply ASC 606 to recognize and measure contract assets and contract liabilities in a business combination. Under current GAAP, an acquirer generally recognizes assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers and other similar contracts that are accounted for in accordance with ASC 606, at fair value on the acquisition date. Under the new guidance the acquirer will recognize contract assets and contract liabilities at the same amounts recorded by the acquiree. The modifications improve comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. The Company adopted ASC 2021-08 on January 1, 2022. The adoption of this new guidance did not have a material impact on the Company's consolidated financial statements. |
Revenues (Tables)
Revenues (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following table depicts the Company's disaggregated revenue for the periods presented: Years Ended December 31, 2023 2022 Subscription $ 119,082 $ 100,522 Advisory 5,455 4,914 Advertising 1,632 2,703 Books 1,166 736 Other revenue 5,310 4,890 Total $ 132,645 $ 113,765 |
Schedule of Revenue by Geographic Operations | The following table depicts the Company’s revenue by geographic operations for the periods presented: Years Ended December 31, 2023 2022 North America $ 107,108 $ 98,951 Europe 19,749 10,072 Australia 1,193 1,122 Asia 4,595 3,620 Total $ 132,645 $ 113,765 |
Schedule of Deferred Revenue | Details of the Company’s deferred revenue for the periods presented are as follows: Balance at December 31, 2021 $ 30,097 Acquired deferred revenue 1,055 Revenue recognized in the current period from amounts in the prior balance ( 29,351 ) New deferrals, net of amounts recognized in the current period 35,139 Effects of foreign currency ( 453 ) Balance at December 31, 2022 36,487 Acquired deferred revenue 3,933 Revenue recognized in the current period from amounts in the prior balance ( 35,598 ) New deferrals, net of amounts recognized in the current period 39,220 Effects of foreign currency 363 Balance at December 31, 2023 $ 44,405 |
Business Combinations (Tables)
Business Combinations (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Business Acquisition [Line Items] | |
Summary of Contingent Consideration | The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At December 31, 2023 and December 31, 2022, the contingent consideration and compensation relates to the following acquisitions: December 31, 2023 December 31, 2022 Curate $ 4 $ 883 FrontierView - 600 Equilibrium 112 43 DT Global 14 53 Total contingent liabilities from acquisitions $ 130 $ 1,579 |
Dragonfly Eye Limited | |
Business Acquisition [Line Items] | |
Summary of Fair Value of Consideration Transferred | The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236 |
Summary of Fair Values of Assets Acquired and Liabilities Assumed | The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236 |
Summary of Components of Identified Intangible Assets Acquired and Estimated Useful Lives | The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 |
Aicel Technologies | |
Business Acquisition [Line Items] | |
Summary of Fair Value of Consideration Transferred | The acquisition date fair value of the consideration transferred for Aicel consisted of the following: Fair value of Class A common stock $ 8,590 Fair value of contingent consideration 88 Total $ 8,678 |
Summary of Fair Values of Assets Acquired and Liabilities Assumed | The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 1,525 Current assets, net 447 Property and equipment, net 53 Equity method investment 45 Intangible assets 3,000 Deferred revenues ( 602 ) Other current liabilities ( 453 ) Debt ( 1,131 ) Total net assets acquired 2,884 Goodwill 5,794 Total purchase price $ 8,678 |
Summary of Components of Identified Intangible Assets Acquired and Estimated Useful Lives | The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Developed technology $ 1,200 8 Database 750 8 Customer relationships 650 11 Tradename 400 7 Total intangible assets acquired $ 3,000 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Summary of Lease Expense | The following table details the composition of lease expense for the year presented: Year Ended Years Ended December 31, 2023 December 31, 2022 Operating lease cost (a) $ 6,138 $ 9,769 Variable lease cost 841 518 Short-term lease cost 550 1,236 Total lease costs $ 7,529 $ 11,523 Sublease income $ ( 1,442 ) $ ( 5,350 ) (a) Excludes operating lease assets impairment charge of $ 378 related to an unoccupied existing office space lease recorded in the first quarter of 2022. |
Summary of Future Minimum Lease Payments | The following tables present the future minimum lease payments and additional information about the Company's lease obligations as of December 31, 2023: 2024 $ 5,402 2025 5,183 2026 5,298 2027 5,288 2028 5,163 Thereafter 13,004 Total minimum lease payments 39,338 Less: Amounts representing interest 10,110 Net minimum lease payments $ 29,228 |
Summary of Additional Information about Lease Obligations | December 31, 2023 December 31, 2022 Weighted average remaining lease term (in years) 7.2 7.5 Weighted average discount rate 8.5 % 8.5 % |
Summary of Supplemental Cash Flow Information | The following table presents supplemental cash flow information for the period presented: Year Ended Year Ended December 31, 2023 December 31, 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows for operating leases $ 9,481 $ 11,805 Supplemental noncash information on lease liabilities arising from obtaining operating lease assets: Operating lease assets obtained in exchange for lease obligations $ 272 $ 2,074 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Summary of Details of Property and Equipment | The following table details property and equipment as of the dates presented: As of December 31, 2023 2022 Leasehold improvements $ 9,526 $ 9,525 Furniture and fixtures 102 98 Equipment 498 495 Computer equipment 2,332 2,177 Total property and equipment $ 12,458 $ 12,295 Less: accumulated depreciation ( 6,317 ) ( 4,970 ) Total property and equipment, net $ 6,141 $ 7,325 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Summary of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets by Major Class | The following table summarizes the gross carrying amounts and accumulated amortization of the Company’s intangible assets by major class: December 31, 2023 December 31, 2022 Weighted Average Gross Carrying Amount Accumulated Amortization Impairment Net Gross Carrying Amount Accumulated Amortization Net Remaining Useful Life (Years) December 31, 2023 Customer relationships $ 88,544 $ ( 32,392 ) $ ( 2,235 ) $ 53,917 $ 81,002 $ ( 24,654 ) $ 56,348 8.3 Developed technology 37,205 ( 26,743 ) ( 1,909 ) 8,553 35,350 ( 17,673 ) 17,677 6.6 Databases 29,895 ( 11,057 ) - 18,838 29,912 ( 8,892 ) 21,020 8.8 Tradenames 12,077 ( 4,367 ) ( 579 ) 7,131 11,480 ( 3,216 ) 8,264 8.3 Expert network 2,692 ( 1,291 ) - 1,401 2,559 ( 800 ) 1,759 3.1 Patents 784 ( 217 ) ( 8 ) 559 700 ( 200 ) 500 17.6 Content library 592 ( 123 ) - 469 592 ( 64 ) 528 7.9 To tal $ 171,789 $ ( 76,190 ) $ ( 4,731 ) $ 90,868 $ 161,595 $ ( 55,499 ) $ 106,096 |
Schedule of Expected Future Amortization Expense for Intangible Assets | The expected future amortization expense for intangible assets as of December 31, 2023 is as follows: 2024 $ 13,364 2025 11,771 2026 11,481 2027 11,069 2028 9,992 Thereafter 33,191 Total $ 90,868 |
Schedule of Capitalized Software Development Costs | Capitalized software development costs are as follows: December 31, 2023 December 31, 2022 Gross Carrying Amount Accumulated Amortization Impairment Net Gross Carrying Amount Accumulated Amortization Net Capitalized software development costs $ 27,659 $ ( 12,795 ) $ ( 1,492 ) $ 13,372 $ 19,815 $ ( 5,869 ) $ 13,946 |
Goodwill (Tables)
Goodwill (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill [Roll Forward] | |
Summary of Changes in Carrying Amounts of Goodwill | The changes in the carrying amounts of goodwill, which are generally not deductible for tax purposes, are as follows: Balance at December 31, 2021 $ 188,768 Acquisitions 5,794 Impact of foreign currency fluctuations ( 200 ) Balance at December 31, 2022 194,362 Acquisition 18,535 Impairment ( 25,841 ) Impact of foreign currency fluctuations 647 Balance at December 31, 2023 $ 187,703 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Summary of Carrying Value of Debt | The following presents the carrying value of the Company’s debt as of the respective period ends: December 31, 2023 December 31, 2022 Senior Term Loan $ 158,228 $ 150,647 New GPO Note 36,954 - Convertible notes 14,052 12,219 Dragonfly Convertible Note 9,002 - Era Convertible Note 5,977 - Aicel Convertible Note 1,156 1,174 PPP loan 144 251 Total gross debt 225,513 164,291 Debt issuance costs ( 3,098 ) ( 2,243 ) Total 222,415 162,048 Less: Current maturities ( 105 ) ( 68 ) Total long-term debt $ 222,310 $ 161,980 |
Summary of Estimated Fair Value of Debt | The following table summarizes the total estimated fair value of the Company's debt as of December 31, 2023 and December 31, 2022, respectively. December 31, 2023 December 31, 2022 Senior Term Loan $ 168,702 $ 165,540 New GPO Note 36,954 - Convertible notes 13,992 16,942 Dragonfly Seller Convertible Notes 10,407 - Era Convertible Notes 5,977 - Total $ 236,032 $ 182,482 |
Summary of Maturities of Debt | Maturities of debt during the years subsequent to December 31, 2023 are as follows: 2024 $ 105 2025 30,340 2026 39,000 2027 110,111 2028 45,957 Total $ 225,513 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement, Noncash Expense [Abstract] | |
Summary of Activities Related to Stock Options and Performance Stock Units | The following table summarizes activities related to stock options and performance stock units during the period presented: Stock Options awards Number of Weighted-average Weighted-average Aggregate Outstanding at December 31, 2021 8,695,002 $ 3.28 7.3 $ 52,941 Granted 2,121,495 6.27 Exercised ( 223,323 ) 1.07 Cancelled and forfeited ( 850,643 ) 3.34 Outstanding at December 31, 2022 9,742,531 $ 3.82 7.5 $ 24,659 Vested and exercisable as of December 31, 2022 4,729,547 $ 2.51 6.5 $ 18,197 Vested and expected to vest as of December 31, 2022 9,742,531 Outstanding at December 31, 2022 9,742,531 $ 3.82 7.5 $ 24,659 Granted 476,902 3.98 Exercised ( 327,447 ) 1.81 Cancelled and forfeited ( 432,441 ) 6.55 Expired ( 189,947 ) 3.71 Outstanding at December 31, 2023 9,269,598 $ 3.74 6.1 $ - Vested and exercisable as of December 31, 2023 5,425,239 $ 3.11 5.1 Vested and expected to vest as of December 31, 2023 3,844,359 |
Summary of Weighted Average Assumptions Used to Estimate Fair Value | The following table summarizes the weighted-average assumptions used to estimate the fair value of stock options granted during the periods presented: Years Ended Years Ended December 31, 2023 December 31, 2022 Expected volatility 45.00 % 30.09 % Expected life (years) 6.00 5.95 Expected dividend yield 0.00 % 0.00 % Risk-free interest rate 4.18 % 2.84 % Fair value of options $ 1.58 $ 4.39 |
Summarizes Restricted Stock Unit Activity | The following table summarizes the Company’s restricted stock unit activity for the periods presented: Restricted Stock Units Number of Weighted-average Weighted-average Aggregate Outstanding at December 31, 2021 773,063 $ 6.26 7.5 $ 6,943 Granted 3,767,746 9.11 Vested ( 1,380,892 ) 8.27 Cancelled and forfeited ( 210,186 ) 8.38 Outstanding at December 31, 2022 2,949,731 $ 8.81 2.7 $ 18,672 Expected to vest as of December 31, 2022 2,949,731 Outstanding at December 31, 2022 2,949,731 $ 8.81 2.7 $ 18,672 Granted 6,606,510 4.42 Vested ( 2,532,946 ) 7.08 Cancelled and forfeited ( 579,188 ) 3.46 Outstanding at December 31, 2023 6,444,107 $ 5.38 1.0 $ 7,346 Expected to vest as of December 31, 2023 6,444,107 |
Transaction Costs, net (Tables)
Transaction Costs, net (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Summary of Transaction Costs Related to Businesses Acquired and Consummation of Business Combination | The Company incurred the following transaction costs related to businesses acquired and the consummation of the Business Combination during the periods presented: Years Ended December 31, 2023 2022 Transaction costs related to acquired businesses $ 1,391 $ 1,181 Non-capitalizable Business Combination costs 415 2,993 Change in contingent consideration liabilities ( 2,043 ) ( 2,121 ) Contingent compensation (benefit) expense ( 530 ) 342 Total transaction costs $ ( 767 ) $ 2,395 |
Earnings (Loss) Per Share (Tabl
Earnings (Loss) Per Share (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Components of Basic and Diluted Earnings (Loss) Per Shares | The components of basic and diluted earnings (loss) per shares are as follows: (in thousands, except per share data) Years Ended December 31, Numerator: 2023 2022 Net loss $ ( 115,461 ) $ ( 218,257 ) Deemed dividend - change in redemption value of preferred stock of Old FiscalNote - ( 26,570 ) Net loss used to compute basic and diluted loss per share $ ( 115,461 ) $ ( 244,827 ) Denominator: Weighted average common stock outstanding, basic and diluted 131,400,109 66,513,704 Net loss per shares, basic $ ( 0.88 ) $ ( 3.68 ) Net loss per shares, diluted $ ( 0.88 ) $ ( 3.68 ) Anti-dilutive securities excluded from diluted loss per share: Anti-dilutive Earnout Awards 19,195,100 19,195,100 Anti-dilutive stock options 979,901 4,844,643 Anti-dilutive Convertible Notes 2,305,666 2,004,928 Anti-dilutive contingently issuable shares 174,468 1,423,339 Anti-dilutive restricted stock units 6,393,154 2,949,731 Anti-dilutive New GPO Note 5,867,750 - Anti-dilutive Aicel Convertible Notes 113,896 116,886 Total anti-dilutive securities excluded from diluted loss per share: 35,029,935 30,534,627 |
Provision (Benefit) from Inco_2
Provision (Benefit) from Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of (Benefit) Provision for Income Taxes | The (benefit) provision for income taxes consisted of the following as of the dates presented: As of December 31, 2023 2022 Current taxes Federal provision $ 80 $ 7 State provision (benefit) 55 ( 75 ) Foreign provision (benefit) 16 ( 110 ) Total current provision (benefit) 151 ( 178 ) Deferred taxes Federal benefit ( 9,882 ) ( 32,725 ) State benefit ( 2,690 ) ( 12,632 ) Foreign benefit ( 3,415 ) ( 2,949 ) Valuation allowance 16,059 45,230 Total deferred provision (benefit) 72 ( 3,076 ) Total provision (benefit) from income taxes $ 223 $ ( 3,254 ) |
Schedule of Reconciliation Between U.S. Federal Statutory Income Tax Rate to Estimated Annual Effective Tax | The reconciliation between the U.S. federal statutory income tax rate to the Company’s estimated annual effective tax for the periods presented is as follows: Years Ended December 31, 2023 2022 U.S. Federal provision at statutory rate 21.0 % 21.0 % State income taxes, net of federal benefit ( 0.1 )% 0.5 % Effects of rate other than statutory ( 0.5 )% ( 0.2 )% AHYDO interest disallowance ( 0.2 )% ( 0.5 )% Warrant revaluation 2.6 % 1.5 % Stock compensation ( 2.4 )% 0.0 % Impairment from goodwill and other long-lived assets ( 4.7 )% 0.0 % Nondeductible expenses from recapitalization ( 2.9 )% ( 4.4 )% Change in valuation allowance ( 12.2 )% ( 16.5 )% Others ( 0.8 )% 0.1 % Effective tax rate ( 0.2 )% 1.5 % |
Schedule of Deferred Tax Assets and Liabilities | Significant components of the Company’s deferred tax assets and liabilities were as follows as of the dates presented: As of December 31, 2023 2022 Deferred tax assets Stock compensation $ 7,341 $ 6,389 Section 163(j) interest limitation 33,161 27,686 Disallowed original issue discount interest 1,527 1,092 Deferred rent - 104 Deferred revenue 7,143 6,378 Reserves and accruals 878 3,855 Capitalized research and development 8,541 5,197 Lease liability 7,375 9,110 Federal net operating loss carryforward 31,682 30,966 State net operating loss carryforward 8,559 8,202 Foreign net operating loss carryforward 7,876 4,563 Other deferred tax assets 898 782 Total deferred tax assets 114,981 104,324 Deferred tax liabilities Basis difference in fixed assets ( 1,505 ) ( 1,772 ) Basis difference in intangibles assets and goodwill ( 20,931 ) ( 23,584 ) Right of use asset ( 4,362 ) ( 5,158 ) Other deferred tax liabilities ( 2,819 ) ( 3,010 ) Total deferred tax liabilities ( 29,617 ) ( 33,524 ) Valuation allowance ( 87,542 ) ( 71,514 ) Net deferred tax liabilities $ ( 2,178 ) $ ( 714 ) |
Summary of Activities Relating to Unrecognized Tax Benefits | T he Company has the following activities relating to unrecognized tax benefits for the periods presented: Years Ended December 31, 2023 2022 Beginning balances at December 31, 2022 and 2021 $ 639 $ 728 Lapses in statutes of limitations - ( 89 ) Ending balances at December 31, 2023 and 2022 $ 639 $ 639 |
Fair Value Measurements and D_2
Fair Value Measurements and Disclosures (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Schedule of Fair Value on a Recurring Basis | The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2023 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,044 $ - $ - $ 3,044 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,591 $ - $ - $ 2,591 Private placement warrants - 2,170 - 2,170 Contingent liabilities from acquisitions - - 130 130 Liability classified warrants (a) - - 23 23 New GPO Note - - 36,954 36,954 Dragonfly Seller Convertible Note - - 9,002 9,002 Era Convertible Note - - 5,977 5,977 (a) Included in other current liabilities on the balance sheet The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2022 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Liabilities: Public warrants $ 10,282 $ - $ - $ 10,282 Private placement warrants - 8,610 - 8,610 Contingent liabilities from acquisitions - - 1,579 1,579 Liability classified warrants (a) - - 182 182 (a) Included in other current liabilities on the balance sheet |
Summary of Changes in Fair Value of Level 3 Liabilities | The following table summarizes changes in fair value of the Company’s level 3 liabilities during the periods presented : Contingent Liability Classified Warrants Embedded Redemption Embedded Redemption Embedded Redemption Balance at December 31, 2021 $ 5,104 $ 1,021 $ 4,228 $ 28,058 $ 2,400 Liability classified warrants at issuance date - 436 - - - Contingent consideration at acquisition date 400 - - - - Contingent compensation recognized 1,273 - - - - Change in fair value included in the determination of net loss(a) ( 2,121 ) ( 115 ) ( 2,097 ) 3,923 1,264 Earned contingent consideration settled ( 531 ) - - - - Cash contingent compensation earned and subsequently settled ( 1,567 ) - - - - Unearned contingent compensation reversal ( 979 ) - - - - Extinguishment and/or settlement upon conversion - ( 1,160 ) ( 2,131 ) ( 31,981 ) ( 3,664 ) Balance at December 31, 2022 1,579 182 - - - Liability classified warrants at issuance date - - - - - Contingent consideration at acquisition date 1,445 - - - - Contingent compensation recognized 337 - - - - Change in fair value included in the determination of net loss (a) ( 357 ) ( 159 ) - - - Earned contingent consideration settled ( 281 ) - - - - Cash contingent compensation earned and subsequently settled ( 39 ) - - - - Unearned contingent compensation reversal ( 1,687 ) - - - - Unearned contingent consideration reversal ( 867 ) Balance at December 31, 2023 $ 130 $ 23 $ - $ - $ - (a) The change in contingent liabilities from acquisitions is recorded as transaction costs on the consolidated statements of operations and comprehensive loss. |
Summary of Contingent Consideration and Compensation Related to Acquisitions | The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At December 31, 2023 and December 31, 2022, the contingent consideration and compensation relates to the following acquisitions: December 31, 2023 December 31, 2022 Curate $ 4 $ 883 FrontierView - 600 Equilibrium 112 43 DT Global 14 53 Total contingent liabilities from acquisitions $ 130 $ 1,579 |
New GPO Note | |
Summary of Inputs and Assumptions | The following table presents the assumptions used to determine the fair value of the New GPO Note at December 31, 2023 and on the Subscription Date of June 30, 2023: December 31, 2023 June 30, 2023 Common stock share price $ 1.14 $ 3.64 Risk free rate 3.88 % 4.10 % Yield 14.50 % 15.50 % Expected volatility 50.00 % 39.00 % Expected term (years) 4.5 5.0 |
Dragonfly Seller Convertible Notes | |
Summary of Inputs and Assumptions | The following table presents the assumptions used to determine the fair value of the Dragonfly Seller Convertible Notes at December 31, 2023 and January 27, 2023: December 31, 2023 January 27, 2023 Common stock share price $ 1.14 $ 5.06 Risk free rate 3.92 % 3.60 % Yield 15.50 % 17.50 % Expected volatility 50.00 % 40.00 % Expected term (years) 4.1 5.0 |
Era Convertible Note | |
Summary of Inputs and Assumptions | The following table presents the as sumptions used to determine the fair value of the Era Convertible Note at December 31, 2023 and December 8, 2023: December 31, 2023 December 8, 2023 Common stock share price $ 1.14 $ 1.33 Risk free rate 4.17 % 4.63 % Yield 153.24 % 163.43 % Expected volatility 63.00 % 61.00 % Expected term (years) 3.9 4.0 |
Acquisitions | |
Summary of Inputs and Assumptions | The following inputs and assumptions were used to value contingent liabilities from acquisitions as of December 31, 2023: Curate Risk premium 11.00 % Risk free rate 5.40 % Revenue volatility 20.00 % Expected life (years) 0.3 |
Private Placement Warrants | |
Summary of Inputs and Assumptions | The following table presents the assumptions used to determine the fair value of the private placement warrants at July 29, 2022: July 29, 2022 Valuation date share price $ 8.43 Risk-free interest rate 2.7 % Expected volatility 40.0 % Expected dividends 0.0 % Expected term (years) 5.00 Fair value (in dollars) $ 2.66 |
Last Out Lender Warrants | |
Summary of Inputs and Assumptions | The Last Out Lender Warrants are classified as Level 3 in the fair value hierarchy. The fair value of the Last Out Lender Warrants (see Note 9, Debt) is calculated using the Black-Scholes calculation with the following inputs: December 31, 2023 Common stock fair value $ 1.14 Time to maturity (years) 1.6 Risk-free interest rate 4.45 % Volatility 122.0 % Exercise price $ 8.56 |
Summary of Business and Signi_3
Summary of Business and Significant Accounting Policies - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||||||||
Jul. 29, 2022 | Feb. 14, 2022 | Apr. 13, 2020 | Dec. 31, 2023 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Jan. 01, 2023 | Jan. 01, 2022 | Dec. 31, 2017 | |
Significant Accounting Policies [Line Items] | ||||||||||
Cash and cash equivalents | $ 16,451,000 | $ 16,451,000 | $ 60,388,000 | |||||||
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Impairments of long-lived assets | Impairments of long-lived assets | Impairments of long-lived assets | Impairments of long-lived assets | ||||||
Accumulated deficit | $ (816,416,000) | $ (816,416,000) | $ (700,743,000) | |||||||
Capitalized contract cost, amortization period | 4 years | 4 years | ||||||||
Practical expedient to expense commissions for renewal contracts, description | The Company has elected to use a practical expedient to expense commissions for renewal contracts when the renewal period is 12 months or less | |||||||||
Impairment of goodwill | $ 20,004,000 | $ 25,841,000 | 0 | |||||||
Impairments of long-lived assets | 0 | 0 | 0 | $ 0 | ||||||
Operating Lease, Right-of-Use Asset | 17,782,000 | 17,782,000 | 21,005,000 | |||||||
Operating Lease, Liability | 29,228,000 | $ 29,228,000 | ||||||||
Impairment charge on intangible assets | $ 6,223,000 | 0 | ||||||||
ASU 2016-02 | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Operating Lease, Right-of-Use Asset | 25,912,000 | |||||||||
Operating Lease, Liability | $ 42,324,000 | |||||||||
ASC 2016-13 | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Allowance for doubtful accounts receivable | $ 680,000 | |||||||||
ASC 2016-13 | Cumulative-Effect Adjustment | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Accumulated deficit | $ 212,000 | |||||||||
ASC 2016-13 | Previously Reported | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Allowance for doubtful accounts receivable | $ 468,000 | |||||||||
Minimum | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Percentage of cash and cash equivalents held | 57% | 57% | ||||||||
Environmental, Sustainability, And Governance ("ESG") | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Impairment of goodwill | $ 5,837,000 | |||||||||
Furniture and Fixtures | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Property and equipment, estimated useful life | 5 years | 5 years | ||||||||
Equipment | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Property and equipment, estimated useful life | 3 years | 3 years | ||||||||
Leasehold Improvements | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] | us-gaap:UsefulLifeTermOfLeaseMember | us-gaap:UsefulLifeTermOfLeaseMember | ||||||||
Internal Use Software | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Property and equipment, estimated useful life | 3 years | 3 years | ||||||||
Washington, D.C | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Cash | $ 750,000 | |||||||||
DSAC | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Proceeds from loans | $ 325,000,000 | |||||||||
Paycheck Protection Program | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Forgiveness of debt | $ 7,667,000 | |||||||||
Remaining balance of loan | $ 333,000 | |||||||||
Loan repayment term | 5 years | |||||||||
CARES Act | Paycheck Protection Program | ||||||||||
Significant Accounting Policies [Line Items] | ||||||||||
Proceeds from issuance of debt | $ 8,000,000 |
Summary of Business and Signi_4
Summary of Business and Significant Accounting Policies - Additional Information (Details1) - DSAC | Jul. 29, 2022 USD ($) |
Significant Accounting Policies [Line Items] | |
Goodwill or other intangible assets recorded | $ 0 |
Merger Agreement | |
Significant Accounting Policies [Line Items] | |
Exchange ratio of shares | 1.187 |
Summary of Business and Signi_5
Summary of Business and Significant Accounting Policies - Additional Information (Details2) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 USD ($) Segment | Dec. 31, 2022 USD ($) | |
Accounting Policies [Abstract] | ||
Cash, cash equalents, restricted cash, and short-term investments | $ 24,434 | $ 61,223 |
Working capital deficit | 40,279 | 37,330 |
Accumulated deficit | (816,416) | (700,743) |
Net loss | $ (115,461) | $ (218,257) |
Number of operating segments | Segment | 1 |
Summary of Business and Signi_6
Summary of Business and Significant Accounting Policies - Additional Information (Details3) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Accounts Receivable | Customer Concentration Risk | Single Customer | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 10% | 10% |
Assets | Geographic Concentration Risk | Single Customer | United States | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 85% | 92% |
Accounts Payable | Supplier Concentration Risk | No Vendors | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 10% | |
Accounts Payable | Supplier Concentration Risk | Two Vendors | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 10% | |
Purchases | Supplier Concentration Risk | No Vendors | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 10% | |
Purchases | Supplier Concentration Risk | One Vendor | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 10% | |
U.S. Federal Government | Revenue | Customer Concentration Risk | ||
Significant Accounting Policies [Line Items] | ||
Concentration risk, percentage | 16% | 18% |
Business Combination with DSAC
Business Combination with DSAC - Additional Information (Details) $ in Thousands | 12 Months Ended | ||
Jul. 29, 2022 USD ($) Vote | Dec. 31, 2023 | Dec. 31, 2022 USD ($) | |
Business Acquisition [Line Items] | |||
Loss on settlement | $ (45,250) | ||
DSAC | |||
Business Acquisition [Line Items] | |||
Proceeds from loans | $ 325,000 | ||
Payments of transaction costs | 45,200 | ||
Repayments of debt | 210,700 | ||
DSAC | Senior Term Loan | |||
Business Acquisition [Line Items] | |||
Proceeds from loans | 150,000 | ||
Debt issuance costs paid | 3,500 | ||
Debt issuance costs capitalized | 2,800 | ||
Loss on settlement | 700 | ||
DSAC | DSACs Trust | |||
Business Acquisition [Line Items] | |||
Proceeds from loans | 61,000 | ||
DSAC | Backstop Agreement With Sponsor Of DSAC | |||
Business Acquisition [Line Items] | |||
Proceeds from loans | 114,000 | ||
DSAC | First Out Term Loan | |||
Business Acquisition [Line Items] | |||
Repayments of debt | 75,300 | ||
DSAC | Last Out Term Loan | |||
Business Acquisition [Line Items] | |||
Repayments of debt | 61,700 | ||
DSAC | Senior Secured Subordinated Promissory Note | |||
Business Acquisition [Line Items] | |||
Repayments of debt | 50,000 | ||
DSAC | 8090 FV Subordinated Promissory Note | |||
Business Acquisition [Line Items] | |||
Repayments of debt | 16,300 | ||
DSAC | 2021 Seller Term Loans | |||
Business Acquisition [Line Items] | |||
Repayments of debt | $ 7,400 | ||
DSAC | Merger Agreement | |||
Business Acquisition [Line Items] | |||
Exchange ratio of shares | 1.187 | ||
Number of votes per share | Vote | 25 | ||
Business combination description | (a) transfer by the holder(s) of New FiscalNote Class B common stock to any other person, except for specified trusts, retirement accounts, corporations or similar entities formed for financial or estate planning purposes and beneficially owned by the holders of New FiscalNote Class B common stock, (b) the death or incapacity of such holder(s) of New FiscalNote Class B common stock, (c) the date specified by an affirmative vote of a majority of the outstanding New FiscalNote Class B common stock, voting as a single class, (d) the date on which the outstanding shares of New FiscalNote Class B common stock represent less than 50% of the shares of New FiscalNote Class B common stock that were outstanding as of the Closing Date, or (e) the seven-year anniversary of the Closing Date. | ||
DSAC | Merger Agreement | Senior Term Loan | |||
Business Acquisition [Line Items] | |||
Debt instrument amount | $ 150,000 |
Revenues - Schedule of Disaggre
Revenues - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disaggregation Of Revenue [Line Items] | ||
Total revenues | $ 132,645 | $ 113,765 |
Subscription | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 119,082 | 100,522 |
Advisory | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 5,455 | 4,914 |
Advertising | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 1,632 | 2,703 |
Books | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 1,166 | 736 |
Other Revenue | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | $ 5,310 | $ 4,890 |
Revenues - Revenue by Geographi
Revenues - Revenue by Geographic Locations (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disaggregation Of Revenue [Line Items] | ||
Total revenues | $ 132,645 | $ 113,765 |
North America | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 107,108 | 98,951 |
Europe | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 19,749 | 10,072 |
Australia | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | 1,193 | 1,122 |
Asia | ||
Disaggregation Of Revenue [Line Items] | ||
Total revenues | $ 4,595 | $ 3,620 |
Revenues - Additional Informati
Revenues - Additional Information (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disaggregation Of Revenue [Line Items] | ||
Contract assets | $ 1,183,000 | $ 1,464,000 |
Capitalized cost | 4,421,000 | 4,081,000 |
Impairments of costs to obtain revenue contracts | 0 | 0 |
Revenue remaining performance obligation | 109,151,000 | |
Sales and Marketing Expense | ||
Disaggregation Of Revenue [Line Items] | ||
Capitalized cost, amortization | $ 3,617,000 | $ 2,786,000 |
Geographic Concentration Risk | Revenue | Revenue | ||
Disaggregation Of Revenue [Line Items] | ||
Concentration risk, percentage | 5% | 5% |
Geographic Concentration Risk | Revenue | United Kingdom | ||
Disaggregation Of Revenue [Line Items] | ||
Concentration risk, percentage | 12% | 6% |
Revenues - Schedule of Deferred
Revenues - Schedule of Deferred Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Contract with Customer, Liability [Abstract] | ||
Beginning balance | $ 36,487 | $ 30,097 |
Acquired deferred revenue | 3,933 | 1,055 |
Revenue recognized in the current period from amounts in the prior balance | (35,598) | (29,351) |
New deferrals, net of amounts recognized in the current period | 39,220 | 35,139 |
Effects of foreign currency | 363 | (453) |
Ending balance | $ 44,405 | $ 36,487 |
Revenues - Additional Informa_2
Revenues - Additional Information (Details1) | Dec. 31, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01 | |
Disaggregation Of Revenue [Line Items] | |
Revenue remaining performance obligation, expected satisfaction period | 1 year |
Revenue, remaining performance obligation, expected timing of satisfaction, year | 2024 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01 | |
Disaggregation Of Revenue [Line Items] | |
Revenue remaining performance obligation, expected satisfaction period | 1 year |
Revenue, remaining performance obligation, expected timing of satisfaction, year | 2025 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01 | |
Disaggregation Of Revenue [Line Items] | |
Revenue remaining performance obligation, expected satisfaction period | 1 year |
Revenue, remaining performance obligation, expected timing of satisfaction, year | 2026 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01 | |
Disaggregation Of Revenue [Line Items] | |
Revenue remaining performance obligation, expected satisfaction period | 1 year |
Revenue, remaining performance obligation, expected timing of satisfaction, year | 2027 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2028-01-01 | |
Disaggregation Of Revenue [Line Items] | |
Revenue remaining performance obligation, expected satisfaction period | 1 year |
Revenue, remaining performance obligation, expected timing of satisfaction, year | 2028 |
Business Combinations - Additio
Business Combinations - Additional Information (Details) £ in Millions | 1 Months Ended | 12 Months Ended | ||||||||
Jan. 27, 2023 USD ($) shares | Jan. 27, 2023 GBP (£) shares | Jul. 29, 2022 USD ($) shares | Jan. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Sep. 30, 2022 USD ($) | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Jan. 27, 2023 GBP (£) | |
Business Acquisition [Line Items] | ||||||||||
Intangible assets, net carrying amount | $ 106,096,000 | $ 90,868,000 | $ 106,096,000 | |||||||
Expense related to the employee earnout awards | 1,803,000 | |||||||||
Employee Earnout Awards | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Expense related to the employee earnout awards | 0 | |||||||||
Dragonfly Eye Limited | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Acquisition consideration | $ 25,236,000 | |||||||||
Transaction costs | 1,272,000 | |||||||||
Payment of transaction cost | 446,000 | |||||||||
Business acquisition, goodwill, expected tax deductible amount | 0 | |||||||||
Cash consideration | 5,617,000 | £ 4.5 | ||||||||
Intangible assets | $ 9,600,000 | |||||||||
Intangible assets amortization period | 6 years | 6 years | ||||||||
Dragonfly Eye Limited | Convertible Promissory Note | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Carrying value of convertible notes | $ 11,100,000 | £ 8.9 | ||||||||
Dragonfly Eye Limited | Maximum | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Eligible additional payment | $ 4,300,000 | £ 3.5 | ||||||||
Dragonfly Eye Limited | Class A Common Stock | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Shares issued in business acquisitions, shares | shares | 1,885,149 | 1,885,149 | ||||||||
Aicel Technologies | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Acquisition consideration | $ 8,678,000 | 300,000 | ||||||||
Acquisition consideration of common shares | shares | 723,684 | |||||||||
Exchange of common stock shares | shares | 859,016 | |||||||||
Contingent consideration of common stock shares | shares | 12,491 | |||||||||
Transaction costs | $ 300,000 | 637,000 | $ 96,000 | |||||||
Business combination, accrued contingent liabilities | $ 300,000 | |||||||||
Business combination, consideration through equity, number of shares | shares | 28,522 | |||||||||
Restricted stock upon achievement of certain revenue targets | shares | 24,833 | |||||||||
Business combination, contingent consideration payment description | The common stock, restricted stock and cash portions of the contingent payments will be paid within eighteen months upon achievement of certain revenue targets | |||||||||
Intangible assets | $ 3,000,000 | |||||||||
Equity-based compensation related to restricted stock contingent payments | 124,000 | 52,000 | ||||||||
Aicel Technologies | Maximum | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Cash consideration | $ 300,000 | |||||||||
DT-Global Asset Acquisition | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Acquisition consideration | $ 600,000 | |||||||||
Transaction costs | 43,000 | |||||||||
Upfront cash payment | 400,000 | |||||||||
Purchase price holdbacks | 100,000 | |||||||||
Contingent consideration related to operational milestones | 100,000 | |||||||||
Fair value of assets acquired | 1,012,000 | |||||||||
Intangible assets | 52,000 | $ 1,012,000 | 52,000 | |||||||
Intangible assets amortization period | 15 years | |||||||||
DT-Global Asset Acquisition | Customer Relationship Intangible Asset | ||||||||||
Business Acquisition [Line Items] | ||||||||||
Intangible assets, net carrying amount | $ 52,000 | $ 52,000 | ||||||||
Payment of liability | $ 39,000 | |||||||||
Business combination, liability recognized | $ 13,000 |
Business Combinations - Summary
Business Combinations - Summary of Fair Value of Consideration Transferred (Details) $ in Thousands, £ in Millions | 1 Months Ended | |||
Jan. 27, 2023 GBP (£) | Jan. 27, 2023 USD ($) | Jul. 29, 2022 USD ($) | Dec. 31, 2022 USD ($) | |
Dragonfly Eye Limited | ||||
Business Acquisition Contingent Consideration [Line Items] | ||||
Cash | £ 4.5 | $ 5,617 | ||
Fair value of common stock | 9,539 | |||
Fair value of Seller Convertible Notes | 8,635 | |||
Fair value of contingent consideration | 1,445 | |||
Total | $ 25,236 | |||
Aicel Technologies | ||||
Business Acquisition Contingent Consideration [Line Items] | ||||
Fair value of common stock | $ 8,590 | |||
Fair value of contingent consideration | 88 | |||
Total | $ 8,678 | $ 300 |
Business Combinations - Summa_2
Business Combinations - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | 1 Months Ended | ||||
Jan. 27, 2023 | Jul. 29, 2022 | Dec. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | |||||
Goodwill | $ 194,362 | $ 187,703 | $ 188,768 | ||
Dragonfly Eye Limited | |||||
Business Acquisition [Line Items] | |||||
Cash and cash equivalents | $ 607 | ||||
Current assets, net | 3,690 | ||||
Property and equipment, net | 18 | ||||
Intangible assets | 9,600 | ||||
Deferred revenues | (3,933) | ||||
Current liabilities | (1,764) | ||||
Deferred tax liabilities | (1,517) | ||||
Total net assets acquired | 6,701 | ||||
Goodwill | 18,535 | ||||
Total purchase price | $ 25,236 | ||||
Aicel Technologies | |||||
Business Acquisition [Line Items] | |||||
Cash and cash equivalents | $ 1,525 | ||||
Current assets, net | 447 | ||||
Property and equipment, net | 53 | ||||
Equity method investment | 45 | ||||
Intangible assets | 3,000 | ||||
Deferred revenues | (602) | ||||
Other current liabilities | (453) | ||||
Debt | (1,131) | ||||
Total net assets acquired | 2,884 | ||||
Goodwill | 5,794 | ||||
Total purchase price | $ 8,678 | $ 300 |
Business Combinations - Summa_3
Business Combinations - Summary of Components of Identified Intangible Assets Acquired and Estimated Useful Lives (Details) - USD ($) $ in Thousands | Jan. 27, 2023 | Jul. 29, 2022 |
Dragonfly Eye Limited | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 9,600 | |
Estimated Useful Life (Years) | 6 years | |
Dragonfly Eye Limited | Developed Technology | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 1,750 | |
Estimated Useful Life (Years) | 10 years | |
Dragonfly Eye Limited | Customer Relationships | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 7,300 | |
Estimated Useful Life (Years) | 10 years | |
Dragonfly Eye Limited | Tradename | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 550 | |
Estimated Useful Life (Years) | 3 years | |
Aicel Technologies | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 3,000 | |
Aicel Technologies | Developed Technology | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 1,200 | |
Estimated Useful Life (Years) | 8 years | |
Aicel Technologies | Database | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 750 | |
Estimated Useful Life (Years) | 8 years | |
Aicel Technologies | Customer Relationships | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 650 | |
Estimated Useful Life (Years) | 11 years | |
Aicel Technologies | Tradename | ||
Acquired Finite Lived Intangible Assets [Line Items] | ||
Estimated Fair Value | $ 400 | |
Estimated Useful Life (Years) | 7 years |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2023 | Mar. 31, 2022 | Mar. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2021 | Dec. 31, 2017 | |
Lessee Lease Description [Line Items] | ||||||
Operating lease asset impairment | $ 378 | $ 378 | ||||
Reduction in operating lease asset | $ 378 | |||||
Payment of sublease termination Fee | $ 1,682 | |||||
Sublease termination fee payable | $ 1,682 | |||||
Lease termination effective date | Mar. 31, 2023 | |||||
Incentive granted | $ 750 | |||||
Minimum | ||||||
Lessee Lease Description [Line Items] | ||||||
Non-cancellable base terms | 1 year | |||||
Maximum | ||||||
Lessee Lease Description [Line Items] | ||||||
Non-cancellable base terms | 9 years |
Leases - Summary of Lease Expen
Leases - Summary of Lease Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Lease, Cost [Abstract] | ||
Operating lease cost | $ 6,138 | $ 9,769 |
Variable lease cost | 841 | 518 |
Short-term lease cost | 550 | 1,236 |
Total lease costs | 7,529 | 11,523 |
Sublease income | $ (1,442) | $ (5,350) |
Leases - Summary of Lease Exp_2
Leases - Summary of Lease Expense (Parenthetical) (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended |
Mar. 31, 2022 | Mar. 31, 2022 | |
Lease, Cost [Abstract] | ||
Operating lease asset impairment | $ 378 | $ 378 |
Leases - Summary of Future Mini
Leases - Summary of Future Minimum Lease Payments (Details) $ in Thousands | Dec. 31, 2023 USD ($) |
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] | |
2024 | $ 5,402 |
2025 | 5,183 |
2026 | 5,298 |
2027 | 5,288 |
2028 | 5,163 |
Thereafter | 13,004 |
Total minimum lease payments | 39,338 |
Less: Amounts representing interest | 10,110 |
Net minimum lease payments | $ 29,228 |
Leases - Summary of Additional
Leases - Summary of Additional Information about Lease Obligations (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Lessee Disclosure [Abstract] | ||
Weighted average remaining lease term (in years) | 7 years 2 months 12 days | 7 years 6 months |
Weighted average discount rate | 8.50% | 8.50% |
Leases - Summary of Supplementa
Leases - Summary of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Lessee Disclosure [Abstract] | ||
Operating cash outflows for operating leases | $ 9,481 | $ 11,805 |
Operating lease assets obtained in exchange for lease obligations | $ 272 | $ 2,074 |
Property, Plant and Equipment -
Property, Plant and Equipment - Summary of Details of Property and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 12,458 | $ 12,295 |
Less: accumulated depreciation | (6,317) | (4,970) |
Total property and equipment, net | 6,141 | 7,325 |
Leasehold Improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 9,526 | 9,525 |
Furniture and Fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 102 | 98 |
Equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | 498 | 495 |
Computer Equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property and equipment | $ 2,332 | $ 2,177 |
Property, Plant and Equipment_2
Property, Plant and Equipment - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Property, Plant and Equipment [Line Items] | ||
Long-term assets | $ 6,141 | $ 7,325 |
Depreciation expense | 1,348 | 1,238 |
General and Administrative Expenses | ||
Property, Plant and Equipment [Line Items] | ||
Depreciation expense | 1,348 | 1,238 |
Outside United States | Maximum | ||
Property, Plant and Equipment [Line Items] | ||
Long-term assets | $ 1,000 | $ 1,000 |
Intangible Assets - Summary of
Intangible Assets - Summary of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets by Major Class (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 171,789,000 | $ 171,789,000 | $ 161,595,000 |
Intangible assets, Accumulated Amortization | (76,190,000) | (76,190,000) | (55,499,000) |
Intangible assets, Impairment | $ (4,731,000) | ||
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] | Goodwill and Intangible Asset Impairment | ||
Intangible assets, Impairment | 6,223,000 | 0 | |
Intangible assets, Net Carrying Amount | 90,868,000 | $ 90,868,000 | 106,096,000 |
Customer Relationships | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | 88,544,000 | 88,544,000 | 81,002,000 |
Intangible assets, Accumulated Amortization | (32,392,000) | (32,392,000) | (24,654,000) |
Intangible assets, Impairment | (2,235,000) | ||
Intangible assets, Net Carrying Amount | $ 53,917,000 | $ 53,917,000 | 56,348,000 |
Weighted Average Remaining Useful Life (Years) | 8 years 3 months 18 days | 8 years 3 months 18 days | |
Developed Technology | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 37,205,000 | $ 37,205,000 | 35,350,000 |
Intangible assets, Accumulated Amortization | (26,743,000) | (26,743,000) | (17,673,000) |
Intangible assets, Impairment | (1,909,000) | ||
Intangible assets, Net Carrying Amount | $ 8,553,000 | $ 8,553,000 | 17,677,000 |
Weighted Average Remaining Useful Life (Years) | 6 years 7 months 6 days | 6 years 7 months 6 days | |
Database | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 29,895,000 | $ 29,895,000 | 29,912,000 |
Intangible assets, Accumulated Amortization | (11,057,000) | (11,057,000) | (8,892,000) |
Intangible assets, Net Carrying Amount | $ 18,838,000 | $ 18,838,000 | 21,020,000 |
Weighted Average Remaining Useful Life (Years) | 8 years 9 months 18 days | 8 years 9 months 18 days | |
Tradename | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 12,077,000 | $ 12,077,000 | 11,480,000 |
Intangible assets, Accumulated Amortization | (4,367,000) | (4,367,000) | (3,216,000) |
Intangible assets, Impairment | (579,000) | ||
Intangible assets, Net Carrying Amount | $ 7,131,000 | $ 7,131,000 | 8,264,000 |
Weighted Average Remaining Useful Life (Years) | 8 years 3 months 18 days | 8 years 3 months 18 days | |
Expert Network | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 2,692,000 | $ 2,692,000 | 2,559,000 |
Intangible assets, Accumulated Amortization | (1,291,000) | (1,291,000) | (800,000) |
Intangible assets, Net Carrying Amount | $ 1,401,000 | $ 1,401,000 | 1,759,000 |
Weighted Average Remaining Useful Life (Years) | 3 years 1 month 6 days | 3 years 1 month 6 days | |
Patents | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 784,000 | $ 784,000 | 700,000 |
Intangible assets, Accumulated Amortization | (217,000) | (217,000) | (200,000) |
Intangible assets, Impairment | (8,000) | ||
Intangible assets, Net Carrying Amount | $ 559,000 | $ 559,000 | 500,000 |
Weighted Average Remaining Useful Life (Years) | 17 years 7 months 6 days | 17 years 7 months 6 days | |
Content Library | |||
Finite Lived Intangible Assets [Line Items] | |||
Intangible assets, Gross Carrying Amount | $ 592,000 | $ 592,000 | 592,000 |
Intangible assets, Accumulated Amortization | (123,000) | (123,000) | (64,000) |
Intangible assets, Net Carrying Amount | $ 469,000 | $ 469,000 | $ 528,000 |
Weighted Average Remaining Useful Life (Years) | 7 years 10 months 24 days | 7 years 10 months 24 days |
Intangible Assets - Additional
Intangible Assets - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | ||
Intangible Assets Disclosure [Line Items] | ||||
Amortization of intangible assets | [1] | $ 11,509,000 | $ 10,451,000 | |
Interest capitalized on capitalized software development costs | 424,000 | 740,000 | ||
Amortization of capitalized software development costs | 6,918,000 | 4,064,000 | ||
Impairment charge on intangible assets | $ 6,223,000 | 0 | ||
Intangible Assets Excluding Developed Technology | ||||
Intangible Assets Disclosure [Line Items] | ||||
Amortization of intangible assets | 11,509,000 | 10,451,000 | ||
Developed Technology | ||||
Intangible Assets Disclosure [Line Items] | ||||
Amortization of intangible assets | 8,942,000 | $ 5,030,000 | ||
Amortization expense | $ 3,890,000 | |||
[1] (1) Amounts include stock-based compensation expenses, as follows: Years Ended December 31, 2023 2022 Cost of revenues $ 283 $ 81 Research and development 1,384 1,007 Sales and marketing 2,057 762 Editorial 400 603 General and administrative 22,933 35,594 |
Intangible Assets - Schedule of
Intangible Assets - Schedule of Expected Future Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | ||
2024 | $ 13,364 | |
2025 | 11,771 | |
2026 | 11,481 | |
2027 | 11,069 | |
2028 | 9,992 | |
Thereafter | 33,191 | |
Intangible assets, Net Carrying Amount | $ 90,868 | $ 106,096 |
Intangible Assets - Schedule _2
Intangible Assets - Schedule of Capitalized Software Development Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Capitalized Computer Software, Net [Abstract] | ||
Capitalized software development costs, Gross Carrying Amount | $ 27,659 | $ 19,815 |
Capitalized software development costs, Accumulated Amortization | (12,795) | (5,869) |
Capitalized software development costs, Impairment | (1,492) | |
Capitalized software development costs, Net Carrying Amount | $ 13,372 | $ 13,946 |
Goodwill - Summary of Changes i
Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) - USD ($) | 3 Months Ended | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill [Roll Forward] | |||
Beginning balance | $ 194,362,000 | $ 188,768,000 | |
Acquisitions | 18,535,000 | 5,794,000 | |
Impairment | $ (20,004,000) | (25,841,000) | 0 |
Impact of foreign currency fluctuations | 647,000 | (200,000) | |
Ending balance | $ 187,703,000 | $ 187,703,000 | $ 194,362,000 |
Goodwill - Additional Informati
Goodwill - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill [Line Items] | ||||
Reporting unit, negative carrying amount, name | PPIM | |||
Impairment of goodwill | $ 20,004,000 | $ 25,841,000 | $ 0 | |
Environmental, Sustainability, and Governance ("ESG") | ||||
Goodwill [Line Items] | ||||
Impairment of goodwill | $ 5,837,000 | |||
Public Policy & Issues Management ("PPIM") | ||||
Goodwill [Line Items] | ||||
Reporting unit, negative carrying amount, amount of allocated goodwill | $ 83,524,000 | $ 83,524,000 |
Debt - Summary of Carrying Valu
Debt - Summary of Carrying Value of Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||
Total gross debt | $ 225,513 | $ 164,291 |
Debt issuance costs | (3,098) | (2,243) |
Total | 222,415 | 162,048 |
Less: Current maturities | (105) | (68) |
Total long-term debt | 222,310 | 161,980 |
Senior Term Loan | ||
Debt Instrument [Line Items] | ||
Total gross debt | 158,228 | 150,647 |
New GPO Note | ||
Debt Instrument [Line Items] | ||
Total gross debt | 36,954 | |
Convertible Notes | ||
Debt Instrument [Line Items] | ||
Total gross debt | 14,052 | 12,219 |
Dragonfly Convertible Note | ||
Debt Instrument [Line Items] | ||
Total gross debt | 9,002 | |
Era Convertible Note | ||
Debt Instrument [Line Items] | ||
Total gross debt | 5,977 | |
Aicel Convertible Note | ||
Debt Instrument [Line Items] | ||
Total gross debt | 1,156 | 1,174 |
PPP Loan | ||
Debt Instrument [Line Items] | ||
Total gross debt | $ 144 | $ 251 |
Debt - Senior Term Loan - Addit
Debt - Senior Term Loan - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||
Aug. 03, 2023 | Aug. 02, 2023 | Mar. 17, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | |||||
Paid-in-kind interest | $ 6,060 | $ 10,958 | |||
Debt issuance costs | 3,098 | $ 2,243 | |||
Earlier of Prepayment or July 29, 2023 | |||||
Debt Instrument [Line Items] | |||||
Debt issuance costs | $ 1,734 | ||||
Earlier of Prepayment or July 29, 2024 | |||||
Debt Instrument [Line Items] | |||||
Debt issuance costs | 2,034 | ||||
Senior Term Loan Amendment | |||||
Debt Instrument [Line Items] | |||||
Maturity date | Jul. 15, 2027 | ||||
Prepayment fee | 1,035 | ||||
Principal amount approved | $ 6,000 | ||||
Exericse price per share | $ 0.01 | ||||
Senior Term Loan Amendment | Class A Common Stock | |||||
Debt Instrument [Line Items] | |||||
Purchase of common stock | 80,000 | ||||
Senior Term Loan Amendment No 3 | |||||
Debt Instrument [Line Items] | |||||
Prepayment fee | $ 8,970 | $ 7,410 | 1,560 | ||
Senior Term Loan | |||||
Debt Instrument [Line Items] | |||||
Principal amount | 150,000 | ||||
Uncommitted incremental loan facility | $ 100,000 | ||||
Percentage of monthly interest in cash | 9% | ||||
Interest payable in kind | 1% | ||||
Maturity date | Jul. 29, 2027 | ||||
Annual interest rate term | The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0% per annum or (ii) 9.0% payable monthly in cash, and (b) interest payable in kind component of 1.00% per annum, payable in kind monthly. | ||||
Prime rate percentage | 8.50% | ||||
Cash interest | $ 20,791 | ||||
Paid-in-kind interest | 1,581 | ||||
Prepayment fee | 8,970 | ||||
Lender fees paid | 2,435 | ||||
Fees paid to third parties | 732 | ||||
Capitalized debt issuance costs | 3,167 | ||||
Amortization | 682 | ||||
Unamortized debt discount | $ 2,412 | ||||
Increase in interest rate event of default | 5% | ||||
Senior Term Loan | Beginning on August 15, 2025 | |||||
Debt Instrument [Line Items] | |||||
Maturity date | Jul. 15, 2027 | ||||
Percentage of outstanding principal amount | 50% | ||||
Monthly basis over the remaining period | 24 months | ||||
Senior Term Loan | Prior to July 30, 2024 | |||||
Debt Instrument [Line Items] | |||||
Prepayment fee | 2% | ||||
Senior Term Loan | Prior to July 30, 2025 | |||||
Debt Instrument [Line Items] | |||||
Prepayment fee | 1% | ||||
Senior Term Loan | On or After July 30, 2025 | |||||
Debt Instrument [Line Items] | |||||
Prepayment fee | 0% | ||||
Senior Term Loan | Earlier of Prepayment or July 29, 2023 | |||||
Debt Instrument [Line Items] | |||||
Debt issuance costs | $ 1,734 | ||||
Senior Term Loan | Earlier of Prepayment or July 29, 2024 | |||||
Debt Instrument [Line Items] | |||||
Debt issuance costs | $ 2,034 | ||||
Senior Term Loan | Prime Rate | |||||
Debt Instrument [Line Items] | |||||
Debt instrument, interest rate | 5% | ||||
Senior Term Loan | Accounts Payable and Accrued Expenses | |||||
Debt Instrument [Line Items] | |||||
Deferred fees recognized as interest expense | $ 1,859 | ||||
Senior Term Loan | Other Non-current Liabilities | |||||
Debt Instrument [Line Items] | |||||
Accretion of final payment as interest expense | $ 2,347 |
Debt - New GPO Note - Additiona
Debt - New GPO Note - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||
Jun. 27, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Jun. 30, 2023 | |
Class A Common Stock | ||||
Debt Instrument [Line Items] | ||||
Shares returned on legal settlement | 5,881,723 | |||
New GPO Note | ||||
Debt Instrument [Line Items] | ||||
Convertible note, acquisition fair value | $ 36,583 | |||
Non-cash loss contingency | $ 3,474 | $ 11,700 | ||
Carrying value of convertible notes | 36,954 | |||
Non-cash gain (loss) of convertible note | 1,411 | |||
Interest expense | 1,781 | |||
New GPO Note | Convertible Promissory Note | ||||
Debt Instrument [Line Items] | ||||
Debt instrument amount | $ 46,794 | |||
Annual effective interest rate | 7.50% | |||
Maturity date | Jul. 03, 2028 | |||
New GPO Note | Class A Common Stock | Convertible Promissory Note | ||||
Debt Instrument [Line Items] | ||||
Shares returned on legal settlement | 5,881,723 | |||
Conversion price | $ 8.28 |
Debt - Convertible Notes - Addi
Debt - Convertible Notes - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | ||
Interest expense, net | $ 29,940 | $ 95,741 |
Loss on debt extinguishment, net | 45,250 | |
Convertible Notes | ||
Debt Instrument [Line Items] | ||
Principal and accrued PIK balance | 14,052 | |
Interest expense, net | 11,541 | |
Interest expense | $ 2,170 | $ 39,219 |
Debt - Dragonfly Seller Convert
Debt - Dragonfly Seller Convertible Notes - Additional Information (Details) - Convertible Notes $ / shares in Units, $ in Thousands, £ in Millions | 12 Months Ended | ||
Dec. 31, 2023 USD ($) $ / shares | Dec. 31, 2022 USD ($) | Dec. 31, 2023 GBP (£) | |
Debt Instrument [Line Items] | |||
Interest expense | $ 2,170 | $ 39,219 | |
Dragonfly Eye Limited | |||
Debt Instrument [Line Items] | |||
Principal amount | $ 11,050 | £ 8.9 | |
Paid-in-kind interest rate | 8% | ||
Maturity date | Jan. 27, 2028 | ||
Conversion price | $ / shares | $ 10 | ||
Convertible note, acquisition fair value | $ 8,635 | ||
Interest expense | 838 | ||
Carrying value of convertible notes | 9,002 | ||
Non-cash gain (loss) of convertible note | $ 673 |
Debt - Era Convertible Note - A
Debt - Era Convertible Note - Additional Information (Details) - Era Convertible Note - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 08, 2023 | |
Debt Instrument [Line Items] | ||
Principal amount | $ 3,750 | |
Convertible Notes | ||
Debt Instrument [Line Items] | ||
Principal amount | 5,500 | |
Additional borrowing capacity | $ 2,000 | |
Maturity date | Dec. 08, 2027 | |
Convertible note, acquisition fair value | $ 5,500 | |
Carrying value of convertible notes | $ 5,977 | |
Non-cash gain (loss) of convertible note | $ (477) |
Debt - Aicel Convertible Note -
Debt - Aicel Convertible Note - Additional Information (Details) - Convertible Notes - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Debt Instrument [Line Items] | ||
Interest expense | $ 2,170 | $ 39,219 |
Aicel Technologies | ||
Debt Instrument [Line Items] | ||
Principal amount | $ 1,131 | |
Paid-in-kind interest rate | 1% | |
Percentage of increase in paid-in-kind interest rate | 12% | |
Convertible note, acquisition fair value | $ 1,131 | |
Maturity date | Jul. 27, 2027 | |
Interest expense | $ 11 | $ 5 |
Carrying value of convertible notes | $ 1,156 |
Debt - PPP Loan - Additional In
Debt - PPP Loan - Additional Information (Details) - USD ($) $ in Thousands | Feb. 14, 2022 | Apr. 13, 2020 | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | ||||
Long-term debt | $ 222,415 | $ 162,048 | ||
PPP Loan | ||||
Debt Instrument [Line Items] | ||||
Forgiveness of debt | $ 7,667 | |||
Remaining balance of loan | $ 333 | |||
Debt instrument, term | 5 years | |||
Short-term debt | 105 | |||
Long-term debt | $ 39 | |||
CARES Act | PPP Loan | ||||
Debt Instrument [Line Items] | ||||
Proceeds from issuance of debt | $ 8,000 | |||
Interest rate | 1% |
Debt - Summary of Estimated Fai
Debt - Summary of Estimated Fair Value of Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | $ 236,032 | $ 182,482 |
Senior Term Loan | ||
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | 168,702 | 165,540 |
New GPO Note | ||
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | 36,954 | |
Convertible Notes | ||
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | 13,992 | $ 16,942 |
Dragonfly Seller Convertible Notes | ||
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | 10,407 | |
Era Convertible Notes | ||
Debt Instrument Fair Value Disclosure [Line Items] | ||
Fair value of debt | $ 5,977 |
Debt - Summary of Maturities of
Debt - Summary of Maturities of Debt (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Maturities of Long-Term Debt [Abstract] | ||
2024 | $ 105 | |
2025 | 30,340 | |
2026 | 39,000 | |
2027 | 110,111 | |
2028 | 45,957 | |
Total | $ 225,513 | $ 164,291 |
Debt - Warrants - Additional In
Debt - Warrants - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | Dec. 31, 2023 | Mar. 17, 2023 | Dec. 31, 2022 |
Class of Warrant or Right [Line Items] | |||
Warrant liabilities | $ 4,761 | $ 18,892 | |
Warrants Associated with Amendment 1 | |||
Class of Warrant or Right [Line Items] | |||
Warrants outstanding | 80,000 | ||
Exercise price | $ 0.01 | ||
Warrant liabilities | $ 90 | ||
Old FiscalNote Warrants | |||
Class of Warrant or Right [Line Items] | |||
Warrants outstanding | 118,700 | ||
Exercise price | $ 8.56 | ||
Warrant liabilities | $ 23 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 7 Months Ended | 12 Months Ended | |
Jul. 29, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Class Of Stock [Line Items] | |||
Shares authorized | 1,809,000,000 | ||
Preferred stock, shares authorized | 100,000,000 | ||
Preferred stock, par value per share | $ 0.0001 | ||
Preferred stock, shares issued | 0 | ||
Preferred stock, shares outstanding | 0 | ||
Class A Common Stock | |||
Class Of Stock [Line Items] | |||
Common stock, shares authorized | 1,700,000,000 | 1,700,000,000 | |
Par value | $ 0.0001 | $ 0.0001 | |
Common stock, shares, issued | 121,679,829 | 123,125,595 | |
Common stock, shares, outstanding | 121,679,829 | 123,125,595 | |
Change in redemption value of preferred stock | $ 26,570 | ||
Class B Common Stock | |||
Class Of Stock [Line Items] | |||
Common stock, shares authorized | 9,000,000 | 9,000,000 | |
Par value | $ 0.0001 | $ 0.0001 | |
Common stock, shares, issued | 8,290,921 | 8,290,921 | |
Common stock, shares, outstanding | 8,290,921 | 8,290,921 |
Earnout Shares and RSUs - Addit
Earnout Shares and RSUs - Additional Information (Details) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 USD ($) Acquisition $ / shares shares | Dec. 31, 2022 USD ($) | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Share-Based Payment Arrangement, Expense | $ | $ 1,803 | |
Earnout Awards | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Expiration period | 5 years | |
Share-Based Payment Arrangement, Expense | $ | $ 17,712 | $ 686 |
Unrecognized compensation expense | $ | $ 730 | |
Unrecognized compensation expense recognition period | 3 years | |
Earnout Awards | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Shares entitled to receive | 19,195,100 | |
Number of tranches | Acquisition | 5 | |
Earnout Awards | Share-Based Compensation Award Tranche One | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 3,839,020 | |
Minimum dollar volume-weighted average share price | $ / shares | $ 10.5 | |
Earnout Awards | Share-Based Compensation Award Tranche Two | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 3,839,020 | |
Minimum dollar volume-weighted average share price | $ / shares | $ 12.5 | |
Earnout Awards | Share-Based Compensation Award Tranche Three | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 3,839,020 | |
Minimum dollar volume-weighted average share price | $ / shares | $ 15 | |
Earnout Awards | Share-Based Compensation Award Tranche Four | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 3,839,020 | |
Minimum dollar volume-weighted average share price | $ / shares | $ 20 | |
Earnout Awards | Share-Based Compensation Award Tranche Five | Common Class A | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 3,839,020 | |
Minimum dollar volume-weighted average share price | $ / shares | $ 25 | |
Earnout Shares | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 0 | |
Other non-current earn out liability | $ | $ 68 | $ 68 |
Earnout RSUs | ||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Number of shares issued | 0 |
Warrant Liabilities - Additiona
Warrant Liabilities - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Jul. 29, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Common Class A | |||
Class Of Warrant Or Right [Line Items] | |||
Warrants exercised | 614,478 | ||
Private Placement Warrants | |||
Class Of Warrant Or Right [Line Items] | |||
Warrant to purchase of common stock shares issued | 7,000,000 | ||
Warrants outstanding | 7,000,000 | 7,000,000 | |
Warrants exercised | 0 | 0 | |
Exercise price | $ 0.31 | $ 1.23 | |
Warrant liability aggregate fair value | $ 4,761 | $ 18,892 | |
New Fiscal Note | |||
Class Of Warrant Or Right [Line Items] | |||
Exercise price | $ 1.571428 | ||
New Fiscal Note | Common Class A | |||
Class Of Warrant Or Right [Line Items] | |||
Warrants exercised | 433,259 | ||
New Fiscal Note | Common Class A | Maximum | |||
Class Of Warrant Or Right [Line Items] | |||
Warrants outstanding | 24,750,000 | ||
Public Warrants | |||
Class Of Warrant Or Right [Line Items] | |||
Warrant to purchase of common stock shares issued | 8,750,000 | ||
Warrants outstanding | 8,358,964 | 8,358,964 | |
Warrants exercised | 0 | 391,036 | |
Shares registered holders acquire from class A common stock | 1.571428 | ||
Warrants expiration date | Jul. 29, 2027 | ||
Public Warrants | Class A Common Stock Equals or Exceeds $11.45 per Share | |||
Class Of Warrant Or Right [Line Items] | |||
Class of warrants, redemption price per unit | $ 0.01 | ||
Class of warrants, redemption notice period | 30 days | ||
Stock price | $ 11.45 | ||
Number of consecutive trading days for determining share price | 20 days | ||
Number of trading days for determining share price | 30 days | ||
Public Warrants | Class A Common Stock Equals or Exceeds $6.36 per Share | |||
Class Of Warrant Or Right [Line Items] | |||
Class of warrants, redemption price per unit | $ 0.1 | ||
Class of warrants, redemption notice period | 30 days | ||
Stock price | $ 6.36 | ||
Number of consecutive trading days for determining share price | 10 days | ||
Warrants exercisable redemption feature | In no event will the warrants be exercisable in connection with this redemption feature for more than 0.567 shares of Class A common stock per warrant (subject to adjustment). | ||
Public Warrants | Common Class A | |||
Class Of Warrant Or Right [Line Items] | |||
Exercise price | $ 7.32 | ||
Old FiscalNote Warrants | |||
Class Of Warrant Or Right [Line Items] | |||
Warrants outstanding | 118,700 | ||
Warrants exercised | 365,002 | ||
Exercise price | $ 8.56 | ||
Warrant liability aggregate fair value | $ 22 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Jul. 27, 2022 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock-based compensation | $ 27,057 | $ 38,047 | ||
2022 Long-Term Incentive Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Percentage of shares issued from outstanding number of shares | 3% | |||
Increase in share reserve | 13,523,734 | |||
Stock-based compensation | $ 24,165 | 36,449 | ||
Stock based compensation expense related to acquisition earnouts | $ 675 | $ 603 | ||
2022 Long-Term Incentive Plan | Common Class A | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Common stock, shares reserved for issuance | 7,916,823 | 20,285,600 | ||
2022 Long-Term Incentive Plan | Performance Stock Options | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 25,000 | 2,673,751 | ||
Stock remaining outstanding | 28,313 | |||
2022 Long-Term Incentive Plan | Performance Stock Units | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 756,812 | |||
Stock remaining outstanding | 2,526,649 | |||
Unrecognized compensation expense | $ 3,803 | |||
Unrecognized compensation expense recognition period | 2 years | |||
2022 Long-Term Incentive Plan | Performance Stock Options and Stock Units | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 476,902 | 2,121,495 | ||
Aggregate grant date fair value awards issues | $ 7,295 | |||
Stock remaining outstanding | 9,269,598 | 9,742,531 | 8,695,002 | |
Stock-based compensation | $ 965 | $ 4,994 | ||
2022 Long-Term Incentive Plan | Restricted Stock Units | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 6,531,510 | |||
Stock remaining outstanding | 6,369,107 | |||
Unrecognized compensation expense | $ 23,087 | |||
Unrecognized compensation expense recognition period | 2 years | |||
2022 Long-Term Incentive Plan | Performance Based Restricted Stock Units | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 75,000 | |||
Stock remaining outstanding | 75,000 | |||
2022 Long-Term Incentive Plan | Stock Options | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Stock issued | 451,902 | |||
Stock options outstanding | 9,241,285 | |||
2022 Employee Stock Purchase Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of shares issued | 102,807 | |||
Stock-based compensation | $ 414 | |||
Common stock fair market value | 85% | |||
2022 Employee Stock Purchase Plan | Maximum | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Employee payroll deductions | 15% | |||
2022 Employee Stock Purchase Plan | Common Class A | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Common stock, shares reserved for issuance | 4,396,208 | |||
2013 Equity Incentive Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Increase in share reserve | 0 | |||
2013 Equity Incentive Plan | Employees, Directors and Consultants | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of shares issued | 12,294,973 |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summarizes Activities Related to Stock Options and Performance Stock Units (Details) - Performance Stock Options and Stock Units - 2022 Long-Term Incentive Plan - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares, Beginning balance | 9,742,531 | 8,695,002 | |
Number of shares, Granted | 476,902 | 2,121,495 | |
Number of shares, Exercised | (327,447) | (223,323) | |
Number of shares, Cancelled and forfeited | (432,441) | (850,643) | |
Number of shares, Expired | (189,947) | ||
Number of shares, Ending balance | 9,269,598 | 9,742,531 | 8,695,002 |
Number of shares, Vested and exercisable | 5,425,239 | 4,729,547 | |
Number of shares, Vested and expected to vest | 3,844,359 | 9,742,531 | |
Weighted-average exercise price, Beginning balance | $ 3.82 | $ 3.28 | |
Weighted-average Grant price, Granted | 3.98 | 6.27 | |
Weighted-average Grant price, Exercised | 1.81 | 1.07 | |
Weighted-average Grant price, Forfeited | 6.55 | 3.34 | |
Weighted-average Grant price, Expired | 3.71 | ||
Weighted-average exercise price, Ending balance | 3.74 | 3.82 | $ 3.28 |
Weighted-average exercise price, Vested and exercisable | $ 3.11 | $ 2.51 | |
Weighted-average remaining contractual life (years) | 6 years 1 month 6 days | 7 years 6 months | 7 years 3 months 18 days |
Vested and Expected to vest, Weighted-average remaining contractual life (years) | 5 years 1 month 6 days | 6 years 6 months | |
Aggregate intrinsic value | $ 0 | $ 24,659 | $ 52,941 |
Aggregate intrinsic value, Vested and exercisable | $ 18,197 |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted (Details) - Performance Stock Units - 2022 Long-Term Incentive Plan - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Expected volatility | 45% | 30.09% |
Expected life (years) | 6 years | 5 years 11 months 12 days |
Expected dividend yield | 0% | 0% |
Risk-free interest rate | 4.18% | 2.84% |
Fair value of options | $ 1.58 | $ 4.39 |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summarizes Restricted Stock Unit Activity (Details) - Restricted Stock Unit Activity - 2022 Long-Term Incentive Plan - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of shares, Beginning balance | 2,949,731 | 773,063 | |
Number of shares, Granted | 6,606,510 | 3,767,746 | |
Number of shares, Vested | (2,532,946) | (1,380,892) | |
Number of shares, Cancelled and forfeited | (579,188) | (210,186) | |
Number of shares, Ending balance | 6,444,107 | 2,949,731 | 773,063 |
Number of shares, Expected to vest | 6,444,107 | 2,949,731 | |
Weighted-average exercise price, Beginning balance | $ 8.81 | $ 6.26 | |
Weighted-average Grant price, Granted | 4.42 | 9.11 | |
Weighted-average Grant price, Vested | 7.08 | 8.27 | |
Weighted-average Grant price, Forfeited | 3.46 | 8.38 | |
Weighted-average exercise price, Ending balance | $ 5.38 | $ 8.81 | $ 6.26 |
Weighted-average remaining contractual life (years) | 1 year | 2 years 8 months 12 days | 7 years 6 months |
Aggregate intrinsic value | $ 7,346 | $ 18,672 | $ 6,943 |
Transaction Costs, net - Summar
Transaction Costs, net - Summary of Transaction Costs Related to Businesses Acquired and Consummation of Business Combination (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | ||
Transaction Costs Gains [Line Items] | |||
Transaction costs related to acquired businesses | $ 1,391 | $ 1,181 | |
Non-capitalizable Business Combination costs | 415 | 2,993 | |
Change in contingent consideration liabilities | (2,043) | (2,121) | |
Contingent compensation (benefit) expense | (530) | 342 | |
Total transaction costs | [1] | $ (767) | $ 2,395 |
[1] (1) Amounts include stock-based compensation expenses, as follows: Years Ended December 31, 2023 2022 Cost of revenues $ 283 $ 81 Research and development 1,384 1,007 Sales and marketing 2,057 762 Editorial 400 603 General and administrative 22,933 35,594 |
Earnings (Loss) Per Share - Add
Earnings (Loss) Per Share - Additional Information (Details) | 12 Months Ended |
Dec. 31, 2023 | |
Common Class A | |
Earnings Per Share Basic [Line Items] | |
Common stock, number of vote per share | one vote |
Common Class B | |
Earnings Per Share Basic [Line Items] | |
Common stock, number of vote per share | twenty-five votes |
Earnings (Loss) Per Share - Com
Earnings (Loss) Per Share - Components of Basic and Diluted Earnings (Loss) Per Shares (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Numerator: | ||
Net loss | $ (115,461) | $ (218,257) |
Deemed dividend - change in redemption value of preferred stock of Old FiscalNote | (26,570) | |
Net loss used to compute basic loss per share | (115,461) | (244,827) |
Net loss used to compute diluted loss per share | $ (115,461) | $ (244,827) |
Denominator: | ||
Weighted average common stock outstanding, basic | 131,400,109 | 66,513,704 |
Weighted average common stock outstanding, diluted | 131,400,109 | 66,513,704 |
Net loss per shares, basic | $ (0.88) | $ (3.68) |
Net loss per shares, diluted | $ (0.88) | $ (3.68) |
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 35,029,935 | 30,534,627 |
Anti-dilutive Earnout Awards | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 19,195,100 | 19,195,100 |
Anti-dilutive Stock Options | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 979,901 | 4,844,643 |
Anti-dilutive Convertible Notes | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 2,305,666 | 2,004,928 |
Anti-dilutive Contingently Issuable Shares | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 174,468 | 1,423,339 |
Anti-dilutive Restricted Stock Units | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 6,393,154 | 2,949,731 |
Anti-dilutive New GPO Note | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 5,867,750 | |
Anti-dilutive Aicel Convertible Notes | ||
Anti-dilutive securities excluded from diluted loss per share: | ||
Total anti-dilutive securities excluded from diluted loss per share: | 113,896 | 116,886 |
Provision (Benefit) from Inco_3
Provision (Benefit) from Income Taxes - Schedule of (Benefit) Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Current taxes | ||
Federal provision | $ 80 | $ 7 |
State provision (benefit) | 55 | (75) |
Foreign provision (benefit) | 16 | (110) |
Total current provision (benefit) | 151 | (178) |
Deferred taxes | ||
Federal benefit | (9,882) | (32,725) |
State benefit | (2,690) | (12,632) |
Foreign benefit | (3,415) | (2,949) |
Valuation allowance | 16,059 | 45,230 |
Total deferred provision (benefit) | 72 | (3,076) |
Total provision (benefit) from income taxes | $ 223 | $ (3,254) |
Provision (Benefit) from Inco_4
Provision (Benefit) from Income Taxes - Schedule of Reconciliation Between U.S. Federal Statutory Income Tax Rate to Estimated Annual Effective Tax (Details) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||
U.S. Federal provision at statutory rate | 21% | 21% |
State income taxes, net of federal benefit | (0.10%) | 0.50% |
Effects of rate other than statutory | (0.50%) | (0.20%) |
AHYDO interest disallowance | (0.20%) | (0.50%) |
Warrant revaluation | 2.60% | 1.50% |
Stock compensation | (2.40%) | 0% |
Impairment from goodwill and other long-lived assets | (4.70%) | 0% |
Nondeductible expenses from recapitalization | (2.90%) | (4.40%) |
Change in valuation allowance | (12.20%) | (16.50%) |
Others | (0.80%) | 0.10% |
Effective tax rate | 0.20% | 1.50% |
Provision (Benefit) from Inco_5
Provision (Benefit) from Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating Loss Carryforwards [Line Items] | |||
Benefit from income taxes | $ 223 | $ (3,254) | |
Pretax loss | $ (115,238) | $ (221,511) | |
Effective tax rates (as a percent) | 0.20% | 1.50% | |
U.S. statutory rate | 21% | 21% | |
Uncertain tax position totaling | $ 639 | ||
Derecognized deferred tax liabilities | $ 89 | ||
Net operating loss carryforwards | 150,662 | ||
Increase in valuation allowance | 16,028 | 40,605 | |
Valuation allowance | 87,542 | 71,514 | |
Capitalization of research and development expense | 180 | 719 | |
Unrecognized tax benefits | 639 | 639 | $ 728 |
Interest on uncertain tax benefits | 80 | 72 | |
Penalties on uncertain tax benefits | 0 | 96 | |
2014 Ownership Change | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards | 1,271 | ||
Conversion of Convertible Notes in Exchange for Shares Upon Closing of the Business Combination | |||
Operating Loss Carryforwards [Line Items] | |||
Valuation allowance | 4,823 | ||
Research and Development Credit Carry Forwards | |||
Operating Loss Carryforwards [Line Items] | |||
Uncertain tax position totaling | 0 | $ 0 | |
Capital Loss Carryforwards | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards | $ 48,602 | ||
Federal | Research and Development Credit Carry Forwards | |||
Operating Loss Carryforwards [Line Items] | |||
Operating loss carryforwards term | 5 years | ||
Federal | U.S. | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards | $ 150,662 | ||
Net operating loss carryforwards, subject to expiration | $ 43,109 | ||
Federal | Minimum | U.S. | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards expiration year | 2033 | ||
Federal | Maximum | U.S. | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards expiration year | 2037 | ||
State | U.S. | |||
Operating Loss Carryforwards [Line Items] | |||
Net operating loss carryforwards | $ 142,064 | ||
Net operating loss carryforwards expiration year | 2029 | ||
Foreign | Research and Development Credit Carry Forwards | |||
Operating Loss Carryforwards [Line Items] | |||
Operating loss carryforwards term | 15 years |
Provision (Benefit) from Inco_6
Provision (Benefit) from Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Deferred tax assets | ||
Stock compensation | $ 7,341 | $ 6,389 |
Section 163(j) interest limitation | 33,161 | 27,686 |
Disallowed original issue discount interest | 1,527 | 1,092 |
Deferred rent | 104 | |
Deferred revenue | 7,143 | 6,378 |
Reserves and accruals | 878 | 3,855 |
Capitalized research and development | 8,541 | 5,197 |
Lease liability | 7,375 | 9,110 |
Federal net operating loss carryforward | 31,682 | 30,966 |
State net operating loss carryforward | 8,559 | 8,202 |
Foreign net operating loss carryforward | 7,876 | 4,563 |
Other deferred tax assets | 898 | 782 |
Total deferred tax assets | 114,981 | 104,324 |
Deferred tax liabilities | ||
Basis difference in fixed assets | (1,505) | (1,772) |
Basis difference in intangibles assets and goodwill | (20,931) | (23,584) |
Right of use asset | (4,362) | (5,158) |
Other deferred tax liabilities | (2,819) | (3,010) |
Total deferred tax liabilities | (29,617) | (33,524) |
Valuation allowance | (87,542) | (71,514) |
Net deferred tax liabilities | $ (2,178) | $ (714) |
Provision (Benefit) from Inco_7
Provision (Benefit) from Income Taxes - Summary of Activities Relating to Unrecognized Tax Benefits (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Income Tax Disclosure [Abstract] | |
Beginning balances | $ 728 |
Lapses in statutes of limitations | (89) |
Ending balances | $ 639 |
Fair Value Measurements and D_3
Fair Value Measurements and Disclosures - Schedule of Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Short Term Investments | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Assets | $ 7,134 | |
Fair Value, Recurring Basis | Cash Equivalents | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Assets | 3,044 | |
Fair Value, Recurring Basis | Short Term Investments | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Assets | 7,134 | |
Fair Value, Recurring Basis | Public Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 2,591 | $ 10,282 |
Fair Value, Recurring Basis | Private Placement Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 2,170 | 8,610 |
Fair Value, Recurring Basis | Contingent Liabilities from Acquisitions | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 130 | 1,579 |
Fair Value, Recurring Basis | Liability Classified Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 23 | 182 |
Fair Value, Recurring Basis | New GPO Note | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 36,954 | |
Fair Value, Recurring Basis | Dragonfly Seller Convertible Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 9,002 | |
Fair Value, Recurring Basis | Era Convertivle Note | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 5,977 | |
Fair Value, Recurring Basis | Level 1 | Cash Equivalents | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Assets | 3,044 | |
Fair Value, Recurring Basis | Level 1 | Public Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 2,591 | 10,282 |
Fair Value, Recurring Basis | Level 2 | Short Term Investments | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Assets | 7,134 | |
Fair Value, Recurring Basis | Level 2 | Private Placement Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 2,170 | 8,610 |
Fair Value, Recurring Basis | Level 3 | Contingent Liabilities from Acquisitions | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 130 | 1,579 |
Fair Value, Recurring Basis | Level 3 | Liability Classified Warrants | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 23 | $ 182 |
Fair Value, Recurring Basis | Level 3 | New GPO Note | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 36,954 | |
Fair Value, Recurring Basis | Level 3 | Dragonfly Seller Convertible Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | 9,002 | |
Fair Value, Recurring Basis | Level 3 | Era Convertivle Note | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Liabilities | $ 5,977 |
Fair Value Measurements and D_4
Fair Value Measurements and Disclosures - Summary of Changes in Fair Value of Level 3 Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Change In Fair Value Of Financial Instruments | Change In Fair Value Of Financial Instruments |
Level 3 | Contingent Liabilities from Acquisitions | ||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Beginning balance | $ 1,579 | $ 5,104 |
Contingent considerations and compensation at acquisition date | 1,445 | 400 |
Contingent compensation recognized | 337 | 1,273 |
Change in fair value included in the determination of net loss | (357) | (2,121) |
Earned contingent consideration settled | (281) | (531) |
Cash contingent compensation earned and subsequently settled | (39) | (1,567) |
Unearned contingent compensation reversal | (1,687) | (979) |
Unearned contingent consideration reversal | (867) | |
Ending balance | 130 | 1,579 |
Level 3 | Liability Classified Warrants | ||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Beginning balance | 182 | 1,021 |
Liability classified warrants at issuance date | 436 | |
Change in fair value included in the determination of net loss | (159) | (115) |
Extinguishment and/or settlement upon conversion | (1,160) | |
Ending balance | $ 23 | 182 |
Level 3 | Embedded Redemption Features on Convertible Notes | ||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Beginning balance | 4,228 | |
Change in fair value included in the determination of net loss | (2,097) | |
Extinguishment and/or settlement upon conversion | (2,131) | |
Level 3 | Embedded Redemption Features on Promissory Note | ||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Beginning balance | 28,058 | |
Change in fair value included in the determination of net loss | 3,923 | |
Extinguishment and/or settlement upon conversion | (31,981) | |
Level 3 | Embedded Redemption Features on 8090 FV Note | ||
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Beginning balance | 2,400 | |
Change in fair value included in the determination of net loss | 1,264 | |
Extinguishment and/or settlement upon conversion | $ (3,664) |
Fair Value Measurements and D_5
Fair Value Measurements and Disclosures - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||||||
Dec. 31, 2023 | Mar. 31, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 08, 2023 | Jun. 30, 2023 | Jan. 27, 2023 | Jul. 29, 2022 | |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Earned cash contingent compensation related to frontier view and forge transferred from level 3 to level 1 | $ 1,267,000 | |||||||
Earned cash contingent compensation other transfer of assets and liabilities between levels | 0 | $ 0 | ||||||
Short Term Investments | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Assets | $ 7,134,000 | 7,134,000 | ||||||
Non-cash gain (loss) of convertible note | (98,000) | |||||||
Curate | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Number of shares issued for settlement of contingent consideration | 83,393 | 83,393 | ||||||
New GPO Note | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Non-cash gain (loss) of convertible note | 1,411,000 | |||||||
Estimated fair value | $ 36,954,000 | 36,954,000 | $ 36,583,000 | |||||
Fair value of Convertible note recognized as liability | $ 36,583,000 | |||||||
Dragonfly Seller Convertible Notes | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Business combination, liability recognized | $ 8,635,000 | |||||||
Non-cash gain (loss) of convertible note | 673,000 | |||||||
Estimated fair value of convertible note | 9,002,000 | 9,002,000 | ||||||
Difference between aggregate fair value and unpaid principal balance | 367,000 | 367,000 | ||||||
Era Convertible Note | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Business combination, liability recognized | 5,977,000 | 5,977,000 | $ 5,500,000 | |||||
Non-cash gain (loss) of convertible note | (477,000) | |||||||
Public Warrants | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Business combination, liability recognized | $ 5,688,000 | |||||||
Estimated fair value of warrants | 2,591,000 | 2,591,000 | 10,282,000 | |||||
Non-cash gain (loss) in fair value of financial instruments | 7,691,000 | (4,594,000) | ||||||
Private Placement Warrants | ||||||||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||||||||
Business combination, liability recognized | $ 29,259,000 | |||||||
Estimated fair value of warrants | $ 2,170,000 | 2,170,000 | 8,610,000 | |||||
Non-cash gain (loss) in fair value of financial instruments | $ 6,440,000 | $ 20,649,000 |
Fair Value Measurements and D_6
Fair Value Measurements and Disclosures - Summary of Inputs and Assumptions (Convertible Notes) (Details) | Dec. 31, 2023 USD ($) | Dec. 31, 2023 | Dec. 31, 2023 yr | Dec. 08, 2023 USD ($) | Dec. 08, 2023 | Dec. 08, 2023 yr | Jun. 30, 2023 yr USD ($) | Jan. 27, 2023 yr USD ($) |
New GPO Note | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | $ | 1.14 | 3.64 | ||||||
Common Stock Share Price | Dragonfly Seller Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | $ | 1.14 | 5.06 | ||||||
Common Stock Share Price | Era Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 1.14 | 4.17 | 1.33 | 4.63 | ||||
Risk Free Rate | Dragonfly Seller Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 0.0392 | 0.036 | ||||||
Risk Free Rate | New GPO Note | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 3.88 | 4.1 | ||||||
Yield | Dragonfly Seller Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 0.155 | 0.175 | ||||||
Yield | New GPO Note | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 14.5 | 15.5 | ||||||
Yield | Era Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 153.24 | 163.43 | ||||||
Expected Volatility | Dragonfly Seller Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 0.50 | 0.40 | ||||||
Expected Volatility | New GPO Note | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 50 | 39 | ||||||
Expected Volatility | Era Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 63 | 61 | ||||||
Expected term (Years) | Dragonfly Seller Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 4.1 | 5 | ||||||
Expected term (Years) | New GPO Note | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 4.5 | 5 | ||||||
Expected term (Years) | Era Convertible Notes | ||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||
Convertible notes measurement input | 3.9 | 4 |
Fair Value Measurements and D_7
Fair Value Measurements and Disclosures - Summary of Contingent Consideration and Compensation Related to Acquisitions (Details) - Level 3 - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Business Acquisition, Contingent Consideration [Line Items] | ||
Total contingent liabilities from acquisitions | $ 130 | $ 1,579 |
Curate | ||
Business Acquisition, Contingent Consideration [Line Items] | ||
Total contingent liabilities from acquisitions | 4 | 883 |
FrontierView | ||
Business Acquisition, Contingent Consideration [Line Items] | ||
Total contingent liabilities from acquisitions | 600 | |
Equilibrium | ||
Business Acquisition, Contingent Consideration [Line Items] | ||
Total contingent liabilities from acquisitions | 112 | 43 |
DT Global | ||
Business Acquisition, Contingent Consideration [Line Items] | ||
Total contingent liabilities from acquisitions | $ 14 | $ 53 |
Fair Value Measurements and D_8
Fair Value Measurements and Disclosures - Summary of Inputs and Assumptions (Contingent Liabilities) (Details) - Curate | Dec. 31, 2023 yr |
Risk Premium | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Measurement input | 0.11 |
Risk Free Rate | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Measurement input | 0.054 |
Revenue Volatility | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Measurement input | 0.20 |
Expected Life (Years) | |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | |
Measurement input | 0.3 |
Fair Value Measurements and D_9
Fair Value Measurements and Disclosures - Summary of Inputs and Assumptions (Warrants) (Details) | Dec. 31, 2023 yr | Jul. 29, 2022 USD ($) yr |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair value | $ | $ 2,660 | |
Last Out Lender Warrants | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 8.56 | |
Share Price | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | $ | 8.43 | |
Share Price | Last Out Lender Warrants | Common Stock | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 1.14 | |
Risk-free Interest Rate | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 0.027 | |
Risk-free Interest Rate | Last Out Lender Warrants | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 4.45 | |
Expected Volatility | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 0.40 | |
Expected Volatility | Last Out Lender Warrants | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 122 | |
Expected Dividends | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | 0 | |
Expected term (Years) | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | yr | 5 | |
Time to Maturity | Last Out Lender Warrants | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Warrants measurement input | yr | 1.6 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Jun. 27, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | |
Loss Contingencies [Line Items] | |||
Repayment of long term debt | $ 107 | $ 189,105 | |
Class A Common Stock | |||
Loss Contingencies [Line Items] | |||
Shares returned on legal settlement | 5,881,723 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) - USD ($) | 12 Months Ended | |
Mar. 11, 2024 | Dec. 31, 2023 | |
Senior Term Loan | ||
Subsequent Event [Line Items] | ||
Maturity date | Jul. 29, 2027 | |
Subsequent Event | Senior Term Loan | ||
Subsequent Event [Line Items] | ||
Pay down amount | $ 65,700,000 | |
Payment of related prepayment and exit fees | $ 7,100,000 | |
Earn out payment proceeds percentage | 70% | |
Prepayment fee and exit fee percentage | 5.75% | |
Maturity date | Jul. 15, 2027 | |
Subsequent Event | Equity Purchase Agreement | Exec Connect Intermediate LLC | ||
Subsequent Event [Line Items] | ||
Perecntage of equity sold | 100% | |
Consideration received on sale of equity | $ 95,000,000 | |
Base purchase price deposited into escrow | 800,000 | |
Subsequent Event | Equity Purchase Agreement | Exec Connect Intermediate LLC | Minimum | ||
Subsequent Event [Line Items] | ||
Cash earn- out payment | 5,000,000 | |
Subsequent Event | Equity Purchase Agreement | Exec Connect Intermediate LLC | Maximum | ||
Subsequent Event [Line Items] | ||
Cash earn- out payment | $ 8,000 |